>GZ630897.1 Sequence 381 from patent US 8288322
CCTCNNNNNNN
>GZ630889.1 Sequence 373 from patent US 8288322
CCCGCNNNNNN
>GZ630883.1 Sequence 367 from patent US 8288322
GCATCNNNNNN
>GZ630881.1 Sequence 365 from patent US 8288322
ACTGGGNNNNN
>GZ630865.1 Sequence 349 from patent US 8288322
ACCTGCNNNNN
>GZ630864.1 Sequence 348 from patent US 8288322
GCNNNNNNNGC
>GZ630863.1 Sequence 347 from patent US 8288322
GAGTCNNNNNN
>GZ630862.1 Sequence 346 from patent US 8288322
NNNNNNGACTC
>GZ630605.1 Sequence 88 from patent US 8288322
NNNNNNGAGAC
>GZ630604.1 Sequence 87 from patent US 8288322
GAGTCNNNNNN
>GZ630602.1 Sequence 85 from patent US 8288322
GCNNNNNNNGC
>GZ630531.1 Sequence 14 from patent US 8288322
NNNNNNGAGAC
>GZ626353.1 Sequence 3 from patent US 8287878
TATGAAAAAAA
>GZ625579.1 Sequence 49 from patent US 8287859
CCGCCACCATG
>HV955955.1 JP 2012519001-A/1: Hyper-IgE Animal Model With Enhanced Immunoglobulin Heavy Chain Class Switching to C-epsilon
GGGCTGGGCTG
>HV950736.1 JP 2012517226-A/31: Synthetic RNA-Based Agonists of TLR7
AATTGAAGCTG
>HV950735.1 JP 2012517226-A/30: Synthetic RNA-Based Agonists of TLR7
AATTGAAGCTT
>HV950734.1 JP 2012517226-A/29: Synthetic RNA-Based Agonists of TLR7
AACTGAAGCTG
>HV950733.1 JP 2012517226-A/28: Synthetic RNA-Based Agonists of TLR7
AACTGAAGCTT
>HV950732.1 JP 2012517226-A/27: Synthetic RNA-Based Agonists of TLR7
TGATGAAGCTT
>HV950731.1 JP 2012517226-A/26: Synthetic RNA-Based Agonists of TLR7
AACTGACGCTG
>HV950730.1 JP 2012517226-A/25: Synthetic RNA-Based Agonists of TLR7
AACTGACGCTT
>HV950729.1 JP 2012517226-A/24: Synthetic RNA-Based Agonists of TLR7
AACTGCGACTT
>HV950728.1 JP 2012517226-A/23: Synthetic RNA-Based Agonists of TLR7
AACTTGAGCTT
>HV950727.1 JP 2012517226-A/22: Synthetic RNA-Based Agonists of TLR7
AAGTGACGATT
>HV950726.1 JP 2012517226-A/21: Synthetic RNA-Based Agonists of TLR7
AAGTGACGCTT
>HV950725.1 JP 2012517226-A/20: Synthetic RNA-Based Agonists of TLR7
AAGTGCGACTT
>HV950724.1 JP 2012517226-A/19: Synthetic RNA-Based Agonists of TLR7
AATTGACGCTG
>HV950723.1 JP 2012517226-A/18: Synthetic RNA-Based Agonists of TLR7
AATTGACGCTT
>HV950722.1 JP 2012517226-A/17: Synthetic RNA-Based Agonists of TLR7
ACGCTGAGCTT
>HV950721.1 JP 2012517226-A/16: Synthetic RNA-Based Agonists of TLR7
ACGTGAAGCTT
>HV950720.1 JP 2012517226-A/15: Synthetic RNA-Based Agonists of TLR7
ACTGAGAGCTT
>HV950719.1 JP 2012517226-A/14: Synthetic RNA-Based Agonists of TLR7
ACTGCGAGCTT
>HV950718.1 JP 2012517226-A/13: Synthetic RNA-Based Agonists of TLR7
ACTTGAAACCT
>HV950717.1 JP 2012517226-A/12: Synthetic RNA-Based Agonists of TLR7
ACTTGAACTTG
>HV950716.1 JP 2012517226-A/11: Synthetic RNA-Based Agonists of TLR7
ACTTGAAGCTT
>HV950715.1 JP 2012517226-A/10: Synthetic RNA-Based Agonists of TLR7
ACTTGACCTGT
>HV950714.1 JP 2012517226-A/9: Synthetic RNA-Based Agonists of TLR7
ACTTGACCTTT
>HV950713.1 JP 2012517226-A/8: Synthetic RNA-Based Agonists of TLR7
ACTTGACGATT
>HV950712.1 JP 2012517226-A/7: Synthetic RNA-Based Agonists of TLR7
ACTTGACTTGA
>HV950711.1 JP 2012517226-A/6: Synthetic RNA-Based Agonists of TLR7
CTGACGAGCTT
>HV950710.1 JP 2012517226-A/5: Synthetic RNA-Based Agonists of TLR7
CTGAGAAGCTT
>HV950709.1 JP 2012517226-A/4: Synthetic RNA-Based Agonists of TLR7
CTTGTGAGCTT
>HV950708.1 JP 2012517226-A/3: Synthetic RNA-Based Agonists of TLR7
TGACGATGATT
>HV950707.1 JP 2012517226-A/2: Synthetic RNA-Based Agonists of TLR7
TGATGACGATT
>HV950706.1 JP 2012517226-A/1: Synthetic RNA-Based Agonists of TLR7
TTGCTGAGCTT
>HV949963.1 WO 2012118092-A/15: Fusion protein
AGGAACAAAGC
>HV957560.1 JP 2012518419-A/16: METABOLIC ENGINEERING OF A GALACTOSE ASSIMILATION PATHWAY IN THE GLYCOENGINEERED YEAST PICHIA PASTORIS
AACTTAATTAA
>HV957559.1 JP 2012518419-A/15: METABOLIC ENGINEERING OF A GALACTOSE ASSIMILATION PATHWAY IN THE GLYCOENGINEERED YEAST PICHIA PASTORIS
TTAGCGGCCGC
>GZ625243.1 Sequence 13 from patent US 8329982
ACACTGCTTAC
>GZ605738.1 Sequence 32 from patent US 8323930
GTGTCGCCCTT
>GZ605737.1 Sequence 31 from patent US 8323930
AAGGGCGACAC
>GZ605735.1 Sequence 29 from patent US 8323930
GTGTCGCCCTT
>GZ599995.1 Sequence 63 from patent US 8318679
AGCTTGAATTC
>GZ599993.1 Sequence 61 from patent US 8318679
GGGATCGTGTA
>GZ599991.1 Sequence 59 from patent US 8318679
GGGATCGTGTA
>GZ599989.1 Sequence 57 from patent US 8318679
CAGACGGTCTA
>GZ599987.1 Sequence 55 from patent US 8318679
AGCTTGAATTC
>GZ599984.1 Sequence 51 from patent US 8318679
AGCTTGAATTC
>GZ599980.1 Sequence 46 from patent US 8318679
AGCTTGAATTC
>GZ599864.1 Sequence 20 from patent US 8318493
GAATAGGAACT
>GZ599863.1 Sequence 19 from patent US 8318493
AGTTCCTATAC
>GZ598511.1 Sequence 2 from patent US 8318433
NNAGAAGCGGG
>GZ596713.1 Sequence 39 from patent US 8314226
CATCTTTGGTG
>GZ596708.1 Sequence 34 from patent US 8314226
AAACTGTAAGT
>GZ596701.1 Sequence 27 from patent US 8314226
AAACTGTAAGT
>GZ596677.1 Sequence 2 from patent US 8314226
CATCTTTGGTG
>GZ596641.1 Sequence 241 from patent US 8314223
GCGTACCTGAC
>GZ595135.1 Sequence 128 from patent US 8314072
GCGTTCTTCCG
>GZ595134.1 Sequence 127 from patent US 8314072
ATAGTGCTCAT
>GZ595133.1 Sequence 126 from patent US 8314072
TGCTCATACTC
>GZ595132.1 Sequence 125 from patent US 8314072
CTCTCGCAAGG
>GZ595126.1 Sequence 118 from patent US 8314072
TCTCAGATGGT
>GZ595121.1 Sequence 109 from patent US 8314072
CTTCGATAGTG
>GZ595113.1 Sequence 101 from patent US 8314072
TTTGCAACCCC
>GZ595112.1 Sequence 100 from patent US 8314072
AATAGGGTTGG
>GZ595094.1 Sequence 79 from patent US 8314072
GGCATCGTCGC
>GZ595078.1 Sequence 63 from patent US 8314072
ACGTTGAGGGG
>GZ594897.1 Sequence 11 from patent US 8313942
GACNNNNNGTC
>GZ594894.1 Sequence 8 from patent US 8313942
GCCNNNNNGGC
>GZ594893.1 Sequence 7 from patent US 8313942
CCANNNNNTGG
>GZ594363.1 Sequence 16 from patent US 8313901
TGGCTCATTCG
>HV945174.1 JP 2012516352-A/14: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV945173.1 JP 2012516352-A/13: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945172.1 JP 2012516352-A/12: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945171.1 JP 2012516352-A/11: SYNTHETIC AGONISTS OF TLR9
TCGTCGACGAT
>HV945170.1 JP 2012516352-A/10: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945169.1 JP 2012516352-A/9: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945168.1 JP 2012516352-A/8: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945167.1 JP 2012516352-A/7: SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV945166.1 JP 2012516352-A/6: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV945165.1 JP 2012516352-A/5: SYNTHETIC AGONISTS OF TLR9
TCGTCGACGAT
>HV945164.1 JP 2012516352-A/4: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV945163.1 JP 2012516352-A/3: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV945162.1 JP 2012516352-A/2: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV945161.1 JP 2012516352-A/1: SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV942216.1 JP 2012161318-A/2: SYSTEMS AND METHODS FOR PROTEIN PRODUCTION
ATTGGNCCACG
>JA795251.1 Sequence 44 from Patent EP2467484
TATCGGGCAGG
>JA795248.1 Sequence 41 from Patent EP2467484
AACCAATCAGA
>JA795247.1 Sequence 40 from Patent EP2467484
AGTCCTCATTT
>JA793406.1 Sequence 69 from Patent WO2012113413
GGGTTTTTGGG
>JA793396.1 Sequence 58 from Patent WO2012113413
GGTTTTTTTGG
>JA802506.1 Sequence 51 from Patent EP2522745
GAGCTGCCTGC
>JA806867.1 Sequence 40 from Patent EP2468867
GCGGTTTGCGG
>JA806829.1 Sequence 2 from Patent EP2468867
GCGGTTTGCGG
>JA802464.1 Sequence 9 from Patent EP2522745
GAGCTGCCTGC
>JA806767.1 Sequence 40 from Patent EP2468866
GCGGTTTGCGG
>JA806729.1 Sequence 2 from Patent EP2468866
GCGGTTTGCGG
>JA806683.1 Sequence 3 from Patent EP2468303
CNGACNGCANC
>JA808923.1 Sequence 56 from Patent EP2468864
TCTTCGGAGTT
>JA808916.1 Sequence 49 from Patent EP2468864
TCTTCGGAGTT
>JA808910.1 Sequence 43 from Patent EP2468864
GGATCTTATTT
>JA808901.1 Sequence 34 from Patent EP2468864
CTACACAAATC
>JA808894.1 Sequence 27 from Patent EP2468864
CAGCGATTTTT
>JA808889.1 Sequence 22 from Patent EP2468864
GGATCTTATTT
>JA808886.1 Sequence 19 from Patent EP2468864
CGGAGACAATG
>JA808876.1 Sequence 9 from Patent EP2468864
GGATCTTATTT
>JA808873.1 Sequence 6 from Patent EP2468864
GATTTCCATGT
>JA808813.1 Sequence 2 from Patent WO2012085603
GAGAAAGAGAA
>JA808812.1 Sequence 1 from Patent WO2012085603
GAGAAAGAGAA
>JA810018.1 Sequence 1151 from Patent EP2468864
GTACTTGCAGA
>JA810017.1 Sequence 1150 from Patent EP2468864
GTACAAGATCC
>JA810015.1 Sequence 1148 from Patent EP2468864
GCAAGACAAGA
>JA810014.1 Sequence 1147 from Patent EP2468864
CTCTGTACCTC
>JA810005.1 Sequence 1138 from Patent EP2468864
GGAAATGATCC
>JA809987.1 Sequence 1120 from Patent EP2468864
CTTGTAGTGTA
>JA809984.1 Sequence 1117 from Patent EP2468864
TTGCATCGGGC
>JA809978.1 Sequence 1111 from Patent EP2468864
GTGGTGCGAGG
>JA809976.1 Sequence 1109 from Patent EP2468864
AGGTTGTCGAC
>JA809971.1 Sequence 1104 from Patent EP2468864
AGTTCACAGGG
>JA806148.1 Sequence 51 from Patent EP2522733
ATGAACTCCAC
>JA806147.1 Sequence 50 from Patent EP2522733
CTTTTGTTGTT
>JA806144.1 Sequence 47 from Patent EP2522733
CTTCCCATAGA
>JA806143.1 Sequence 46 from Patent EP2522733
AGAGGATTAGT
>JA806140.1 Sequence 43 from Patent EP2522733
AGCGATAGAAG
>JA806135.1 Sequence 38 from Patent EP2522733
ATCAGTGTGAA
>JA806132.1 Sequence 35 from Patent EP2522733
AAGCAATCTAC
>JA806128.1 Sequence 31 from Patent EP2522733
ACTGGGCTGAT
>JA806127.1 Sequence 30 from Patent EP2522733
GGAAATCAAGA
>JA806120.1 Sequence 23 from Patent EP2522733
GTCAACCTTCC
>JA806119.1 Sequence 22 from Patent EP2522733
GGAAGATCATA
>JA806116.1 Sequence 19 from Patent EP2522733
CGTGGAAAGTA
>JA806115.1 Sequence 18 from Patent EP2522733
CTCATCTTGTT
>JA806112.1 Sequence 15 from Patent EP2522733
AATGGTTGGAG
>JA806111.1 Sequence 14 from Patent EP2522733
GCGAGAACACA
>JA808186.1 Sequence 40 from Patent WO2012084996
GCGGTTTGCGG
>JA808148.1 Sequence 2 from Patent WO2012084996
GCGGTTTGCGG
>JA806038.1 Sequence 51 from Patent EP2522732
ATGAACTCCAC
>JA806037.1 Sequence 50 from Patent EP2522732
CTTTTGTTGTT
>JA806034.1 Sequence 47 from Patent EP2522732
CTTCCCATAGA
>JA806033.1 Sequence 46 from Patent EP2522732
AGAGGATTAGT
>JA806030.1 Sequence 43 from Patent EP2522732
AGCGATAGAAG
>JA806025.1 Sequence 38 from Patent EP2522732
ATCAGTGTGAA
>JA806022.1 Sequence 35 from Patent EP2522732
AAGCAATCTAC
>JA806018.1 Sequence 31 from Patent EP2522732
ACTGGGCTGAT
>JA806017.1 Sequence 30 from Patent EP2522732
GGAAATCAAGA
>JA806010.1 Sequence 23 from Patent EP2522732
GTCAACCTTCC
>JA806009.1 Sequence 22 from Patent EP2522732
GGAAGATCATA
>JA806006.1 Sequence 19 from Patent EP2522732
CGTGGAAAGTA
>JA806005.1 Sequence 18 from Patent EP2522732
CTCATCTTGTT
>JA806002.1 Sequence 15 from Patent EP2522732
AATGGTTGGAG
>JA806001.1 Sequence 14 from Patent EP2522732
GCGAGAACACA
>JA805928.1 Sequence 51 from Patent EP2522731
ATGAACTCCAC
>JA805927.1 Sequence 50 from Patent EP2522731
CTTTTGTTGTT
>JA805924.1 Sequence 47 from Patent EP2522731
CTTCCCATAGA
>JA805923.1 Sequence 46 from Patent EP2522731
AGAGGATTAGT
>JA805920.1 Sequence 43 from Patent EP2522731
AGCGATAGAAG
>JA805915.1 Sequence 38 from Patent EP2522731
ATCAGTGTGAA
>JA805912.1 Sequence 35 from Patent EP2522731
AAGCAATCTAC
>JA805908.1 Sequence 31 from Patent EP2522731
ACTGGGCTGAT
>JA805907.1 Sequence 30 from Patent EP2522731
GGAAATCAAGA
>JA805900.1 Sequence 23 from Patent EP2522731
GTCAACCTTCC
>JA805899.1 Sequence 22 from Patent EP2522731
GGAAGATCATA
>JA805896.1 Sequence 19 from Patent EP2522731
CGTGGAAAGTA
>JA805895.1 Sequence 18 from Patent EP2522731
CTCATCTTGTT
>JA805892.1 Sequence 15 from Patent EP2522731
AATGGTTGGAG
>JA805891.1 Sequence 14 from Patent EP2522731
GCGAGAACACA
>JA809954.1 Sequence 1087 from Patent EP2468864
ATGAGGCCGGA
>JA809950.1 Sequence 1083 from Patent EP2468864
TTCCCACTGTA
>JA809944.1 Sequence 1077 from Patent EP2468864
AGAAACCTTCC
>JA809942.1 Sequence 1075 from Patent EP2468864
AAGCCCATACA
>JA809940.1 Sequence 1073 from Patent EP2468864
TTGTAGCACTC
>JA809931.1 Sequence 1064 from Patent EP2468864
CCGGGACTCTC
>JA809928.1 Sequence 1061 from Patent EP2468864
CTGAAAATCAA
>JA809923.1 Sequence 1056 from Patent EP2468864
CTGCTCTTGGG
>JA809917.1 Sequence 1050 from Patent EP2468864
GACTGTGAGCT
>JA809914.1 Sequence 1047 from Patent EP2468864
CTTAAATGGAA
>JA809912.1 Sequence 1045 from Patent EP2468864
GAACTCAGCAG
>JA809911.1 Sequence 1044 from Patent EP2468864
AGAGAGTGTAC
>JA809907.1 Sequence 1040 from Patent EP2468864
CCTGTGACAAA
>JA809904.1 Sequence 1037 from Patent EP2468864
ATTTAAATATG
>JA809900.1 Sequence 1033 from Patent EP2468864
AGTAGTGAGGA
>JA809899.1 Sequence 1032 from Patent EP2468864
GAGGAGACTTG
>JA809896.1 Sequence 1029 from Patent EP2468864
CTATCTCGCCT
>JA809892.1 Sequence 1025 from Patent EP2468864
TGACATCATAT
>JA809887.1 Sequence 1020 from Patent EP2468864
AGTTCTCTTCA
>JA809881.1 Sequence 1014 from Patent EP2468864
ATGCTGTAGAC
>JA809877.1 Sequence 1010 from Patent EP2468864
CACTATTATCA
>JA809875.1 Sequence 1008 from Patent EP2468864
ATGTAGACTGC
>JA809874.1 Sequence 1007 from Patent EP2468864
GAACATGATGG
>JA809872.1 Sequence 1005 from Patent EP2468864
CACATCATCAC
>JA809868.1 Sequence 1001 from Patent EP2468864
GAATTGGTAGA
>JA809856.1 Sequence 989 from Patent EP2468864
AACGCAAGTTG
>JA809855.1 Sequence 988 from Patent EP2468864
TCCTTTATCCT
>JA809853.1 Sequence 986 from Patent EP2468864
ATCTTGCTGAG
>JA809848.1 Sequence 981 from Patent EP2468864
CTGCTACCACT
>JA809844.1 Sequence 977 from Patent EP2468864
TCCTTTTGCTT
>JA809843.1 Sequence 976 from Patent EP2468864
CACACACATAC
>JA809840.1 Sequence 973 from Patent EP2468864
AGTTAGGAGCC
>JA809838.1 Sequence 971 from Patent EP2468864
TTTGAGGCTCA
>JA809834.1 Sequence 967 from Patent EP2468864
ACGCCAGTCAA
>JA809832.1 Sequence 965 from Patent EP2468864
AAGCCCTTCAG
>JA809831.1 Sequence 964 from Patent EP2468864
AAAGCCCTTCA
>JA809830.1 Sequence 963 from Patent EP2468864
CAAAAGCCCTT
>JA809829.1 Sequence 962 from Patent EP2468864
TCAAAAGCCCT
>JA809824.1 Sequence 957 from Patent EP2468864
GAAAAGCTCCG
>JA809823.1 Sequence 956 from Patent EP2468864
CAGCGGCCAGT
>JA809820.1 Sequence 953 from Patent EP2468864
GAAGCCCTTCA
>JA809819.1 Sequence 952 from Patent EP2468864
AAGAAGCCCTT
>JA809817.1 Sequence 950 from Patent EP2468864
CCAGCATGGCC
>JA809795.1 Sequence 928 from Patent EP2468864
GCCTGAAACAC
>JA809791.1 Sequence 924 from Patent EP2468864
TGCCGTTCAGG
>JA809784.1 Sequence 917 from Patent EP2468864
AAGACCACCAC
>JA823938.1 Sequence 1047 from Patent EP2471920
CTTAAATGGAA
>JA823936.1 Sequence 1045 from Patent EP2471920
GAACTCAGCAG
>JA823935.1 Sequence 1044 from Patent EP2471920
AGAGAGTGTAC
>JA823931.1 Sequence 1040 from Patent EP2471920
CCTGTGACAAA
>JA823928.1 Sequence 1037 from Patent EP2471920
ATTTAAATATG
>JA823924.1 Sequence 1033 from Patent EP2471920
AGTAGTGAGGA
>JA823923.1 Sequence 1032 from Patent EP2471920
GAGGAGACTTG
>JA823920.1 Sequence 1029 from Patent EP2471920
CTATCTCGCCT
>JA823916.1 Sequence 1025 from Patent EP2471920
TGACATCATAT
>JA823911.1 Sequence 1020 from Patent EP2471920
AGTTCTCTTCA
>JA823905.1 Sequence 1014 from Patent EP2471920
ATGCTGTAGAC
>JA823901.1 Sequence 1010 from Patent EP2471920
CACTATTATCA
>JA823899.1 Sequence 1008 from Patent EP2471920
ATGTAGACTGC
>JA823898.1 Sequence 1007 from Patent EP2471920
GAACATGATGG
>JA823896.1 Sequence 1005 from Patent EP2471920
CACATCATCAC
>JA823892.1 Sequence 1001 from Patent EP2471920
GAATTGGTAGA
>JA823880.1 Sequence 989 from Patent EP2471920
AACGCAAGTTG
>JA823879.1 Sequence 988 from Patent EP2471920
TCCTTTATCCT
>JA823877.1 Sequence 986 from Patent EP2471920
ATCTTGCTGAG
>JA823872.1 Sequence 981 from Patent EP2471920
CTGCTACCACT
>JA823868.1 Sequence 977 from Patent EP2471920
TCCTTTTGCTT
>JA823867.1 Sequence 976 from Patent EP2471920
CACACACATAC
>JA823864.1 Sequence 973 from Patent EP2471920
AGTTAGGAGCC
>JA823862.1 Sequence 971 from Patent EP2471920
TTTGAGGCTCA
>JA823858.1 Sequence 967 from Patent EP2471920
ACGCCAGTCAA
>JA823856.1 Sequence 965 from Patent EP2471920
AAGCCCTTCAG
>JA823855.1 Sequence 964 from Patent EP2471920
AAAGCCCTTCA
>JA823854.1 Sequence 963 from Patent EP2471920
CAAAAGCCCTT
>JA823853.1 Sequence 962 from Patent EP2471920
TCAAAAGCCCT
>JA823848.1 Sequence 957 from Patent EP2471920
GAAAAGCTCCG
>JA823847.1 Sequence 956 from Patent EP2471920
CAGCGGCCAGT
>JA823844.1 Sequence 953 from Patent EP2471920
GAAGCCCTTCA
>JA823843.1 Sequence 952 from Patent EP2471920
AAGAAGCCCTT
>JA823841.1 Sequence 950 from Patent EP2471920
CCAGCATGGCC
>JA823819.1 Sequence 928 from Patent EP2471920
GCCTGAAACAC
>JA823815.1 Sequence 924 from Patent EP2471920
TGCCGTTCAGG
>JA823808.1 Sequence 917 from Patent EP2471920
AAGACCACCAC
>JA823790.1 Sequence 899 from Patent EP2471920
AGGAAGAGAGG
>JA823789.1 Sequence 898 from Patent EP2471920
GCTGGAGTGGT
>JA818999.1 Sequence 214 from Patent EP2474626
GCCGCCTGAAA
>JA809766.1 Sequence 899 from Patent EP2468864
AGGAAGAGAGG
>JA809765.1 Sequence 898 from Patent EP2468864
GCTGGAGTGGT
>JA809737.1 Sequence 870 from Patent EP2468864
ACTGCATTTGT
>JA809734.1 Sequence 867 from Patent EP2468864
AACATGGGCTG
>JA809725.1 Sequence 858 from Patent EP2468864
AGCCCATACAG
>JA809720.1 Sequence 853 from Patent EP2468864
GGGAAGAGGAC
>JA809719.1 Sequence 852 from Patent EP2468864
AGGTGAGGTTA
>JA809681.1 Sequence 814 from Patent EP2468864
GATGTAGCCGC
>JA809674.1 Sequence 807 from Patent EP2468864
AATCCTCCTGA
>JA809671.1 Sequence 804 from Patent EP2468864
CCAGCCTAGAG
>JA809669.1 Sequence 802 from Patent EP2468864
GCTGCTGAACC
>JA809667.1 Sequence 800 from Patent EP2468864
TTCCTCAAGCA
>JA809666.1 Sequence 799 from Patent EP2468864
AATGGCCCTGA
>JA809661.1 Sequence 794 from Patent EP2468864
ATCAGTTCTGC
>JA809645.1 Sequence 778 from Patent EP2468864
TGCTGACCTCA
>JA809635.1 Sequence 768 from Patent EP2468864
GTTACCTGCGA
>JA809634.1 Sequence 767 from Patent EP2468864
GATGGGTTACC
>JA809622.1 Sequence 755 from Patent EP2468864
TCTACAATTGG
>JA809608.1 Sequence 741 from Patent EP2468864
AAAAGCTCCGG
>JA809605.1 Sequence 738 from Patent EP2468864
CCTTCAGCGGC
>JA809604.1 Sequence 737 from Patent EP2468864
GCCCTTCAGCG
>JA809601.1 Sequence 734 from Patent EP2468864
CTTCTCCCTGA
>JA809599.1 Sequence 732 from Patent EP2468864
AGGAAAGCCCT
>JA809592.1 Sequence 725 from Patent EP2468864
CCTGCGGGTTT
>JA809590.1 Sequence 723 from Patent EP2468864
AGTTCACGGCC
>JA809569.1 Sequence 702 from Patent EP2468864
CTATTCAGTGG
>JA823966.1 Sequence 1075 from Patent EP2471920
AAGCCCATACA
>JA823964.1 Sequence 1073 from Patent EP2471920
TTGTAGCACTC
>JA823955.1 Sequence 1064 from Patent EP2471920
CCGGGACTCTC
>JA823952.1 Sequence 1061 from Patent EP2471920
CTGAAAATCAA
>JA823947.1 Sequence 1056 from Patent EP2471920
CTGCTCTTGGG
>JA823941.1 Sequence 1050 from Patent EP2471920
GACTGTGAGCT
>JA823761.1 Sequence 870 from Patent EP2471920
ACTGCATTTGT
>JA823758.1 Sequence 867 from Patent EP2471920
AACATGGGCTG
>JA823749.1 Sequence 858 from Patent EP2471920
AGCCCATACAG
>JA823744.1 Sequence 853 from Patent EP2471920
GGGAAGAGGAC
>JA823743.1 Sequence 852 from Patent EP2471920
AGGTGAGGTTA
>JA823705.1 Sequence 814 from Patent EP2471920
GATGTAGCCGC
>JA823698.1 Sequence 807 from Patent EP2471920
AATCCTCCTGA
>JA823695.1 Sequence 804 from Patent EP2471920
CCAGCCTAGAG
>JA823693.1 Sequence 802 from Patent EP2471920
GCTGCTGAACC
>JA823691.1 Sequence 800 from Patent EP2471920
TTCCTCAAGCA
>JA823690.1 Sequence 799 from Patent EP2471920
AATGGCCCTGA
>JA823685.1 Sequence 794 from Patent EP2471920
ATCAGTTCTGC
>JA823669.1 Sequence 778 from Patent EP2471920
TGCTGACCTCA
>JA823659.1 Sequence 768 from Patent EP2471920
GTTACCTGCGA
>JA823658.1 Sequence 767 from Patent EP2471920
GATGGGTTACC
>JA823646.1 Sequence 755 from Patent EP2471920
TCTACAATTGG
>JA823632.1 Sequence 741 from Patent EP2471920
AAAAGCTCCGG
>JA823629.1 Sequence 738 from Patent EP2471920
CCTTCAGCGGC
>JA823628.1 Sequence 737 from Patent EP2471920
GCCCTTCAGCG
>JA823625.1 Sequence 734 from Patent EP2471920
CTTCTCCCTGA
>JA823623.1 Sequence 732 from Patent EP2471920
AGGAAAGCCCT
>JA823616.1 Sequence 725 from Patent EP2471920
CCTGCGGGTTT
>JA823614.1 Sequence 723 from Patent EP2471920
AGTTCACGGCC
>JA823593.1 Sequence 702 from Patent EP2471920
CTATTCAGTGG
>JA823592.1 Sequence 701 from Patent EP2471920
ACTATTCAGTG
>JA823590.1 Sequence 699 from Patent EP2471920
ACCCAAGCTTA
>JA823588.1 Sequence 697 from Patent EP2471920
AGGGTCGGAAC
>JA823578.1 Sequence 687 from Patent EP2471920
CCTGTTTGTTC
>JA823558.1 Sequence 667 from Patent EP2471920
AGAGGAAGAGG
>JA823546.1 Sequence 655 from Patent EP2471920
TATCGGCATGC
>JA823522.1 Sequence 631 from Patent EP2471920
TCTCTGAACAG
>JA823518.1 Sequence 627 from Patent EP2471920
TGAATTTCAGG
>JA823506.1 Sequence 615 from Patent EP2471920
CATAAGTTGTG
>JA823494.1 Sequence 603 from Patent EP2471920
CATGCTGCTGG
>JA823478.1 Sequence 587 from Patent EP2471920
TCTGTGAAGTG
>JA823446.1 Sequence 555 from Patent EP2471920
GAGAAAGTTTG
>JA823563.1 Sequence 672 from Patent EP2471920
GAGTGATATGG
>JA823515.1 Sequence 624 from Patent EP2471920
ACTCCCAATAA
>JA823483.1 Sequence 592 from Patent EP2471920
GTGAAACCTCA
>JA823451.1 Sequence 560 from Patent EP2471920
TAGTAGGGAGG
>JA823447.1 Sequence 556 from Patent EP2471920
AAAGAACTACT
>JA823548.1 Sequence 657 from Patent EP2471920
CCAGAATTGCC
>JA823520.1 Sequence 629 from Patent EP2471920
AGGAAAGTGAA
>JA823424.1 Sequence 533 from Patent EP2471920
TTCCAGCCCAC
>JA823400.1 Sequence 509 from Patent EP2471920
AGCAAGGTTTA
>JA823553.1 Sequence 662 from Patent EP2471920
ACAGCTACACC
>JA823549.1 Sequence 658 from Patent EP2471920
TGGTGATCTGG
>JA823537.1 Sequence 646 from Patent EP2471920
CTGAGAAAGCT
>JA823529.1 Sequence 638 from Patent EP2471920
AGAGAGAGAAA
>JA823517.1 Sequence 626 from Patent EP2471920
GTCTTTCTCTA
>JA823513.1 Sequence 622 from Patent EP2471920
CAACCACATGC
>JA823497.1 Sequence 606 from Patent EP2471920
GAATGTGGGTA
>JA823489.1 Sequence 598 from Patent EP2471920
CCAGAGCTGTG
>JA809566.1 Sequence 699 from Patent EP2468864
ACCCAAGCTTA
>JA809554.1 Sequence 687 from Patent EP2468864
CCTGTTTGTTC
>JA809534.1 Sequence 667 from Patent EP2468864
AGAGGAAGAGG
>JA809539.1 Sequence 672 from Patent EP2468864
GAGTGATATGG
>JA809564.1 Sequence 697 from Patent EP2468864
AGGGTCGGAAC
>JA809568.1 Sequence 701 from Patent EP2468864
ACTATTCAGTG
>JA809529.1 Sequence 662 from Patent EP2468864
ACAGCTACACC
>JA809524.1 Sequence 657 from Patent EP2468864
CCAGAATTGCC
>JA809496.1 Sequence 629 from Patent EP2468864
AGGAAAGTGAA
>JA809400.1 Sequence 533 from Patent EP2468864
TTCCAGCCCAC
>JA809376.1 Sequence 509 from Patent EP2468864
AGCAAGGTTTA
>JA809525.1 Sequence 658 from Patent EP2468864
TGGTGATCTGG
>JA809513.1 Sequence 646 from Patent EP2468864
CTGAGAAAGCT
>JA809505.1 Sequence 638 from Patent EP2468864
AGAGAGAGAAA
>JA809493.1 Sequence 626 from Patent EP2468864
GTCTTTCTCTA
>JA809489.1 Sequence 622 from Patent EP2468864
CAACCACATGC
>JA809473.1 Sequence 606 from Patent EP2468864
GAATGTGGGTA
>JA809465.1 Sequence 598 from Patent EP2468864
CCAGAGCTGTG
>JA807951.1 Sequence 2 from Patent WO2012084991
GCGGTTTGCGG
>JA807775.1 Sequence 40 from Patent WO2012084993
GCGGTTTGCGG
>JA809522.1 Sequence 655 from Patent EP2468864
TATCGGCATGC
>JA809498.1 Sequence 631 from Patent EP2468864
TCTCTGAACAG
>JA809494.1 Sequence 627 from Patent EP2468864
TGAATTTCAGG
>JA809482.1 Sequence 615 from Patent EP2468864
CATAAGTTGTG
>JA809470.1 Sequence 603 from Patent EP2468864
CATGCTGCTGG
>JA809454.1 Sequence 587 from Patent EP2468864
TCTGTGAAGTG
>JA809422.1 Sequence 555 from Patent EP2468864
GAGAAAGTTTG
>JA809491.1 Sequence 624 from Patent EP2468864
ACTCCCAATAA
>JA809459.1 Sequence 592 from Patent EP2468864
GTGAAACCTCA
>JA809427.1 Sequence 560 from Patent EP2468864
TAGTAGGGAGG
>JA809423.1 Sequence 556 from Patent EP2468864
AAAGAACTACT
>JA807989.1 Sequence 40 from Patent WO2012084991
GCGGTTTGCGG
>JA822947.1 Sequence 56 from Patent EP2471920
TCTTCGGAGTT
>JA822940.1 Sequence 49 from Patent EP2471920
TCTTCGGAGTT
>JA822934.1 Sequence 43 from Patent EP2471920
GGATCTTATTT
>JA822925.1 Sequence 34 from Patent EP2471920
CTACACAAATC
>JA822918.1 Sequence 27 from Patent EP2471920
CAGCGATTTTT
>JA822913.1 Sequence 22 from Patent EP2471920
GGATCTTATTT
>JA822910.1 Sequence 19 from Patent EP2471920
CGGAGACAATG
>JA822900.1 Sequence 9 from Patent EP2471920
GGATCTTATTT
>JA822897.1 Sequence 6 from Patent EP2471920
GATTTCCATGT
>JA807737.1 Sequence 2 from Patent WO2012084993
GCGGTTTGCGG
>JA807518.1 Sequence 2 from Patent WO2012085282
AAAAACTGGAC
>JA792828.1 Sequence 6 from Patent EP2492343
TCCGGCTCTGC
>JA824042.1 Sequence 1151 from Patent EP2471920
GTACTTGCAGA
>JA824041.1 Sequence 1150 from Patent EP2471920
GTACAAGATCC
>JA824039.1 Sequence 1148 from Patent EP2471920
GCAAGACAAGA
>JA824038.1 Sequence 1147 from Patent EP2471920
CTCTGTACCTC
>JA824029.1 Sequence 1138 from Patent EP2471920
GGAAATGATCC
>JA824011.1 Sequence 1120 from Patent EP2471920
CTTGTAGTGTA
>JA824008.1 Sequence 1117 from Patent EP2471920
TTGCATCGGGC
>JA824002.1 Sequence 1111 from Patent EP2471920
GTGGTGCGAGG
>JA824000.1 Sequence 1109 from Patent EP2471920
AGGTTGTCGAC
>JA823995.1 Sequence 1104 from Patent EP2471920
AGTTCACAGGG
>JA823978.1 Sequence 1087 from Patent EP2471920
ATGAGGCCGGA
>JA823974.1 Sequence 1083 from Patent EP2471920
TTCCCACTGTA
>JA823968.1 Sequence 1077 from Patent EP2471920
AGAAACCTTCC
>JA817605.1 Sequence 87 from Patent EP2468880
ATCTTCCTCGC
>JA817604.1 Sequence 86 from Patent EP2468880
AGCTTCCTGTA
>JA817603.1 Sequence 85 from Patent EP2468880
TTCTTCCTATG
>JA817602.1 Sequence 84 from Patent EP2468880
CCATTCCTAGG
>JA817601.1 Sequence 83 from Patent EP2468880
AACTTCCTGTC
>JA817600.1 Sequence 82 from Patent EP2468880
GCTCTCCTCGG
>JA817599.1 Sequence 81 from Patent EP2468880
GCTCTCCTCCC
>JA817598.1 Sequence 80 from Patent EP2468880
AACCTCCTCTC
>JA817597.1 Sequence 79 from Patent EP2468880
GGTCTCCTAAA
>JA817596.1 Sequence 78 from Patent EP2468880
AGTCTCCTTTC
>JA817595.1 Sequence 77 from Patent EP2468880
ATGCTCCTACA
>JA817594.1 Sequence 76 from Patent EP2468880
TGGCTCCTACC
>JA817593.1 Sequence 75 from Patent EP2468880
ACGCTCCTGCT
>JA817570.1 Sequence 52 from Patent EP2468880
CCTCGAGCGAC
>JA817569.1 Sequence 51 from Patent EP2468880
AATCGAGCTGT
>JA784404.1 Sequence 48 from Patent EP2511382
CTCCACGGAGG
>JA784403.1 Sequence 47 from Patent EP2511382
CTCCACGGAGC
>JA784402.1 Sequence 46 from Patent EP2511382
CTCCACGGATA
>JA784401.1 Sequence 45 from Patent EP2511382
CTCCACGGACA
>JA784400.1 Sequence 44 from Patent EP2511382
CTCCACGGAAA
>JA784399.1 Sequence 43 from Patent EP2511382
CTCCACGGTGA
>JA784398.1 Sequence 42 from Patent EP2511382
CTCCACGGGGA
>JA784397.1 Sequence 41 from Patent EP2511382
CTCCACGGCGA
>JA784396.1 Sequence 40 from Patent EP2511382
CTCCACGCAGA
>JA784395.1 Sequence 39 from Patent EP2511382
CTCCACTGAGA
>JA784394.1 Sequence 38 from Patent EP2511382
CTCCACCGAGA
>JA784393.1 Sequence 37 from Patent EP2511382
CTCTACGGAGA
>JA784392.1 Sequence 36 from Patent EP2511382
CTCGACGGAGA
>JA784391.1 Sequence 35 from Patent EP2511382
CTTCACGGAGA
>JA784390.1 Sequence 34 from Patent EP2511382
CTGCACGGAGA
>JA784389.1 Sequence 33 from Patent EP2511382
CCCCACGGAGA
>JA784388.1 Sequence 32 from Patent EP2511382
CACCACGGAGA
>JA784387.1 Sequence 31 from Patent EP2511382
TTCCACGGAGA
>JA784386.1 Sequence 30 from Patent EP2511382
GTCCACGGAGA
>JA784385.1 Sequence 29 from Patent EP2511382
ATCCACGGAGA
>JA784384.1 Sequence 28 from Patent EP2511382
CTCCACGGAGA
>JA784359.1 Sequence 3 from Patent EP2511382
CTCCNNGGAGA
>JA783315.1 Sequence 17 from Patent EP2464748
AGTGATCAGCA
>JA783313.1 Sequence 15 from Patent EP2464748
ACAGAGTCGTA
>JA783285.1 Sequence 3 from Patent EP2418215
TGCTANNNTTG
>JA782831.1 Sequence 72 from Patent EP2305693
TGCTTGCAAGC
>HV931752.1 JP 2011504736-A/248: MCP-1 binding nucleic acids and use thereof
CCAATGTCGCC
>HV931747.1 JP 2011504736-A/243: MCP-1 binding nucleic acids and use thereof
GAGGGACGTGC
>HV928112.1 JP 2010512773-A/1907: Oligonucleotide-, Protein and/or peptide-polymer Conjugates
GCACTTGTAGC
>HV936083.1 JP 2011516062-A/16: Methods and Devices Based upon a Novel Form of Nucleic Acid Duplex on a Surface
GCCCACTACAG
>HV936082.1 JP 2011516062-A/15: Methods and Devices Based upon a Novel Form of Nucleic Acid Duplex on a Surface
CGCCCACTACA
>HV930618.1 JP 2011502474-A/15: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TATATATTGTT
>HV930610.1 JP 2011502474-A/7: COMPOUNDS AND METHODS ASSOCIATED WITH DIFFERENTIAL METHYLATION OF HUMAN PAPILLOMA VIRUS GENOMES IN EPITHELIAL CELLS
TACATACCGCT
>HV819306.1 JP 2011083296-A/45: Vectors for Directional Cloning
NNNGTTTCCAN
>HV819305.1 JP 2011083296-A/44: Vectors for Directional Cloning
NNNGTTTATCN
>HV819300.1 JP 2011083296-A/39: Vectors for Directional Cloning
GCANNNNNTGC
>HV819298.1 JP 2011083296-A/37: Vectors for Directional Cloning
CCNNNNNNNGG
>HV819297.1 JP 2011083296-A/36: Vectors for Directional Cloning
GCTCTTCNNNN
>HV819295.1 JP 2011083296-A/34: Vectors for Directional Cloning
GCTCTTCNNNN
>HV819277.1 JP 2011083296-A/16: Vectors for Directional Cloning
NNNNGAAGAGC
>HV819275.1 JP 2011083296-A/14: Vectors for Directional Cloning
CCANNNNNTGG
>HV819273.1 JP 2011083296-A/12: Vectors for Directional Cloning
GCNNNNNNNGC
>HV819272.1 JP 2011083296-A/11: Vectors for Directional Cloning
CCNNNNNNNGG
>HV819270.1 JP 2011083296-A/9: Vectors for Directional Cloning
NNNNNGAGACC
>HV819268.1 JP 2011083296-A/7: Vectors for Directional Cloning
GCCNNNNNGGC
>HV819267.1 JP 2011083296-A/6: Vectors for Directional Cloning
NNNNNGAGACG
>HV781788.1 JP 2010088443-A/69: MN Gene and Protein
ACACAGAAGGG
>HV781786.1 JP 2010088443-A/67: MN Gene and Protein
CTCCAGTCCAG
>HV781785.1 JP 2010088443-A/66: MN Gene and Protein
CCCTAGCTCCA
>HV781784.1 JP 2010088443-A/65: MN Gene and Protein
TCACAGGCTCA
>HV781783.1 JP 2010088443-A/64: MN Gene and Protein
CCCCAGGAGGG
>HV781782.1 JP 2010088443-A/63: MN Gene and Protein
TTTCAGATCCA
>HV781781.1 JP 2010088443-A/62: MN Gene and Protein
ACGCAGTGCAA
>HV781780.1 JP 2010088443-A/61: MN Gene and Protein
CCCCAGGCGAC
>HV781779.1 JP 2010088443-A/60: MN Gene and Protein
ATACAGGGGAT
>HV781778.1 JP 2010088443-A/59: MN Gene and Protein
CACAGGTATTA
>HV781777.1 JP 2010088443-A/58: MN Gene and Protein
TGCTGGTGAGT
>HV781776.1 JP 2010088443-A/57: MN Gene and Protein
GCCAGGTACAG
>HV781775.1 JP 2010088443-A/56: MN Gene and Protein
AGCAGGTGGGC
>HV781774.1 JP 2010088443-A/55: MN Gene and Protein
GGAAGGTCAGT
>HV781773.1 JP 2010088443-A/54: MN Gene and Protein
TGGAGGTACCA
>HV781772.1 JP 2010088443-A/53: MN Gene and Protein
CCGAGGTGAGC
>HV781771.1 JP 2010088443-A/52: MN Gene and Protein
CAGTCGTGAGG
>HV781770.1 JP 2010088443-A/51: MN Gene and Protein
TGGAGGTGAGA
>HV781769.1 JP 2010088443-A/50: MN Gene and Protein
AGAAGGTAAGT
>HV813654.1 JP 2011050387-A/83: EF-Tu mRNA as a marker for viability of bacteria
AAGCGAAAATC
>HV813621.1 JP 2011050387-A/50: EF-Tu mRNA as a marker for viability of bacteria
AAGCGAAAATC
>HV856581.1 JP 2010507386-A/40: Oligoribonucleotides and uses thereof
TTTTTTGGGGG
>HV856565.1 JP 2010507386-A/24: Oligoribonucleotides and uses thereof
GTTGTGTGGGG
>HV818408.1 JP 2011078437-A/6: LIGAND FOR G-PROTEIN COUPLED RECEPTOR FPRL2 AND USES THEREOF
GGGGACTTTCC
>HV818035.1 JP 2011036259-A/37: Methods for Identifying Functionally Related Genes and Drug Targets
NNTTTATTTNN
>HV817755.1 JP 2011072320-A/1: A nucleotide sequence having a function for suppressing gene expression
GGGAAGGGGAT
>HV821567.1 JP 2011137838-A/37: Methods for isolating and characterizing endogenous mRNA-protein (mRNP) complexes
NNTTTATTTNN
>HV785283.1 JP 2010046092-A/106: Evolving New Molecular Function
TATCTACAGAG
>HV785278.1 JP 2010046092-A/101: Evolving New Molecular Function
TGTACGAATTC
>HV785276.1 JP 2010046092-A/99: Evolving New Molecular Function
GAATTCGTACC
>HV785274.1 JP 2010046092-A/97: Evolving New Molecular Function
TGTACGAATTC
>HV785272.1 JP 2010046092-A/95: Evolving New Molecular Function
GAATTCGTACC
>HV785270.1 JP 2010046092-A/93: Evolving New Molecular Function
TGTACGAATTC
>HV785269.1 JP 2010046092-A/92: Evolving New Molecular Function
GAATTCGTACA
>HV785268.1 JP 2010046092-A/91: Evolving New Molecular Function
GAATTCGTACC
>HV785267.1 JP 2010046092-A/90: Evolving New Molecular Function
GGTACGAATTC
>HV785262.1 JP 2010046092-A/85: Evolving New Molecular Function
TGTACGAATTC
>HV785259.1 JP 2010046092-A/82: Evolving New Molecular Function
GAATTCGTACC
>HV785201.1 JP 2010046092-A/24: Evolving New Molecular Function
TAAGATCTGCT
>HV785200.1 JP 2010046092-A/23: Evolving New Molecular Function
TCCTGATGTAA
>HV785199.1 JP 2010046092-A/22: Evolving New Molecular Function
TATCTACAGAG
>HV785198.1 JP 2010046092-A/21: Evolving New Molecular Function
TTAACGAGAGA
>HV785197.1 JP 2010046092-A/20: Evolving New Molecular Function
TATAGATCAGC
>HV785191.1 JP 2010046092-A/14: Evolving New Molecular Function
TGGTACGAATT
>HV785183.1 JP 2010046092-A/6: Evolving New Molecular Function
TGGTACGAATT
>HV784857.1 JP 2010031051-A/15: Method to Inhibit Cell Growth Using Oligonucleotides
CGGGCTTATTG
>HV784856.1 JP 2010031051-A/14: Method to Inhibit Cell Growth Using Oligonucleotides
TAGATGTGGTG
>HV784852.1 JP 2010031051-A/10: Method to Inhibit Cell Growth Using Oligonucleotides
GATCGATCGAT
>HV784851.1 JP 2010031051-A/9: Method to Inhibit Cell Growth Using Oligonucleotides
CTAACCCTAAC
>HV784847.1 JP 2010031051-A/5: Method to Inhibit Cell Growth Using Oligonucleotides
GTTAGGGTTAG
>GZ594030.1 Sequence 14 from patent US 8309794
GCTCCACCGCG
>GZ593971.1 Sequence 77 from patent US 8309791
GACTTCAACTG
>GZ593967.1 Sequence 73 from patent US 8309791
CAGTTGAAGTA
>GZ593965.1 Sequence 71 from patent US 8309791
CAGTTGAAGTC
>GZ592738.1 Sequence 44 from patent US 8309699
TCATCTCGCGA
>GZ513546.1 Sequence 7 from patent US 8278049
SSSSSSSSSSS
>GZ513527.1 Sequence 1 from patent US 8278045
GCCAGCCATGG
>GZ513494.1 Sequence 113 from patent US 8278043
YTTACTCAGAG
>GZ513490.1 Sequence 109 from patent US 8278043
MTGAGAGCTGT
>GZ589400.1 Sequence 359 from patent US 8304396
TCGTCGTTTTG
>GZ589386.1 Sequence 345 from patent US 8304396
GTTTTGTCGTT
>GZ589385.1 Sequence 344 from patent US 8304396
GTTTTGTCGTT
>GZ548041.1 Sequence 5324 from patent US 8298788
GTGGTGAAGAC
>GZ544419.1 Sequence 3 from patent US 8298542
ATCGGGCTCCA
>GZ543828.1 Sequence 1 from patent US 8296075
ACACACACACC
>GZ543826.1 Sequence 8 from patent US 8296074
TATCATCTTTG
>GZ543535.1 Sequence 92 from patent US 8293979
TAGCGGCCGCA
>GZ542299.1 Sequence 5324 from patent US 8293884
GTGGTGAAGAC
>GZ534828.1 Sequence 148 from patent US 8293517
TCAAGAGGTTA
>GZ534827.1 Sequence 147 from patent US 8293517
CATATAGCTGG
>GZ534826.1 Sequence 146 from patent US 8293517
TCATGAGGTTA
>GZ534825.1 Sequence 145 from patent US 8293517
CAACTACCTGG
>GZ534824.1 Sequence 144 from patent US 8293517
TCATGGGGTTA
>GZ534823.1 Sequence 143 from patent US 8293517
CATATCGCTCG
>GZ534822.1 Sequence 142 from patent US 8293517
TCAAGAGGTTA
>GZ534821.1 Sequence 141 from patent US 8293517
CAGGGACCTCG
>GZ534820.1 Sequence 140 from patent US 8293517
TCATGAGGTTA
>GZ534819.1 Sequence 139 from patent US 8293517
CACATAGCTCG
>GZ534818.1 Sequence 138 from patent US 8293517
TCATGAGGTTA
>GZ534817.1 Sequence 137 from patent US 8293517
CAAATAGCTCG
>GZ534816.1 Sequence 136 from patent US 8293517
TCAAGAGATTA
>GZ534815.1 Sequence 135 from patent US 8293517
CATATAACTCG
>GZ534814.1 Sequence 134 from patent US 8293517
TCATGAGGTTA
>GZ534813.1 Sequence 133 from patent US 8293517
CATACCTCTCG
>GZ534812.1 Sequence 132 from patent US 8293517
TCAGGAGATTA
>GZ534811.1 Sequence 131 from patent US 8293517
CATCTATCTCG
>GZ534810.1 Sequence 130 from patent US 8293517
TCAGAGTGTTA
>GZ534809.1 Sequence 129 from patent US 8293517
CAACGAACTGG
>GZ534808.1 Sequence 128 from patent US 8293517
TGAAGAGGTTA
>GZ534807.1 Sequence 127 from patent US 8293517
GAAAGAGCTCG
>GZ534806.1 Sequence 126 from patent US 8293517
TCAGGGATTTA
>GZ534805.1 Sequence 125 from patent US 8293517
CATATGGCTGG
>GZ534804.1 Sequence 124 from patent US 8293517
TCAGAGGATTA
>GZ534803.1 Sequence 123 from patent US 8293517
CACTGATCTCG
>GZ534802.1 Sequence 122 from patent US 8293517
TCAGGGTATTA
>GZ534801.1 Sequence 121 from patent US 8293517
CATCCCACTCG
>GZ534800.1 Sequence 120 from patent US 8293517
TCAAGATGTTA
>GZ534799.1 Sequence 119 from patent US 8293517
CAAACATCTCG
>GZ534798.1 Sequence 118 from patent US 8293517
TCAGAGGGTTA
>GZ534797.1 Sequence 117 from patent US 8293517
CAAGGCGCTCG
>GZ534796.1 Sequence 116 from patent US 8293517
TCAGGAGATTA
>GZ534795.1 Sequence 115 from patent US 8293517
CAATGGACTCG
>GZ534794.1 Sequence 114 from patent US 8293517
TCAGGAGATTA
>GZ534793.1 Sequence 113 from patent US 8293517
GAAGCTACTCG
>GZ534792.1 Sequence 112 from patent US 8293517
TGATGGAATTA
>GZ534791.1 Sequence 111 from patent US 8293517
CATATTGGTCG
>GZ534790.1 Sequence 110 from patent US 8293517
TCAGAGGATTA
>GZ534789.1 Sequence 109 from patent US 8293517
CAGTGGTCTCG
>GZ534788.1 Sequence 108 from patent US 8293517
TCAGGAGATTA
>GZ534787.1 Sequence 107 from patent US 8293517
CAAATATCTCG
>GZ534786.1 Sequence 106 from patent US 8293517
TCAAGGTATTA
>GZ534785.1 Sequence 105 from patent US 8293517
CAAATATCTCG
>GZ534784.1 Sequence 104 from patent US 8293517
TCATAGTGTTA
>GZ534783.1 Sequence 103 from patent US 8293517
CAACTAACTGG
>GZ534782.1 Sequence 102 from patent US 8293517
TCATGCTATTA
>GZ534781.1 Sequence 101 from patent US 8293517
CATAGGACTCG
>GZ534780.1 Sequence 100 from patent US 8293517
TCAGGGTTTTA
>GZ534779.1 Sequence 99 from patent US 8293517
CACAGATCTCG
>GZ534778.1 Sequence 98 from patent US 8293517
TCAGTGGATTA
>GZ534777.1 Sequence 97 from patent US 8293517
CAATCCACTGG
>GZ534776.1 Sequence 96 from patent US 8293517
TCATGGATTTA
>GZ534775.1 Sequence 95 from patent US 8293517
CATAGTACTCG
>GZ534774.1 Sequence 94 from patent US 8293517
TCATGAGGTTA
>GZ534773.1 Sequence 93 from patent US 8293517
CATACCTCTCG
>GZ534772.1 Sequence 92 from patent US 8293517
TCAGAGATTTA
>GZ534771.1 Sequence 91 from patent US 8293517
CAAATATCTCG
>GZ534770.1 Sequence 90 from patent US 8293517
TCAGGAGATTA
>GZ534769.1 Sequence 89 from patent US 8293517
GAAGTGTCTCG
>GZ534768.1 Sequence 88 from patent US 8293517
TCAAGAGTTTA
>GZ534767.1 Sequence 87 from patent US 8293517
CATAGATCTCG
>GZ534766.1 Sequence 86 from patent US 8293517
TCATACTATTA
>GZ534765.1 Sequence 85 from patent US 8293517
CAAACTCCTCG
>GZ534764.1 Sequence 84 from patent US 8293517
TCAAGGGGTTA
>GZ534763.1 Sequence 83 from patent US 8293517
CATCCCAGTCG
>GZ534762.1 Sequence 82 from patent US 8293517
TCAAAGGGTTA
>GZ534761.1 Sequence 81 from patent US 8293517
CACCCACCTCG
>GZ534760.1 Sequence 80 from patent US 8293517
TCATGGTTTTA
>GZ534759.1 Sequence 79 from patent US 8293517
CACACCACTCG
>GZ534758.1 Sequence 78 from patent US 8293517
TCAAAGAGTTA
>GZ534757.1 Sequence 77 from patent US 8293517
CATGGTTCTGG
>GZ534756.1 Sequence 76 from patent US 8293517
TCATGGGATTA
>GZ534755.1 Sequence 75 from patent US 8293517
CAAGGGACTCG
>GZ534754.1 Sequence 74 from patent US 8293517
TCAGAGTGTTA
>GZ534753.1 Sequence 73 from patent US 8293517
CAACTCACTCG
>GZ534752.1 Sequence 72 from patent US 8293517
TCAGTGAATTA
>GZ534751.1 Sequence 71 from patent US 8293517
CAATTCACTCG
>GZ534750.1 Sequence 70 from patent US 8293517
TCAATGAGTTA
>GZ534749.1 Sequence 69 from patent US 8293517
CAAAGTTCTCG
>GZ534748.1 Sequence 68 from patent US 8293517
TCAATCAGTTA
>GZ534747.1 Sequence 67 from patent US 8293517
CACAGAACTGG
>GZ534746.1 Sequence 66 from patent US 8293517
TCAGAATTTTA
>GZ534745.1 Sequence 65 from patent US 8293517
CAATTATCTCG
>GZ534744.1 Sequence 64 from patent US 8293517
TCAGGAGGTTA
>GZ534743.1 Sequence 63 from patent US 8293517
CATCTTGCTCG
>GZ534742.1 Sequence 62 from patent US 8293517
TCATTGGGTTA
>GZ534741.1 Sequence 61 from patent US 8293517
CATAGGGGTCG
>GZ534740.1 Sequence 60 from patent US 8293517
TCAGTGATTTA
>GZ534739.1 Sequence 59 from patent US 8293517
CAAACGACTCG
>GZ534738.1 Sequence 58 from patent US 8293517
TCAGACGATTA
>GZ534737.1 Sequence 57 from patent US 8293517
CACAGTCCTCG
>GZ534736.1 Sequence 56 from patent US 8293517
TCAATGGGTTA
>GZ534735.1 Sequence 55 from patent US 8293517
CATACCTCTCG
>GZ534734.1 Sequence 54 from patent US 8293517
TCAAGGGATTA
>GZ534733.1 Sequence 53 from patent US 8293517
CAATCCCCTCG
>GZ534732.1 Sequence 52 from patent US 8293517
TCACCTCCTTA
>GZ534731.1 Sequence 51 from patent US 8293517
CAGGAGGCTCG
>GZ534730.1 Sequence 50 from patent US 8293517
TCANNNNNTTA
>GZ534729.1 Sequence 49 from patent US 8293517
CANNNNNCTCG
>GZ534712.1 Sequence 32 from patent US 8293517
TCAAGAGGTTA
>GZ534711.1 Sequence 31 from patent US 8293517
CATATACCTCG
>GZ534710.1 Sequence 30 from patent US 8293517
TCAAGAGGTTA
>GZ534709.1 Sequence 29 from patent US 8293517
CAACTACCTCG
>GZ534708.1 Sequence 28 from patent US 8293517
TCATGAGGTTA
>GZ534707.1 Sequence 27 from patent US 8293517
CATATCCCTCG
>GZ534706.1 Sequence 26 from patent US 8293517
TCATGGGATTA
>GZ534705.1 Sequence 25 from patent US 8293517
CACCGACCTCG
>GZ534704.1 Sequence 24 from patent US 8293517
TCAAGAGGTTA
>GZ534703.1 Sequence 23 from patent US 8293517
CACATACCTCG
>GZ534702.1 Sequence 22 from patent US 8293517
TCATGAGGTTA
>GZ534701.1 Sequence 21 from patent US 8293517
CAAATACCTCG
>GZ534700.1 Sequence 20 from patent US 8293517
TCAGAGGATTA
>GZ534699.1 Sequence 19 from patent US 8293517
CATAATCCTCG
>GZ534698.1 Sequence 18 from patent US 8293517
TCATGAGGTTA
>GZ534697.1 Sequence 17 from patent US 8293517
CATACCTCTCG
>GZ534696.1 Sequence 16 from patent US 8293517
TCAAGAGGTTA
>GZ534695.1 Sequence 15 from patent US 8293517
CAAACACCTCG
>GZ534694.1 Sequence 14 from patent US 8293517
TCAGGGATTTA
>GZ534693.1 Sequence 13 from patent US 8293517
CATATCCCTCG
>GZ534692.1 Sequence 12 from patent US 8293517
TCACACACTTA
>GZ534691.1 Sequence 11 from patent US 8293517
CAGTGTGCTCG
>GZ534690.1 Sequence 10 from patent US 8293517
TCACCTCCTTA
>GZ534689.1 Sequence 9 from patent US 8293517
CAGGAGGCTCG
>GZ534688.1 Sequence 8 from patent US 8293517
TCANNNNNTTA
>GZ534687.1 Sequence 7 from patent US 8293517
CANNNNNCTCG
>GZ534391.1 Sequence 88 from patent US 8293503
NNNGTTTCCAN
>GZ534390.1 Sequence 87 from patent US 8293503
NNNGTTTATCN
>GZ534385.1 Sequence 81 from patent US 8293503
GCANNNNNTGC
>GZ534383.1 Sequence 79 from patent US 8293503
CCNNNNNNNGG
>GZ534382.1 Sequence 78 from patent US 8293503
GCTCTTCNNNN
>GZ534380.1 Sequence 76 from patent US 8293503
GCTCTTCNNNN
>GZ534362.1 Sequence 16 from patent US 8293503
NNNNGAAGAGC
>GZ534360.1 Sequence 14 from patent US 8293503
CCANNNNNTGG
>GZ534358.1 Sequence 12 from patent US 8293503
GCNNNNNNNGC
>GZ534357.1 Sequence 11 from patent US 8293503
CCNNNNNNNGG
>GZ534355.1 Sequence 9 from patent US 8293503
NNNNNGAGACC
>GZ534353.1 Sequence 7 from patent US 8293503
GCCNNNNNGGC
>GZ534352.1 Sequence 6 from patent US 8293503
NNNNNGAGACG
>GZ533669.1 Sequence 190 from patent US 8293483
CGGAACAAGGG
>GZ533668.1 Sequence 189 from patent US 8293483
CGGAACAAGGG
>GZ532442.1 Sequence 5324 from patent US 8293249
GTGGTGAAGAC
>GZ529545.1 Sequence 2 from patent US 8293209
CCACGAGCTTC
>GZ529544.1 Sequence 1 from patent US 8293209
GAAGCTCGTGG
>GZ528824.1 Sequence 156 from patent US 8283334
GCAGACCCCGC
>GZ528799.1 Sequence 125 from patent US 8283334
AGGCCCCTGAG
>GZ528481.1 Sequence 38 from patent US 8283330
ATGGGGAGGCA
>GZ528411.1 Sequence 359 from patent US 8283328
TCGTCGTTTTG
>GZ528397.1 Sequence 345 from patent US 8283328
GTTTTGTCGTT
>GZ528396.1 Sequence 344 from patent US 8283328
GTTTTGTCGTT
>GZ528021.1 Sequence 33 from patent US 8283294
TAATCAATCGG
>HV778245.1 WO 2012091101-A/17: A bioluminescent probe system for multiply recognizing ligands
NNNCNNNGNNN
>GZ511033.1 Sequence 2 from patent US 8271206
CTGGGTTACAG
>GZ507535.1 Sequence 5 from patent US 8268561
CAGGGGCGGCT
>GZ507530.1 Sequence 53 from patent US 8268560
TATTCCGTCAT
>GZ507483.1 Sequence 6 from patent US 8268560
TATTCCGTCAT
>HV764814.1 JP 2012105662-A/16: HUMAN TOLL HOMOLOGUES
TAAGCTTAACG
>HV764309.1 JP 2012115270-A/7: THYMIDINE KINASE MUTANTS AND FUSION PROTEINS HAVING THYMIDINE KINASE AND GUANYLATE KINASE ACTIVITIES
ATGAGGTACCG
>HV755969.1 JP 2012508016-A/1406: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
GCCNNNNNGGC
>HV752922.1 JP 2012508586-A/101: COMPOSITIONS KITS AND METHODS FOR DETECTION OF CAMPYLOBACTER NUCLEIC ACID
CAGTTGGAAAC
>HV752901.1 JP 2012508586-A/80: COMPOSITIONS KITS AND METHODS FOR DETECTION OF CAMPYLOBACTER NUCLEIC ACID
GTTTTTCGGTG
>HV750123.1 WO 2012067220-A/21: Efficient protein-expression method
CCTATTACATC
>HV759145.1 JP 2012508017-A/273: Anti-DLL4 Antibodies and Uses Thereof
CTAACTGGGGA
>HV754830.1 JP 2012508016-A/267: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
CTAACTGGGGA
>HV756719.1 JP 2012508016-A/2156: COMBINATORIAL ANTIBODY LIBRARIES AND USES THEREOF
TCCCCAGTTAG
>HV748576.1 JP 2012100671-A/216: Toxin Peptide Therapeutic Agents
GCAGAGTCCAC
>HV748574.1 JP 2012100671-A/214: Toxin Peptide Therapeutic Agents
GGGTCGAGACG
>HV748399.1 JP 2012100671-A/39: Toxin Peptide Therapeutic Agents
GCAGAGTCCAC
>HV748398.1 JP 2012100671-A/38: Toxin Peptide Therapeutic Agents
TTATTGTATAC
>HV748397.1 JP 2012100671-A/37: Toxin Peptide Therapeutic Agents
TATGCGAGACG
>HV748396.1 JP 2012100671-A/36: Toxin Peptide Therapeutic Agents
GCAGAGAATTC
>HV748393.1 JP 2012100671-A/33: Toxin Peptide Therapeutic Agents
TGGTTGAGACG
>GZ497252.1 Sequence 41 from patent US 8263826
YMRATDATTAN
>GZ497249.1 Sequence 38 from patent US 8263826
WAAWTTAWTMH
>GZ497243.1 Sequence 32 from patent US 8263826
NNNATDATTAN
>GZ497240.1 Sequence 29 from patent US 8263826
HAWHTTAWTNN
>GZ496504.1 Sequence 38 from patent US 8263758
CAAATTCCAAA
>GZ495099.1 Sequence 5 from patent US 8263365
GTGCAGATCTG
>GZ495091.1 Sequence 5 from patent US 8263364
GTGCAGATCTG
>GZ494893.1 Sequence 3 from patent US 8263335
ATCGGATCCAT
>GZ494815.1 Sequence 180 from patent US 8263091
TCGTTTGTTCT
>GZ490582.1 Sequence 181 from patent US 8258286
AGCGGCCGCCA
>GZ486709.1 Sequence 37 from patent US 8258102
TTAGGCTTATA
>GZ486566.1 Sequence 399 from patent US 8257969
GGAAAAACCCC
>GZ486550.1 Sequence 383 from patent US 8257969
GGGTCAGGGAT
>GZ486457.1 Sequence 289 from patent US 8257969
GGTGAGTGAGG
>GZ486413.1 Sequence 243 from patent US 8257969
CCATGTCAAAC
>GZ486379.1 Sequence 209 from patent US 8257969
GCTGAATCAGC
>GZ486378.1 Sequence 208 from patent US 8257969
GCTGATTCAGC
>GZ486348.1 Sequence 177 from patent US 8257969
AGGTCAAGGTG
>GZ486343.1 Sequence 172 from patent US 8257969
ACTGAGTCACC
>GZ486342.1 Sequence 171 from patent US 8257969
GGTGACTCAGT
>GZ486333.1 Sequence 162 from patent US 8257969
GAAGGAAAGAG
>GZ486313.1 Sequence 142 from patent US 8257969
ATCTGTCACTG
>GZ486309.1 Sequence 138 from patent US 8257969
TTGACGCCTGT
>GZ486303.1 Sequence 132 from patent US 8257969
GGAGGAAACAG
>GZ486299.1 Sequence 128 from patent US 8257969
GGAAAAAGTGG
>GZ478070.1 Sequence 1107 from patent US 8252739
CCGCCACCATG
>GZ477304.1 Sequence 42 from patent US 8252574
AGCAAATAGAC
>GZ477303.1 Sequence 41 from patent US 8252574
GTCTATTTGCT
>GZ477302.1 Sequence 40 from patent US 8252574
TGCATATTGAC
>GZ477301.1 Sequence 39 from patent US 8252574
ACCATATTGAC
>GZ477300.1 Sequence 38 from patent US 8252574
AGGATATTGAC
>GZ477299.1 Sequence 37 from patent US 8252574
AGCAAATTGAC
>GZ477298.1 Sequence 36 from patent US 8252574
AGCATTTTGAC
>GZ477297.1 Sequence 35 from patent US 8252574
AGCATAATGAC
>GZ477296.1 Sequence 34 from patent US 8252574
AGCATATAGAC
>GZ477295.1 Sequence 33 from patent US 8252574
AGCATATTCAC
>GZ477294.1 Sequence 32 from patent US 8252574
AGCATATTGTC
>GZ477293.1 Sequence 31 from patent US 8252574
AGCATATTGAG
>GZ477292.1 Sequence 30 from patent US 8252574
AGCATATTGAC
>GZ477291.1 Sequence 29 from patent US 8252574
GTCAATATGCA
>GZ477290.1 Sequence 28 from patent US 8252574
GTCAATATGGT
>GZ477289.1 Sequence 27 from patent US 8252574
GTCAATATCCT
>GZ477288.1 Sequence 26 from patent US 8252574
GTCAATTTGCT
>GZ477287.1 Sequence 25 from patent US 8252574
GTCAAAATGCT
>GZ477286.1 Sequence 24 from patent US 8252574
GTCATTATGCT
>GZ477285.1 Sequence 23 from patent US 8252574
GTCTATATGCT
>GZ477284.1 Sequence 22 from patent US 8252574
GTGAATATGCT
>GZ477283.1 Sequence 21 from patent US 8252574
GACAATATGCT
>GZ477282.1 Sequence 20 from patent US 8252574
CTCAATATGCT
>GZ477271.1 Sequence 3 from patent US 8252574
GTGAACATGTT
>GZ477270.1 Sequence 2 from patent US 8252574
GTCAATATGCT
>GZ464770.1 Sequence 1358 from patent US 8242254
TATTCTTCGTT
>GZ464769.1 Sequence 1357 from patent US 8242254
TACTCATGCCA
>GZ463801.1 Sequence 389 from patent US 8242254
TCCACCCTCAA
>GZ463252.1 Sequence 10 from patent US 8242245
ACCGCCCTCCG
>GZ462617.1 Sequence 51 from patent US 8241896
GAAAGCTGGGT
>GZ462616.1 Sequence 50 from patent US 8241896
AAAAGCAGGCT
>GZ462314.1 Sequence 197 from patent US 8241879
CAATNTCTNCK
>GZ462304.1 Sequence 187 from patent US 8241879
CRSGCYWGKGC
>GZ462299.1 Sequence 182 from patent US 8241879
GNCCSARTNGC
>GZ462279.1 Sequence 162 from patent US 8241879
CAYAMRTGYNC
>GZ462260.1 Sequence 143 from patent US 8241879
GCCAGACCTAC
>GZ462246.1 Sequence 129 from patent US 8241879
CYNNGGSSANC
>GZ462243.1 Sequence 126 from patent US 8241879
ARRARAAAGGN
>GZ462215.1 Sequence 98 from patent US 8241879
TTTYCACATGC
>GZ462212.1 Sequence 95 from patent US 8241879
AAANGGNARAM
>GZ462209.1 Sequence 92 from patent US 8241879
YKNTTTWYYTC
>GZ462204.1 Sequence 87 from patent US 8241879
GNGCCRSNNTM
>GZ462189.1 Sequence 72 from patent US 8241879
TTKTTTTYTTC
>GZ461943.1 Sequence 3 from patent US 8241860
TAAGGAGGTGA
>GZ459876.1 Sequence 51 from patent US 8237019
ATGAACTCCAC
>GZ459875.1 Sequence 50 from patent US 8237019
CTTTTGTTGTT
>GZ459872.1 Sequence 47 from patent US 8237019
CTTCCCATAGA
>GZ459871.1 Sequence 46 from patent US 8237019
AGAGGATTAGT
>GZ459868.1 Sequence 43 from patent US 8237019
AGCGATAGAAG
>GZ459863.1 Sequence 38 from patent US 8237019
ATCAGTGTGAA
>GZ459860.1 Sequence 35 from patent US 8237019
AAGCAATCTAC
>GZ459856.1 Sequence 31 from patent US 8237019
ACTGGGCTGAT
>GZ459855.1 Sequence 30 from patent US 8237019
GGAAATCAAGA
>GZ459850.1 Sequence 23 from patent US 8237019
GTCAACCTTCC
>GZ459849.1 Sequence 22 from patent US 8237019
GGAAGATCATA
>GZ459846.1 Sequence 19 from patent US 8237019
CGTGGAAAGTA
>GZ459845.1 Sequence 18 from patent US 8237019
CTCATCTTGTT
>GZ459842.1 Sequence 15 from patent US 8237019
AATGGTTGGAG
>GZ459841.1 Sequence 14 from patent US 8237019
GCGAGAACACA
>GZ457360.1 Sequence 107 from patent US 8236774
RGGGRMTYYCC
>GZ457359.1 Sequence 106 from patent US 8236774
TGGGCTTCCCC
>GZ457210.1 Sequence 16 from patent US 8236771
GTGTGCTGTCC
>GZ456743.1 Sequence 7 from patent US 8236541
ATGAGGTACCG
>GZ455934.1 Sequence 88 from patent US 8236500
CTGTTTCTAGT
>GZ453822.1 Sequence 26 from patent US 8236493
GGGNCCCTTAA
>GZ452900.1 Sequence 47 from patent US 8232584
TTACACGGGGG
>GZ452896.1 Sequence 40 from patent US 8232584
TTACCGGGGGG
>GZ452892.1 Sequence 32 from patent US 8232584
TTACAGGGGGG
>GZ452889.1 Sequence 25 from patent US 8232584
TTACGGGGGGG
>GZ452654.1 Sequence 10 from patent US 8232453
GCATGCTCCGC
>GZ452652.1 Sequence 8 from patent US 8232453
GTCGACTCCGC
>GZ450256.1 Sequence 70 from patent US 8232259
CGAGCGTTCTC
>GZ449597.1 Sequence 337 from patent US 8232058
CACAGTCCAAC
>GZ449529.1 Sequence 269 from patent US 8232058
GGGAGACGTCG
>GZ449201.1 Sequence 6 from patent US 8232054
GGGGTTTTGGG
>GZ448433.1 Sequence 119 from patent US 8227193
GGGGGYNNCCY
>HV742648.1 JP 2012506709-A/111: Sequencing of nucleic acid molecules by mass spectrometry
GCGTGGTGTGA
>HV742608.1 JP 2012506709-A/71: Sequencing of nucleic acid molecules by mass spectrometry
GCACGTCCCTC
>HV742558.1 JP 2012506709-A/21: Sequencing of nucleic acid molecules by mass spectrometry
GCACGTCCCTC
>HV704848.1 JP 2012504962-A/69: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
CAATCCCAATC
>HV704824.1 JP 2012504962-A/45: TELOMERASE INHIBITORS AND METHODS OF USE THEREOF
GAACGGTGGAA
>HV702795.1 JP 2012080886-A/41: Mutant AOX1 promoters
TGCATTGTCTC
>HV701815.1 JP 2012080873-A/2: DNA sequencer and DNA sequencing method
CGTCCTCTGAA
>HV701814.1 JP 2012080873-A/1: DNA sequencer and DNA sequencing method
TTCAGAGGACG
>GZ446031.1 Sequence 16 from patent US 8207400
CCGTTAAATTT
>GZ446030.1 Sequence 15 from patent US 8207400
GTACTAAAACC
>GZ445015.1 Sequence 43 from patent US 8207318
GGCCATAAGGG
>GZ445014.1 Sequence 42 from patent US 8207318
GCCTTGTTCCC
>GZ445013.1 Sequence 41 from patent US 8207318
ATCCGGTTCCC
>GZ445012.1 Sequence 40 from patent US 8207318
GGCCTAAAGGG
>GZ445011.1 Sequence 39 from patent US 8207318
TAGGCCAAGGG
>GZ445010.1 Sequence 38 from patent US 8207318
CGGAACAAGGG
>GZ445009.1 Sequence 37 from patent US 8207318
GTTCCGAAGGG
>GZ445008.1 Sequence 34 from patent US 8207318
CGGAACAAGGG
>GZ445007.1 Sequence 33 from patent US 8207318
GTTCCGAAGGG
>GZ443307.1 Sequence 3 from patent US 8206952
ATCGGATCCAT
>GZ441776.1 Sequence 2 from patent US 8206926
GCCNNNNNGGC
>GZ441641.1 Sequence 28 from patent US 8206921
CGGAGGCTAAC
>GZ441640.1 Sequence 27 from patent US 8206921
CGGAGGCTAAC
>GZ441017.1 Sequence 106 from patent US 8206914
TATCTACAGAG
>GZ441012.1 Sequence 101 from patent US 8206914
TGTACGAATTC
>GZ441010.1 Sequence 99 from patent US 8206914
GAATTCGTACC
>GZ441008.1 Sequence 97 from patent US 8206914
TGTACGAATTC
>GZ441006.1 Sequence 95 from patent US 8206914
GAATTCGTACC
>GZ441004.1 Sequence 93 from patent US 8206914
TGTACGAATTC
>GZ441003.1 Sequence 92 from patent US 8206914
GAATTCGTACA
>GZ441002.1 Sequence 91 from patent US 8206914
GAATTCGTACC
>GZ441001.1 Sequence 90 from patent US 8206914
GGTACGAATTC
>GZ440996.1 Sequence 85 from patent US 8206914
TGTACGAATTC
>GZ440993.1 Sequence 82 from patent US 8206914
GAATTCGTACC
>GZ440935.1 Sequence 24 from patent US 8206914
TAAGATCTGCT
>GZ440934.1 Sequence 23 from patent US 8206914
TCCTGATGTAA
>GZ440933.1 Sequence 22 from patent US 8206914
TATCTACAGAG
>GZ440932.1 Sequence 21 from patent US 8206914
TTAACGAGAGA
>GZ440931.1 Sequence 20 from patent US 8206914
TATAGATCAGC
>GZ440925.1 Sequence 14 from patent US 8206914
TGGTACGAATT
>GZ440917.1 Sequence 6 from patent US 8206914
TGGTACGAATT
>GZ440518.1 Sequence 271 from patent US 8206904
CGCTGGACCGT
>GZ439983.1 Sequence 3 from patent US 8206724
ATCGGGCTCCA
>GZ439967.1 Sequence 54 from patent US 8206718
TTAAGCCGGAG
>GZ439966.1 Sequence 53 from patent US 8206718
TCGACTCCGGC
>GZ439111.1 Sequence 13 from patent US 8212108
ACACTGCTTAC
>GZ437772.1 Sequence 11 from patent US 8211644
GNNGGTGCTNT
>GZ437769.1 Sequence 8 from patent US 8211644
GAAGGTGATAT
>GZ437766.1 Sequence 5 from patent US 8211644
GAAGGTGATAT
>GZ437763.1 Sequence 2 from patent US 8211644
GAAGGTGATAT
>GZ436301.1 Sequence 1107 from patent US 8211439
CCGCCACCATG
>GZ352336.1 Sequence 17 from patent US 8198404
GGGTACCCTGC
>GZ347153.1 Sequence 19 from patent US 8198079
ATCAAACTAGA
>GZ379451.1 Sequence 30 from patent US 8224578
AAGGAGGNATG
>GZ379446.1 Sequence 25 from patent US 8224578
WWWATTTAWWW
>GZ378430.1 Sequence 130 from patent US 8222398
TNGAANGTTCG
>GZ378429.1 Sequence 129 from patent US 8222398
TNGAANGTTCG
>GZ378427.1 Sequence 127 from patent US 8222398
TCGAANGTTCG
>GZ378419.1 Sequence 119 from patent US 8222398
TNGACCGTTCG
>GZ378418.1 Sequence 118 from patent US 8222398
TNGAACGTTCG
>GZ378412.1 Sequence 112 from patent US 8222398
TCGACCGTTCG
>GZ378403.1 Sequence 103 from patent US 8222398
TCGAACGTTCG
>GZ376296.1 Sequence 107 from patent US 8222392
RGGGRMTYYCC
>GZ376295.1 Sequence 106 from patent US 8222392
TGGGCTTCCCC
>GZ364692.1 Sequence 5 from patent US 8216514
GTGCAGATCTG
>GZ362695.1 Sequence 1358 from patent US 8097416
TATTCTTCGTT
>GZ362694.1 Sequence 1357 from patent US 8097416
TACTCATGCCA
>GZ361726.1 Sequence 389 from patent US 8097416
TCCACCCTCAA
>GZ358431.1 Sequence 662 from patent US 8093037
GCCAGACCTAC
>GZ358418.1 Sequence 649 from patent US 8093037
CYNNGGSSANC
>GZ358415.1 Sequence 646 from patent US 8093037
ARRARAAAGGN
>GZ358391.1 Sequence 622 from patent US 8093037
CAATNTCTNCK
>GZ358380.1 Sequence 611 from patent US 8093037
TTTYCACATGC
>GZ358376.1 Sequence 607 from patent US 8093037
AAANGGNARAM
>GZ358375.1 Sequence 606 from patent US 8093037
CRSGCYWGKGC
>GZ358370.1 Sequence 601 from patent US 8093037
YKNTTTWYYTC
>GZ358365.1 Sequence 596 from patent US 8093037
GNCCSARTNGC
>GZ358360.1 Sequence 591 from patent US 8093037
GNGCCRSNNTM
>GZ358335.1 Sequence 566 from patent US 8093037
TTKTTTTYTTC
>GZ358328.1 Sequence 559 from patent US 8093037
CAYAMRTGYNC
>GZ356902.1 Sequence 21 from patent US 8092991
ACTGGGNNNNN
>GZ356899.1 Sequence 16 from patent US 8092991
CGTCTCNNNNN
>GZ356898.1 Sequence 15 from patent US 8092991
GGTCTCNNNNN
>GZ356896.1 Sequence 13 from patent US 8092991
GCTCTTCNNNN
>GZ356891.1 Sequence 8 from patent US 8092991
ACTGGGNNNNN
>GZ356887.1 Sequence 2 from patent US 8092991
GGTCTCNNNNN
>GZ356886.1 Sequence 1 from patent US 8092991
CGTCTCNNNNN
>GZ355265.1 Sequence 31 from patent US 8202974
AATTGAAGCTG
>GZ355264.1 Sequence 30 from patent US 8202974
AATTGAAGCTT
>GZ355263.1 Sequence 29 from patent US 8202974
AACTGAAGCTG
>GZ355262.1 Sequence 28 from patent US 8202974
AACTGAAGCTT
>GZ355261.1 Sequence 27 from patent US 8202974
TGATGAAGCTT
>GZ355260.1 Sequence 26 from patent US 8202974
AACTGACGCTG
>GZ355259.1 Sequence 25 from patent US 8202974
AACTGACGCTT
>GZ355258.1 Sequence 24 from patent US 8202974
AACTGCGACTT
>GZ355257.1 Sequence 23 from patent US 8202974
AACTTGAGCTT
>GZ355256.1 Sequence 22 from patent US 8202974
AAGTGACGATT
>GZ355255.1 Sequence 21 from patent US 8202974
AAGTGACGCTT
>GZ355254.1 Sequence 20 from patent US 8202974
AAGTGCGACTT
>GZ355253.1 Sequence 19 from patent US 8202974
AATTGACGCTG
>GZ355252.1 Sequence 18 from patent US 8202974
AATTGACGCTT
>GZ355251.1 Sequence 17 from patent US 8202974
ACGCTGAGCTT
>GZ355250.1 Sequence 16 from patent US 8202974
ACGTGAAGCTT
>GZ355249.1 Sequence 15 from patent US 8202974
ACTGAGAGCTT
>GZ355248.1 Sequence 14 from patent US 8202974
ACTGCGAGCTT
>GZ355247.1 Sequence 13 from patent US 8202974
ACTTGAAACCT
>GZ355246.1 Sequence 12 from patent US 8202974
ACTTGAACTTG
>GZ355245.1 Sequence 11 from patent US 8202974
ACTTGAAGCTT
>GZ355244.1 Sequence 10 from patent US 8202974
ACTTGACCTGT
>GZ355243.1 Sequence 9 from patent US 8202974
ACTTGACCTTT
>GZ355242.1 Sequence 8 from patent US 8202974
ACTTGACGATT
>GZ355241.1 Sequence 7 from patent US 8202974
ACTTGACTTGA
>GZ355240.1 Sequence 6 from patent US 8202974
CTGACGAGCTT
>GZ355239.1 Sequence 5 from patent US 8202974
CTGAGAAGCTT
>GZ355238.1 Sequence 4 from patent US 8202974
CTTGTGAGCTT
>GZ355237.1 Sequence 3 from patent US 8202974
TGACGATGATT
>GZ355236.1 Sequence 2 from patent US 8202974
TGATGACGATT
>GZ355235.1 Sequence 1 from patent US 8202974
TTGCTGAGCTT
>GZ355061.1 Sequence 62 from patent US 8202850
CTATCTGACGT
>GZ355059.1 Sequence 60 from patent US 8202850
ACGTTCTCTGT
>GZ355052.1 Sequence 53 from patent US 8202850
CCTACTAGCGT
>GZ355049.1 Sequence 50 from patent US 8202850
GCGTTCTCATC
>GZ355039.1 Sequence 40 from patent US 8202850
TCTGANGTTCT
>GZ355038.1 Sequence 39 from patent US 8202850
TCTGTNGTTCT
>GZ355037.1 Sequence 38 from patent US 8202850
TCTTTCNTTCT
>GZ355036.1 Sequence 37 from patent US 8202850
TCTTTNGTTCT
>GZ355032.1 Sequence 33 from patent US 8202850
TCTGTCGTTCT
>GZ355026.1 Sequence 27 from patent US 8202850
TCTGANNTTCT
>GZ355025.1 Sequence 26 from patent US 8202850
TCTGACNTTCT
>GZ355023.1 Sequence 24 from patent US 8202850
TCTGACNTTCT
>GZ355019.1 Sequence 20 from patent US 8202850
TCTGTNNTTCT
>GZ355018.1 Sequence 19 from patent US 8202850
TCTGTCNTTCT
>GZ355017.1 Sequence 18 from patent US 8202850
TCTGTCNTTCT
>GZ355012.1 Sequence 13 from patent US 8202850
TCTGACGTTCT
>AB420881.1 Bombyx mori non-coding RNA, ovarian small RNA-34691, complete sequence
TGGATTGCTGA
>AB400814.1 Bombyx mori non-coding RNA, ovarian small RNA-14624, complete sequence
CTACGTCCGAA
>HV694468.1 JP 2012504395-A/71: Tetracycline inducible transcription control sequence
ATGTAAACCAT
>HV699947.1 JP 2012504657-A/117: TREATMENT OF APOLIPOPROTEIN-A1 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO APOLIPOPROTEIN-A1
GGATGAAGAAG
>HV699869.1 JP 2012504657-A/39: TREATMENT OF APOLIPOPROTEIN-A1 RELATED DISEASES BY INHIBITION OF NATURAL ANTISENSE TRANSCRIPT TO APOLIPOPROTEIN-A1
CTTCTTCATCC
>HV692962.1 JP 2012051921-A/17: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TGCAAGCTTGC
>HV692961.1 JP 2012051921-A/16: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCNAACNTTCN
>HV692960.1 JP 2012051921-A/15: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTANGTACT
>HV692959.1 JP 2012051921-A/14: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGAANGTTCT
>HV692958.1 JP 2012051921-A/13: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTAGTA
>HV692957.1 JP 2012051921-A/12: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGANGAT
>HV692956.1 JP 2012051921-A/11: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCAGTNGACTG
>HV692955.1 JP 2012051921-A/10: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCAGTNGTTAG
>HV692954.1 JP 2012051921-A/9: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGACAG
>HV692953.1 JP 2012051921-A/8: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGACAG
>HV692952.1 JP 2012051921-A/7: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV692951.1 JP 2012051921-A/6: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV692950.1 JP 2012051921-A/5: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV692949.1 JP 2012051921-A/4: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV692948.1 JP 2012051921-A/3: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV692947.1 JP 2012051921-A/2: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
ACACACCAACT
>HV692946.1 JP 2012051921-A/1: IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS COMPRISING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV697937.1 JP 2012503983-A/11: Compatible Display Vector Systems
GACNNNNNGTC
>HV697934.1 JP 2012503983-A/8: Compatible Display Vector Systems
GCCNNNNNGGC
>HV697933.1 JP 2012503983-A/7: Compatible Display Vector Systems
CCANNNNNTGG
>HV697922.1 JP 2012503982-A/11: Phage Display Vector
GACNNNNNGTC
>HV697919.1 JP 2012503982-A/8: Phage Display Vector
GCCNNNNNGGC
>HV697918.1 JP 2012503982-A/7: Phage Display Vector
CCANNNNNTGG
>HV697860.1 JP 2012503490-A/7: Single Chain Antibody Library Design
GACNNNNNGTC
>HV697856.1 JP 2012503490-A/3: Single Chain Antibody Library Design
CCANNNNNTGG
>HV689308.1 JP 2012060940-A/26: Primer set and detecting method for beta-actin
CCGAGCGTGGC
>HV695708.1 JP 2012502630-A/35: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAACTCC
>HV695707.1 JP 2012502630-A/34: Compositions and Methods for Regulating Cell Osmolarity
GGAGTTTTCCA
>HV695706.1 JP 2012502630-A/33: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAACAC
>HV695705.1 JP 2012502630-A/32: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATCTCC
>HV695704.1 JP 2012502630-A/31: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTTT
>HV695703.1 JP 2012502630-A/30: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTTT
>HV695702.1 JP 2012502630-A/29: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTCC
>HV695701.1 JP 2012502630-A/28: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAGTTAC
>HV695700.1 JP 2012502630-A/27: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTAC
>HV695698.1 JP 2012502630-A/25: Compositions and Methods for Regulating Cell Osmolarity
TGGAATTCTAT
>HV695697.1 JP 2012502630-A/24: Compositions and Methods for Regulating Cell Osmolarity
ATAGAATTCCA
>HV695696.1 JP 2012502630-A/23: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAACTAC
>HV695695.1 JP 2012502630-A/22: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATCCC
>HV695694.1 JP 2012502630-A/21: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATACC
>HV695693.1 JP 2012502630-A/20: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAAAACC
>HV695692.1 JP 2012502630-A/19: Compositions and Methods for Regulating Cell Osmolarity
AGGAAAATCAC
>HV695691.1 JP 2012502630-A/18: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATTTAC
>HV695690.1 JP 2012502630-A/17: Compositions and Methods for Regulating Cell Osmolarity
TGGAATATTAC
>HV695689.1 JP 2012502630-A/16: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATTAC
>HV695688.1 JP 2012502630-A/15: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HV695687.1 JP 2012502630-A/14: Compositions and Methods for Regulating Cell Osmolarity
CGGAAAATCAC
>HV695686.1 JP 2012502630-A/13: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HV695685.1 JP 2012502630-A/12: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAATTT
>HV695684.1 JP 2012502630-A/11: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAATAT
>HV695683.1 JP 2012502630-A/10: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAAGTCC
>HV695682.1 JP 2012502630-A/9: Compositions and Methods for Regulating Cell Osmolarity
TGGAAAATCAC
>HV695678.1 JP 2012502630-A/5: Compositions and Methods for Regulating Cell Osmolarity
TGGAAATTTGT
>HV695677.1 JP 2012502630-A/4: Compositions and Methods for Regulating Cell Osmolarity
HGGAAANNHNH
>HV695674.1 JP 2012502630-A/1: Compositions and Methods for Regulating Cell Osmolarity
HGGAAWNNHNH
>HV599884.1 JP 2011004744-A/994: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599883.1 JP 2011004744-A/993: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599882.1 JP 2011004744-A/992: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599881.1 JP 2011004744-A/991: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599880.1 JP 2011004744-A/990: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599879.1 JP 2011004744-A/989: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599878.1 JP 2011004744-A/988: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599877.1 JP 2011004744-A/987: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599876.1 JP 2011004744-A/986: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599875.1 JP 2011004744-A/985: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599874.1 JP 2011004744-A/984: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599873.1 JP 2011004744-A/983: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV588856.1 JP 2010273681-A/179: Methods for Selecting Medications
GAAGGAGCTGA
>HV588846.1 JP 2010273681-A/169: Methods for Selecting Medications
GCATTCCTCAC
>HV588845.1 JP 2010273681-A/168: Methods for Selecting Medications
GCATTCCTCAG
>HV588831.1 JP 2010273681-A/154: Methods for Selecting Medications
AAAGGGAGCCA
>HV588820.1 JP 2010273681-A/143: Methods for Selecting Medications
ACGTCGGAGAT
>HV588806.1 JP 2010273681-A/129: Methods for Selecting Medications
GCACAGAGCAT
>HV588805.1 JP 2010273681-A/128: Methods for Selecting Medications
GCACAGAGCAC
>HV588766.1 JP 2010273681-A/89: Methods for Selecting Medications
GGACGAGTAGC
>HV588765.1 JP 2010273681-A/88: Methods for Selecting Medications
GGACGAGTAGA
>HV588760.1 JP 2010273681-A/83: Methods for Selecting Medications
TTCAGGTGGCT
>HV599872.1 JP 2011004744-A/982: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599871.1 JP 2011004744-A/981: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599870.1 JP 2011004744-A/980: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599869.1 JP 2011004744-A/979: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599868.1 JP 2011004744-A/978: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599867.1 JP 2011004744-A/977: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599866.1 JP 2011004744-A/976: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599865.1 JP 2011004744-A/975: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599864.1 JP 2011004744-A/974: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599863.1 JP 2011004744-A/973: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599862.1 JP 2011004744-A/972: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599861.1 JP 2011004744-A/971: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599860.1 JP 2011004744-A/970: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599859.1 JP 2011004744-A/969: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599858.1 JP 2011004744-A/968: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599857.1 JP 2011004744-A/967: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599856.1 JP 2011004744-A/966: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599855.1 JP 2011004744-A/965: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599854.1 JP 2011004744-A/964: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599853.1 JP 2011004744-A/963: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599852.1 JP 2011004744-A/962: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599851.1 JP 2011004744-A/961: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599850.1 JP 2011004744-A/960: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599849.1 JP 2011004744-A/959: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599848.1 JP 2011004744-A/958: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599847.1 JP 2011004744-A/957: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599846.1 JP 2011004744-A/956: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599845.1 JP 2011004744-A/955: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599844.1 JP 2011004744-A/954: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599843.1 JP 2011004744-A/953: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599842.1 JP 2011004744-A/952: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599841.1 JP 2011004744-A/951: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599840.1 JP 2011004744-A/950: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599839.1 JP 2011004744-A/949: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV599838.1 JP 2011004744-A/948: HBM Variants that Modulate Bone Mass and Lipid Levels
GATGATGATGA
>HV588726.1 JP 2010273681-A/49: Methods for Selecting Medications
GGTGTCGGAAA
>HV588725.1 JP 2010273681-A/48: Methods for Selecting Medications
GGTGTCGGAAC
>HV588714.1 JP 2010273681-A/37: Methods for Selecting Medications
GAGCTGGTGAA
>HV588713.1 JP 2010273681-A/36: Methods for Selecting Medications
GAGCTGGTGAG
>HV599516.1 JP 2011004744-A/626: HBM Variants that Modulate Bone Mass and Lipid Levels
GTGGTGAAGAC
>HV590933.1 JP 2011015690-A/652: Albumin Fusion Proteins
CCGCCACCATG
>HV586542.1 JP 2010535242-A/185: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCG
>HV586541.1 JP 2010535242-A/184: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGGTCGTTCT
>HV586540.1 JP 2010535242-A/183: NOVEL SYNTHETIC AGONISTS OF TLR9
CATTCGTTCAG
>HV586539.1 JP 2010535242-A/182: NOVEL SYNTHETIC AGONISTS OF TLR9
CATTCGTTCAG
>HV586537.1 JP 2010535242-A/180: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586536.1 JP 2010535242-A/179: NOVEL SYNTHETIC AGONISTS OF TLR9
TATGCGTTTTT
>HV586531.1 JP 2010535242-A/174: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586530.1 JP 2010535242-A/173: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGACAG
>HV586528.1 JP 2010535242-A/171: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586527.1 JP 2010535242-A/170: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAG
>HV586526.1 JP 2010535242-A/169: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGATCGATCG
>HV586525.1 JP 2010535242-A/168: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGACGAT
>HV586524.1 JP 2010535242-A/167: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586523.1 JP 2010535242-A/166: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586522.1 JP 2010535242-A/165: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586521.1 JP 2010535242-A/164: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586520.1 JP 2010535242-A/163: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586519.1 JP 2010535242-A/162: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586518.1 JP 2010535242-A/161: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586517.1 JP 2010535242-A/160: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586516.1 JP 2010535242-A/159: NOVEL SYNTHETIC AGONISTS OF TLR9
TAGTCGTTTTT
>HV586515.1 JP 2010535242-A/158: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586514.1 JP 2010535242-A/157: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV586513.1 JP 2010535242-A/156: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV586512.1 JP 2010535242-A/155: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV586511.1 JP 2010535242-A/154: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586510.1 JP 2010535242-A/153: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586509.1 JP 2010535242-A/152: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586508.1 JP 2010535242-A/151: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTTT
>HV586507.1 JP 2010535242-A/150: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAG
>HV586506.1 JP 2010535242-A/149: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586505.1 JP 2010535242-A/148: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586504.1 JP 2010535242-A/147: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586503.1 JP 2010535242-A/146: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTTT
>HV586502.1 JP 2010535242-A/145: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAG
>HV586501.1 JP 2010535242-A/144: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586500.1 JP 2010535242-A/143: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAG
>HV586499.1 JP 2010535242-A/142: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586498.1 JP 2010535242-A/141: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAC
>HV586497.1 JP 2010535242-A/140: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586496.1 JP 2010535242-A/139: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586495.1 JP 2010535242-A/138: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTCT
>HV586494.1 JP 2010535242-A/137: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586493.1 JP 2010535242-A/136: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAC
>HV586492.1 JP 2010535242-A/135: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586490.1 JP 2010535242-A/133: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586489.1 JP 2010535242-A/132: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586488.1 JP 2010535242-A/131: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586487.1 JP 2010535242-A/130: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586486.1 JP 2010535242-A/129: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586485.1 JP 2010535242-A/128: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586484.1 JP 2010535242-A/127: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586483.1 JP 2010535242-A/126: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586482.1 JP 2010535242-A/125: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTTT
>HV586481.1 JP 2010535242-A/124: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTAG
>HV586480.1 JP 2010535242-A/123: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586479.1 JP 2010535242-A/122: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586478.1 JP 2010535242-A/121: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586477.1 JP 2010535242-A/120: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586476.1 JP 2010535242-A/119: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586475.1 JP 2010535242-A/118: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586474.1 JP 2010535242-A/117: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586473.1 JP 2010535242-A/116: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586472.1 JP 2010535242-A/115: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586471.1 JP 2010535242-A/114: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586470.1 JP 2010535242-A/113: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586469.1 JP 2010535242-A/112: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586468.1 JP 2010535242-A/111: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586467.1 JP 2010535242-A/110: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586466.1 JP 2010535242-A/109: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586465.1 JP 2010535242-A/108: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586464.1 JP 2010535242-A/107: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586463.1 JP 2010535242-A/106: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586462.1 JP 2010535242-A/105: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586461.1 JP 2010535242-A/104: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586460.1 JP 2010535242-A/103: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586459.1 JP 2010535242-A/102: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586458.1 JP 2010535242-A/101: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGGTCGTTCG
>HV586457.1 JP 2010535242-A/100: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCG
>HV586455.1 JP 2010535242-A/98: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586454.1 JP 2010535242-A/97: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586453.1 JP 2010535242-A/96: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586452.1 JP 2010535242-A/95: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586451.1 JP 2010535242-A/94: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586450.1 JP 2010535242-A/93: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586449.1 JP 2010535242-A/92: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586448.1 JP 2010535242-A/91: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586447.1 JP 2010535242-A/90: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586446.1 JP 2010535242-A/89: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586445.1 JP 2010535242-A/88: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586444.1 JP 2010535242-A/87: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586443.1 JP 2010535242-A/86: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586442.1 JP 2010535242-A/85: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586441.1 JP 2010535242-A/84: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586440.1 JP 2010535242-A/83: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586439.1 JP 2010535242-A/82: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586438.1 JP 2010535242-A/81: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586437.1 JP 2010535242-A/80: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586436.1 JP 2010535242-A/79: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586435.1 JP 2010535242-A/78: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586434.1 JP 2010535242-A/77: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586433.1 JP 2010535242-A/76: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586432.1 JP 2010535242-A/75: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586431.1 JP 2010535242-A/74: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586430.1 JP 2010535242-A/73: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTTGTCGTTC
>HV586429.1 JP 2010535242-A/72: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTTGTCGTTC
>HV586428.1 JP 2010535242-A/71: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586427.1 JP 2010535242-A/70: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586426.1 JP 2010535242-A/69: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586425.1 JP 2010535242-A/68: NOVEL SYNTHETIC AGONISTS OF TLR9
TAGTCGTTCTC
>HV586424.1 JP 2010535242-A/67: NOVEL SYNTHETIC AGONISTS OF TLR9
TGGTCGTTCTT
>HV586423.1 JP 2010535242-A/66: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTCTT
>HV586422.1 JP 2010535242-A/65: NOVEL SYNTHETIC AGONISTS OF TLR9
TAGTCGTTTTT
>HV586421.1 JP 2010535242-A/64: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586420.1 JP 2010535242-A/63: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586419.1 JP 2010535242-A/62: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586418.1 JP 2010535242-A/61: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGATCGATCG
>HV586417.1 JP 2010535242-A/60: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586416.1 JP 2010535242-A/59: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGACGAT
>HV586406.1 JP 2010535242-A/49: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTTT
>HV586405.1 JP 2010535242-A/48: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586404.1 JP 2010535242-A/47: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTTT
>HV586403.1 JP 2010535242-A/46: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586402.1 JP 2010535242-A/45: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586401.1 JP 2010535242-A/44: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586400.1 JP 2010535242-A/43: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586399.1 JP 2010535242-A/42: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586398.1 JP 2010535242-A/41: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586397.1 JP 2010535242-A/40: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586396.1 JP 2010535242-A/39: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586395.1 JP 2010535242-A/38: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586394.1 JP 2010535242-A/37: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586393.1 JP 2010535242-A/36: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586392.1 JP 2010535242-A/35: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586391.1 JP 2010535242-A/34: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586390.1 JP 2010535242-A/33: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586389.1 JP 2010535242-A/32: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586388.1 JP 2010535242-A/31: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586387.1 JP 2010535242-A/30: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586386.1 JP 2010535242-A/29: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586385.1 JP 2010535242-A/28: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586383.1 JP 2010535242-A/26: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586382.1 JP 2010535242-A/25: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586381.1 JP 2010535242-A/24: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586380.1 JP 2010535242-A/23: NOVEL SYNTHETIC AGONISTS OF TLR9
CAGTCGTTCAG
>HV586379.1 JP 2010535242-A/22: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586378.1 JP 2010535242-A/21: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586377.1 JP 2010535242-A/20: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586376.1 JP 2010535242-A/19: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586375.1 JP 2010535242-A/18: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586374.1 JP 2010535242-A/17: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586373.1 JP 2010535242-A/16: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586372.1 JP 2010535242-A/15: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586371.1 JP 2010535242-A/14: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTTGTCGTTC
>HV586370.1 JP 2010535242-A/13: NOVEL SYNTHETIC AGONISTS OF TLR9
TAGTCGTTCTC
>HV586367.1 JP 2010535242-A/10: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTCGTTTTT
>HV586366.1 JP 2010535242-A/9: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTCT
>HV586364.1 JP 2010535242-A/7: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGAACGTTCG
>HV586360.1 JP 2010535242-A/3: NOVEL SYNTHETIC AGONISTS OF TLR9
TCAGTCGTTAC
>HV586359.1 JP 2010535242-A/2: NOVEL SYNTHETIC AGONISTS OF TLR9
TCTGTCGTTGT
>HV586358.1 JP 2010535242-A/1: NOVEL SYNTHETIC AGONISTS OF TLR9
TCGTACGTACG
>HV586115.1 JP 2010284172-A/15: Peptide Acceptor Ligation Methods
AAAAAAAAAAA
>HV580632.1 JP 2010531664-A/1: SYSTEM AND METHOD FOR ADAPTIVE REAGENT CONTROL IN NUCLEIC ACID SEQUENCING
GCGCCCCCCCC
>GZ341876.1 Sequence 191 from patent US 8188261
TCAGTCGCAGT
>GZ341875.1 Sequence 190 from patent US 8188261
TTGACTGTTGA
>GZ341874.1 Sequence 189 from patent US 8188261
TGCTGCTTGTG
>GZ341873.1 Sequence 188 from patent US 8188261
TGCTGCTTGTG
>GZ341872.1 Sequence 187 from patent US 8188261
TGCTGCTTGTG
>GZ341871.1 Sequence 186 from patent US 8188261
TGCTGCTGCTG
>GZ341870.1 Sequence 185 from patent US 8188261
TGCTGCCTTTG
>GZ341869.1 Sequence 184 from patent US 8188261
TGTTGTGTGAC
>GZ341868.1 Sequence 183 from patent US 8188261
TTGAACGACTT
>GZ341867.1 Sequence 182 from patent US 8188261
TGTTGTGTGAC
>GZ341866.1 Sequence 181 from patent US 8188261
TGCTGCTGCTG
>GZ341865.1 Sequence 180 from patent US 8188261
TGCTGCCTTTG
>GZ341864.1 Sequence 179 from patent US 8188261
TGTTGTGTGAC
>GZ341863.1 Sequence 178 from patent US 8188261
TGCTGCCTTTG
>GZ341862.1 Sequence 177 from patent US 8188261
TTGCTGAACGC
>GZ341861.1 Sequence 176 from patent US 8188261
TGCTTGAACGC
>GZ341860.1 Sequence 175 from patent US 8188261
TGCTGACGACT
>GZ341859.1 Sequence 174 from patent US 8188261
TGCGCTGAACT
>GZ341858.1 Sequence 173 from patent US 8188261
TGCGACTGACT
>GZ341857.1 Sequence 172 from patent US 8188261
TGCGAACGCTT
>GZ341856.1 Sequence 171 from patent US 8188261
TGACTGCGACT
>GZ341855.1 Sequence 170 from patent US 8188261
TGACGCTGACT
>GZ341854.1 Sequence 169 from patent US 8188261
TGGCTTGACGC
>GZ341853.1 Sequence 168 from patent US 8188261
AACTGTTGACC
>GZ341852.1 Sequence 167 from patent US 8188261
CTGAAGCTTGT
>GZ341851.1 Sequence 166 from patent US 8188261
CTGAAGCTTGT
>GZ341850.1 Sequence 165 from patent US 8188261
TGCTGCTTCTG
>GZ341849.1 Sequence 164 from patent US 8188261
TGCTGCTTCTG
>GZ341848.1 Sequence 163 from patent US 8188261
TGCCTTTGCTG
>GZ341847.1 Sequence 162 from patent US 8188261
TTCTGCTTCTG
>GZ341846.1 Sequence 161 from patent US 8188261
TGCTGCTTCTG
>GZ341845.1 Sequence 160 from patent US 8188261
TGCCTTTGCTG
>GZ341844.1 Sequence 159 from patent US 8188261
TTCTGCTTCTG
>GZ341843.1 Sequence 158 from patent US 8188261
GTCCTTGCTTG
>GZ341842.1 Sequence 157 from patent US 8188261
TGACGATGAGT
>GZ341841.1 Sequence 156 from patent US 8188261
TGCTGCTTCTG
>GZ341840.1 Sequence 155 from patent US 8188261
TGCTGCTTGTG
>GZ341839.1 Sequence 154 from patent US 8188261
TGAACGTGAAC
>GZ341838.1 Sequence 153 from patent US 8188261
TGAAGCTTGAA
>GZ341837.1 Sequence 152 from patent US 8188261
TGCTGCTGCTG
>GZ341836.1 Sequence 151 from patent US 8188261
CAACGAACCCT
>GZ341835.1 Sequence 150 from patent US 8188261
TGCTGCTTGTG
>GZ341834.1 Sequence 149 from patent US 8188261
TGCTGCTTGTG
>GZ341833.1 Sequence 148 from patent US 8188261
TGCTGCTTGTG
>GZ341832.1 Sequence 147 from patent US 8188261
TGCTGCCTTTG
>GZ341831.1 Sequence 146 from patent US 8188261
TGCTGCCTTTG
>GZ341830.1 Sequence 145 from patent US 8188261
TGCTGCCTTTG
>GZ341829.1 Sequence 144 from patent US 8188261
TGCTGCCTTTG
>GZ341828.1 Sequence 143 from patent US 8188261
TGCTGCCTTTG
>GZ341827.1 Sequence 142 from patent US 8188261
TGATGGAACGA
>GZ341826.1 Sequence 141 from patent US 8188261
TTGAACGACTT
>GZ341825.1 Sequence 140 from patent US 8188261
TTGTTGAACGA
>GZ341824.1 Sequence 139 from patent US 8188261
TTGACGATGAG
>GZ341823.1 Sequence 138 from patent US 8188261
TGATGAAGCTT
>GZ341822.1 Sequence 137 from patent US 8188261
GTTGAGGAACT
>GZ341821.1 Sequence 136 from patent US 8188261
TTGAGCTGGAC
>GZ341820.1 Sequence 135 from patent US 8188261
TGAGCGTGAAC
>GZ341819.1 Sequence 134 from patent US 8188261
TGCGAGACTGC
>GZ341818.1 Sequence 133 from patent US 8188261
TGTTGAACGAC
>GZ341817.1 Sequence 132 from patent US 8188261
TGTTGAGGAAC
>GZ341816.1 Sequence 131 from patent US 8188261
TGACGATGAGT
>GZ341815.1 Sequence 130 from patent US 8188261
TGGCTTGACGC
>GZ341814.1 Sequence 129 from patent US 8188261
TGAGCGTGAAC
>GZ341813.1 Sequence 128 from patent US 8188261
TGTTGAACGAC
>GZ341812.1 Sequence 127 from patent US 8188261
TGACTGATGAC
>GZ341811.1 Sequence 126 from patent US 8188261
GTTGAACGACT
>GZ341810.1 Sequence 125 from patent US 8188261
TGCGAGACTGC
>GZ341809.1 Sequence 124 from patent US 8188261
TGTTGAGGAAC
>GZ341808.1 Sequence 123 from patent US 8188261
TGATGAGGACT
>GZ341807.1 Sequence 122 from patent US 8188261
TGACGATGAGT
>GZ341806.1 Sequence 121 from patent US 8188261
TGCTGCTTGAA
>GZ341805.1 Sequence 120 from patent US 8188261
TGGCTTGACGC
>GZ341804.1 Sequence 119 from patent US 8188261
TGCTGCTTCTG
>GZ341803.1 Sequence 118 from patent US 8188261
TGCTGCTTCTG
>GZ341802.1 Sequence 117 from patent US 8188261
TGCTGCCTTTG
>GZ341801.1 Sequence 116 from patent US 8188261
TGCTGCTTCTG
>GZ341800.1 Sequence 115 from patent US 8188261
TGCCTTTGCTG
>GZ341799.1 Sequence 114 from patent US 8188261
TGCTGCCTTTG
>GZ341798.1 Sequence 113 from patent US 8188261
TTCTGCTTCTG
>GZ341797.1 Sequence 112 from patent US 8188261
GTCCTTGCTTG
>GZ341796.1 Sequence 111 from patent US 8188261
TGCTGCCTTTG
>GZ341795.1 Sequence 110 from patent US 8188261
TGCTGCCTTTG
>GZ341794.1 Sequence 109 from patent US 8188261
TGCTGCCTTTG
>GZ341793.1 Sequence 108 from patent US 8188261
TGCTGCCTTTG
>GZ341792.1 Sequence 107 from patent US 8188261
TGCTGCCTTTG
>GZ341791.1 Sequence 106 from patent US 8188261
TGCTGCCTTTG
>GZ341790.1 Sequence 105 from patent US 8188261
TGCTGCCTTTG
>GZ341789.1 Sequence 104 from patent US 8188261
TGCTGCCTTTG
>GZ341788.1 Sequence 103 from patent US 8188261
TGCTGCCTTTG
>GZ341787.1 Sequence 102 from patent US 8188261
AAGACTGAACT
>GZ341786.1 Sequence 101 from patent US 8188261
CCGACTTGGAC
>GZ341785.1 Sequence 100 from patent US 8188261
TCGACTTCCAG
>GZ341784.1 Sequence 99 from patent US 8188261
TTGGACTCCAG
>GZ341783.1 Sequence 98 from patent US 8188261
AACTGCTGGAT
>GZ341782.1 Sequence 97 from patent US 8188261
ACGTCTGACGA
>GZ341781.1 Sequence 96 from patent US 8188261
CGATGCGATGA
>GZ341780.1 Sequence 95 from patent US 8188261
ACTTTGACGAT
>GZ341779.1 Sequence 94 from patent US 8188261
ACGATTGTGAC
>GZ341778.1 Sequence 93 from patent US 8188261
CGTTGTGATGA
>GZ341777.1 Sequence 92 from patent US 8188261
CAACGACCTGT
>GZ341776.1 Sequence 91 from patent US 8188261
CAACGACCTGT
>GZ341775.1 Sequence 90 from patent US 8188261
AACGAACCGAC
>GZ341774.1 Sequence 89 from patent US 8188261
CCGATGCATCG
>GZ341773.1 Sequence 88 from patent US 8188261
TGTTGTGTGAC
>GZ341772.1 Sequence 87 from patent US 8188261
GCACACTTGTT
>GZ341771.1 Sequence 86 from patent US 8188261
CACTGTTGAGA
>GZ341770.1 Sequence 85 from patent US 8188261
AACTGTTGACC
>GZ341769.1 Sequence 84 from patent US 8188261
ATGCTGCGCTG
>GZ341768.1 Sequence 83 from patent US 8188261
ATGCTGCGCTG
>GZ341767.1 Sequence 82 from patent US 8188261
ATGCTGCGCTG
>GZ341766.1 Sequence 81 from patent US 8188261
CAACGACCTGT
>GZ341765.1 Sequence 80 from patent US 8188261
AACTGTTGACC
>GZ341764.1 Sequence 79 from patent US 8188261
CACTGTTGAGA
>GZ341763.1 Sequence 78 from patent US 8188261
CAACGACCTGT
>GZ341762.1 Sequence 77 from patent US 8188261
AACTGTTGACC
>GZ341761.1 Sequence 76 from patent US 8188261
CACTGTTGAGA
>GZ341760.1 Sequence 75 from patent US 8188261
AAAAAAAAAAA
>GZ341759.1 Sequence 74 from patent US 8188261
AGCACAACTGT
>GZ341758.1 Sequence 73 from patent US 8188261
CCGATGCATCG
>GZ341757.1 Sequence 72 from patent US 8188261
CCGATGCATCG
>GZ341756.1 Sequence 71 from patent US 8188261
CCGATGCATCG
>GZ341755.1 Sequence 70 from patent US 8188261
CCGATGCCGAC
>GZ341754.1 Sequence 69 from patent US 8188261
CCGATGCCGAC
>GZ341753.1 Sequence 68 from patent US 8188261
CCGATGCCGAC
>GZ341752.1 Sequence 67 from patent US 8188261
GTGCCTGATGA
>GZ341751.1 Sequence 66 from patent US 8188261
GTGCCTGATGA
>GZ341750.1 Sequence 65 from patent US 8188261
GTGCCTGATGA
>GZ341749.1 Sequence 64 from patent US 8188261
CCGATGCATCG
>GZ341748.1 Sequence 63 from patent US 8188261
CCGATGCCGAC
>GZ341747.1 Sequence 62 from patent US 8188261
GTGCCTGATGA
>GZ341746.1 Sequence 61 from patent US 8188261
TTGACGTTGAC
>GZ341745.1 Sequence 60 from patent US 8188261
TTGACGTTGAC
>GZ341744.1 Sequence 59 from patent US 8188261
TTGACGTTGAC
>GZ341743.1 Sequence 58 from patent US 8188261
TTGACGTTGAC
>GZ341742.1 Sequence 57 from patent US 8188261
TGTTCGAACAC
>GZ341741.1 Sequence 56 from patent US 8188261
TGTTGTTTGTG
>GZ341740.1 Sequence 55 from patent US 8188261
TGCTGCTTTTG
>GZ341739.1 Sequence 54 from patent US 8188261
TTGACTGATGA
>GZ341738.1 Sequence 53 from patent US 8188261
TGCTGCTTGAA
>GZ341737.1 Sequence 52 from patent US 8188261
TGATGAAGCTT
>GZ341736.1 Sequence 51 from patent US 8188261
TGTTGTTTGTG
>GZ341735.1 Sequence 50 from patent US 8188261
TGCTGCTTTTG
>GZ341734.1 Sequence 49 from patent US 8188261
AGTGTTTTCTG
>GZ341733.1 Sequence 48 from patent US 8188261
TGCGCGAACTT
>GZ341732.1 Sequence 47 from patent US 8188261
TGACGACTTGC
>GZ341731.1 Sequence 46 from patent US 8188261
TGACGACTGCT
>GZ341730.1 Sequence 45 from patent US 8188261
TGACGACGCTT
>GZ341729.1 Sequence 44 from patent US 8188261
TGCTGCTTCTG
>GZ341728.1 Sequence 43 from patent US 8188261
TGCTGCCTTTG
>GZ341727.1 Sequence 42 from patent US 8188261
TGCTGCTTCTG
>GZ341726.1 Sequence 41 from patent US 8188261
TGACGATGAGT
>GZ341725.1 Sequence 40 from patent US 8188261
TGCTGCCTTTG
>GZ341724.1 Sequence 39 from patent US 8188261
TGCTGCTTCTG
>GZ341723.1 Sequence 38 from patent US 8188261
TGCTGCTTCTG
>GZ341722.1 Sequence 37 from patent US 8188261
TGCTGCTTGTG
>GZ341721.1 Sequence 36 from patent US 8188261
TGCTGCTTGTG
>GZ341720.1 Sequence 35 from patent US 8188261
CTGAAGCTTGT
>GZ341719.1 Sequence 34 from patent US 8188261
GATTGTGACGT
>GZ341718.1 Sequence 33 from patent US 8188261
TGCTGCCTTTG
>GZ341717.1 Sequence 32 from patent US 8188261
TGCTGCTTGTG
>GZ341716.1 Sequence 31 from patent US 8188261
TGCTGCTTGTG
>GZ341715.1 Sequence 30 from patent US 8188261
TGTTGTGTGAC
>GZ341714.1 Sequence 29 from patent US 8188261
TGCTGCTTCTG
>GZ341713.1 Sequence 28 from patent US 8188261
TGCTGCTTCTG
>GZ341712.1 Sequence 27 from patent US 8188261
TGCTGCCTTTG
>GZ341711.1 Sequence 26 from patent US 8188261
TGCTGCCTTTG
>GZ341710.1 Sequence 25 from patent US 8188261
TGCTGCCTTTG
>GZ341709.1 Sequence 24 from patent US 8188261
TGCTGCTTCTG
>GZ341708.1 Sequence 23 from patent US 8188261
TGCTGCTTGTG
>GZ341707.1 Sequence 22 from patent US 8188261
TGCTGCTTGTG
>GZ341706.1 Sequence 21 from patent US 8188261
TGCTGCTTGTG
>GZ341705.1 Sequence 20 from patent US 8188261
TGCTGCCTTTG
>GZ341704.1 Sequence 19 from patent US 8188261
TGCTGCCTTTG
>GZ341703.1 Sequence 18 from patent US 8188261
TGCTGCCTTTG
>GZ341702.1 Sequence 17 from patent US 8188261
TGCTGCTTGTG
>GZ341701.1 Sequence 16 from patent US 8188261
TGCTGCTTGTG
>GZ341700.1 Sequence 15 from patent US 8188261
TGCTGCTTGTG
>GZ341699.1 Sequence 14 from patent US 8188261
TGCTGCTTGTG
>GZ341698.1 Sequence 13 from patent US 8188261
TGCTGCTTGTG
>GZ341697.1 Sequence 12 from patent US 8188261
ATGCTGCGCTG
>GZ341696.1 Sequence 11 from patent US 8188261
GTGCCTGATGA
>GZ341695.1 Sequence 10 from patent US 8188261
TTGACGTTGAC
>GZ341694.1 Sequence 9 from patent US 8188261
GTCCTTTGCTG
>GZ341693.1 Sequence 8 from patent US 8188261
TTCTGCTTCTG
>GZ341692.1 Sequence 7 from patent US 8188261
GTCCTTGCTTG
>GZ341691.1 Sequence 6 from patent US 8188261
TGCTGCCTTTG
>GZ341690.1 Sequence 5 from patent US 8188261
TGCTGCTTGTG
>GZ341689.1 Sequence 4 from patent US 8188261
GTCCTTTGCTG
>GZ341688.1 Sequence 3 from patent US 8188261
TGCTGCCTTTG
>GZ341687.1 Sequence 2 from patent US 8188261
TGCTGCCTTTG
>GZ341686.1 Sequence 1 from patent US 8188261
TTCTGCTTCTG
>GZ340615.1 Sequence 41 from patent US 8188254
TCGTCGTTTTA
>GZ340588.1 Sequence 14 from patent US 8188254
GTCGAGGAGGT
>GZ340576.1 Sequence 2 from patent US 8188254
CCGTTTTGTGG
>GZ340549.1 Sequence 3 from patent US 8188252
TTTGGCGGGAA
>GZ335785.1 Sequence 1 from patent US 8106251
GCTGTCGGAAG
>GZ335721.1 Sequence 26 from patent US 8106180
CTCGAGCTCCA
>GZ335376.1 Sequence 125 from patent US 8106173
CAGAAGCAGCA
>GZ335375.1 Sequence 124 from patent US 8106173
TGCTGCTTCTG
>GZ335373.1 Sequence 122 from patent US 8106173
CCNNCCNNCCC
>GZ335369.1 Sequence 118 from patent US 8106173
CCCNNNCCCNN
>GZ335368.1 Sequence 117 from patent US 8106173
TGCTGCTTGTG
>GZ335367.1 Sequence 116 from patent US 8106173
TGCTGCTTGTG
>GZ335365.1 Sequence 114 from patent US 8106173
TGCTGCTTGTG
>GZ335364.1 Sequence 113 from patent US 8106173
GTCCTTTGCTG
>GZ335363.1 Sequence 112 from patent US 8106173
GTCCTTTGCTG
>GZ335362.1 Sequence 111 from patent US 8106173
TGCTGCCTTTG
>GZ335361.1 Sequence 110 from patent US 8106173
TGCTGCCTTTG
>GZ335360.1 Sequence 109 from patent US 8106173
GTCCTTGCTTG
>GZ335359.1 Sequence 108 from patent US 8106173
TTCTGCTTCTG
>GZ335358.1 Sequence 107 from patent US 8106173
TTCTGCTTCTG
>GZ335357.1 Sequence 106 from patent US 8106173
TTCTGCTTCTG
>GZ335356.1 Sequence 105 from patent US 8106173
GTCCTTGCTTG
>GZ335355.1 Sequence 104 from patent US 8106173
GTCCTTGCTTG
>GZ335354.1 Sequence 103 from patent US 8106173
CAACGAACCCT
>GZ335353.1 Sequence 102 from patent US 8106173
AGTGTTTTCTG
>GZ335352.1 Sequence 101 from patent US 8106173
TGCTGCTTCTG
>GZ335351.1 Sequence 100 from patent US 8106173
TGCTGCTTCTG
>GZ335350.1 Sequence 99 from patent US 8106173
AGTGTTTTCTG
>GZ335349.1 Sequence 98 from patent US 8106173
TGCTGAGTGTT
>GZ335348.1 Sequence 97 from patent US 8106173
AGCACAACTGT
>GZ335347.1 Sequence 96 from patent US 8106173
CAACGACCTGT
>GZ335346.1 Sequence 95 from patent US 8106173
AACTGTTGACC
>GZ335345.1 Sequence 94 from patent US 8106173
CACTGTTGACA
>GZ335344.1 Sequence 93 from patent US 8106173
CACTGTTGAGA
>GZ335343.1 Sequence 92 from patent US 8106173
GCACACTTGTT
>GZ335342.1 Sequence 91 from patent US 8106173
GTTTGCACAAC
>GZ335341.1 Sequence 90 from patent US 8106173
TCTGAATTCAG
>GZ335340.1 Sequence 89 from patent US 8106173
GTCCTTGCTTG
>GZ335339.1 Sequence 88 from patent US 8106173
TTGGTTGTTTG
>GZ335338.1 Sequence 87 from patent US 8106173
TGAAGCTTCTG
>GZ335337.1 Sequence 86 from patent US 8106173
AGAAGCTTCTG
>GZ335336.1 Sequence 84 from patent US 8106173
GTCCTTCAACT
>GZ335335.1 Sequence 83 from patent US 8106173
AGTTGAAGGAC
>GZ335327.1 Sequence 75 from patent US 8106173
TGCTGCTTGTG
>GZ335326.1 Sequence 74 from patent US 8106173
GTCCTTGCTTG
>GZ335325.1 Sequence 73 from patent US 8106173
TTGGTTGTTTG
>GZ335324.1 Sequence 72 from patent US 8106173
GTCCTTGCTTG
>GZ335323.1 Sequence 71 from patent US 8106173
TTGGTTGTTTG
>GZ335322.1 Sequence 70 from patent US 8106173
TGTTRTGTGAC
>GZ335321.1 Sequence 69 from patent US 8106173
GTCCTTCTCTG
>GZ335320.1 Sequence 68 from patent US 8106173
TTCTGCTTCTG
>GZ335319.1 Sequence 67 from patent US 8106173
TTCTGCTTCTG
>GZ335318.1 Sequence 66 from patent US 8106173
TGCCTTGAACT
>GZ335317.1 Sequence 65 from patent US 8106173
TTGCTGTTGCT
>GZ335316.1 Sequence 63 from patent US 8106173
TGCTGCTTCTG
>GZ335315.1 Sequence 62 from patent US 8106173
GTCCTTTGCTG
>GZ335314.1 Sequence 61 from patent US 8106173
GTCCTTGCTTG
>GZ335313.1 Sequence 60 from patent US 8106173
TGCTGCCTTTG
>GZ335312.1 Sequence 59 from patent US 8106173
TTGGTTGTTTG
>GZ335311.1 Sequence 58 from patent US 8106173
TGNTGCTTCTG
>GZ335310.1 Sequence 57 from patent US 8106173
TGCTGCTTCTG
>GZ335309.1 Sequence 56 from patent US 8106173
TGCTGCTTGTG
>GZ335308.1 Sequence 55 from patent US 8106173
TGCTGCTTCTG
>GZ335307.1 Sequence 54 from patent US 8106173
TGCTGCTTGTG
>GZ335306.1 Sequence 53 from patent US 8106173
TGCTGCTTGTG
>GZ335305.1 Sequence 52 from patent US 8106173
TGCTGCTTGTG
>GZ335304.1 Sequence 51 from patent US 8106173
TGCTGCTTGTG
>GZ335303.1 Sequence 50 from patent US 8106173
GTCCTTGCTTG
>GZ335302.1 Sequence 49 from patent US 8106173
TTGGTTGTTTG
>GZ335301.1 Sequence 48 from patent US 8106173
CTTTGGTGTGT
>GZ335300.1 Sequence 47 from patent US 8106173
TTGGTTGTTTG
>GZ335299.1 Sequence 46 from patent US 8106173
CTTTGGTGTGT
>GZ335298.1 Sequence 45 from patent US 8106173
TTGCTGTTGCT
>GZ335297.1 Sequence 44 from patent US 8106173
TTGCCCTTGCC
>GZ335296.1 Sequence 43 from patent US 8106173
TGCTGCTGCTG
>GZ335295.1 Sequence 42 from patent US 8106173
TGCTGCTTGTG
>GZ335294.1 Sequence 41 from patent US 8106173
TGCTGCTGCTG
>GZ335293.1 Sequence 40 from patent US 8106173
GTCCTTTGCTG
>GZ335292.1 Sequence 39 from patent US 8106173
GTCCTTGCTTG
>GZ335291.1 Sequence 38 from patent US 8106173
TGCTGCCTTTG
>GZ335290.1 Sequence 37 from patent US 8106173
GGCTGCTTGTG
>GZ335289.1 Sequence 36 from patent US 8106173
TGCTGCTTGTG
>GZ335288.1 Sequence 35 from patent US 8106173
TGCTGCTTGTG
>GZ335287.1 Sequence 34 from patent US 8106173
CTGGCGGCCTT
>GZ335286.1 Sequence 33 from patent US 8106173
TGTTGTGTGAC
>GZ335285.1 Sequence 32 from patent US 8106173
TGCTGCTTGTG
>GZ335284.1 Sequence 31 from patent US 8106173
TGCTGCTTCTG
>GZ335283.1 Sequence 30 from patent US 8106173
TGCTGCTTGTG
>GZ335282.1 Sequence 29 from patent US 8106173
TGCTGCTTGTG
>GZ335281.1 Sequence 28 from patent US 8106173
TGCTGCTTATG
>GZ335280.1 Sequence 27 from patent US 8106173
TGCTGCTGCTG
>GZ335279.1 Sequence 26 from patent US 8106173
TGCTGCTTGTG
>GZ335278.1 Sequence 25 from patent US 8106173
TGCTGCTACTG
>GZ335277.1 Sequence 24 from patent US 8106173
TGCTGCTTCTG
>GZ335276.1 Sequence 23 from patent US 8106173
TGCTGCTTCTG
>GZ335275.1 Sequence 22 from patent US 8106173
TGCTGCTTCTG
>GZ335274.1 Sequence 21 from patent US 8106173
TGCTGCTTCTG
>GZ335273.1 Sequence 20 from patent US 8106173
TGCTGCTTCTG
>GZ335272.1 Sequence 19 from patent US 8106173
NTCCTTCAACT
>GZ335271.1 Sequence 18 from patent US 8106173
TNCTNCTTCTN
>GZ335270.1 Sequence 17 from patent US 8106173
TNCTNCTTCTN
>GZ335269.1 Sequence 16 from patent US 8106173
NTCCTTCAACT
>GZ335268.1 Sequence 15 from patent US 8106173
GTCCTTCAACT
>GZ335267.1 Sequence 14 from patent US 8106173
TGCTGCTTCTG
>GZ335266.1 Sequence 13 from patent US 8106173
GTCCTTCAACT
>GZ335265.1 Sequence 12 from patent US 8106173
GTCCTTCAACT
>GZ335264.1 Sequence 11 from patent US 8106173
TGCTGCTTCTG
>GZ335263.1 Sequence 10 from patent US 8106173
TGCTGCTTCTG
>GZ335262.1 Sequence 9 from patent US 8106173
TGCTGCTTCTG
>GZ335259.1 Sequence 5 from patent US 8106173
GTGTGTGTGTG
>GZ335258.1 Sequence 4 from patent US 8106173
TNCAANCTTNC
>GZ335257.1 Sequence 3 from patent US 8106173
TCTGTGCTTCT
>GZ335256.1 Sequence 2 from patent US 8106173
CTGTGCTTCTC
>GZ335255.1 Sequence 1 from patent US 8106173
TGCTGCTTCTG
>GZ330575.1 Sequence 5232 from patent US 8105826
GTGGTGAAGAC
>GZ324322.1 Sequence 141 from patent US 8105775
TGCATAGGGTT
>GZ324321.1 Sequence 140 from patent US 8105775
TGCATAGGGCC
>GZ324320.1 Sequence 139 from patent US 8105775
TGCATAGGCTC
>GZ324319.1 Sequence 138 from patent US 8105775
TGCATAGAGTC
>GZ324318.1 Sequence 137 from patent US 8105775
TGCATAAGGTC
>GZ324317.1 Sequence 136 from patent US 8105775
TGCATGGGGTC
>GZ324316.1 Sequence 135 from patent US 8105775
TGCACAGGGTC
>GZ324315.1 Sequence 134 from patent US 8105775
TGCGTAGGGTC
>GZ324314.1 Sequence 133 from patent US 8105775
TGTATAGGGTC
>GZ324313.1 Sequence 132 from patent US 8105775
TACATAGGGTC
>GZ324312.1 Sequence 131 from patent US 8105775
CGCATAGGGTC
>GZ324311.1 Sequence 130 from patent US 8105775
TGCATAGGGTC
>GZ324306.1 Sequence 125 from patent US 8105775
TGCATAGGGCC
>GZ324305.1 Sequence 124 from patent US 8105775
TGCATAGGGTT
>GZ324304.1 Sequence 123 from patent US 8105775
TGCATAGGGCT
>GZ324303.1 Sequence 122 from patent US 8105775
TGCATAGAGCT
>GZ324302.1 Sequence 121 from patent US 8105775
TGCATAAGGCT
>GZ324301.1 Sequence 120 from patent US 8105775
TGCATGGGGCT
>GZ324300.1 Sequence 119 from patent US 8105775
TGCACAGGGCT
>GZ324299.1 Sequence 118 from patent US 8105775
TGCGTAGGGCT
>GZ324298.1 Sequence 117 from patent US 8105775
TGTATAGGGCT
>GZ324297.1 Sequence 116 from patent US 8105775
TACATAGGGCT
>GZ324296.1 Sequence 115 from patent US 8105775
CGCATAGGGCT
>GZ324295.1 Sequence 114 from patent US 8105775
TGCATAGGGCT
>GZ321628.1 Sequence 2 from patent US 8183359
ACGTAGCATCC
>GZ321341.1 Sequence 39 from patent US 8183222
GATCGATCGAT
>GZ321330.1 Sequence 27 from patent US 8183222
GTTAGGGTTAG
>GZ321329.1 Sequence 26 from patent US 8183222
GTTAGGGTTAG
>GZ321328.1 Sequence 25 from patent US 8183222
GTTAGGGTTAG
>GZ321327.1 Sequence 24 from patent US 8183222
GTTAGGGTTAG
>GZ321315.1 Sequence 5 from patent US 8183222
GTTAGGGTTAG
>GZ321314.1 Sequence 4 from patent US 8183222
GTACGTACGTA
>GZ321313.1 Sequence 3 from patent US 8183222
CTAACCCTAAC
>GZ321312.1 Sequence 2 from patent US 8183222
GTTAGGGTTAG
>GZ319771.1 Sequence 210 from patent US 8182990
ACAGNTCCCGT
>GZ319476.1 Sequence 3 from patent US 8182986
CTTTGGCCACG
>GZ307563.1 Sequence 281 from patent US 8193159
CCAATGTCGCC
>GZ307559.1 Sequence 255 from patent US 8193159
GAGGGACGTGC
>GZ306854.1 Sequence 63 from patent US 8192953
AGCTTGAATTC
>GZ306852.1 Sequence 61 from patent US 8192953
GGGATCGTGTA
>GZ306850.1 Sequence 59 from patent US 8192953
GGGATCGTGTA
>GZ306848.1 Sequence 57 from patent US 8192953
CAGACGGTCTA
>GZ306846.1 Sequence 55 from patent US 8192953
AGCTTGAATTC
>GZ306843.1 Sequence 51 from patent US 8192953
AGCTTGAATTC
>GZ306839.1 Sequence 46 from patent US 8192953
AGCTTGAATTC
>GZ305836.1 Sequence 42 from patent US 8192932
CACTATCGGAA
>GZ305304.1 Sequence 60 from patent US 8178659
GCTAGTAATCG
>GZ305303.1 Sequence 47 from patent US 8178659
GTGCTGCATGG
>GZ305299.1 Sequence 21 from patent US 8178659
TATTGCACAAT
>GZ305295.1 Sequence 1 from patent US 8178659
GCGGCAGGCCT
>GZ302942.1 Sequence 43 from patent US 8178504
CCANNNNNTGG
>GZ302941.1 Sequence 41 from patent US 8178504
GCNNNNNNNGC
>GZ302938.1 Sequence 37 from patent US 8178504
CCTNNNNNAGG
>GZ302935.1 Sequence 33 from patent US 8178504
GCANNNNNTGC
>GZ302934.1 Sequence 32 from patent US 8178504
CCNNNNNNNGG
>GZ302932.1 Sequence 30 from patent US 8178504
GCCNNNNNGGC
>GZ302929.1 Sequence 26 from patent US 8178504
GACNNNNNGTC
>GZ302140.1 Sequence 20 from patent US 8178298
ATATCCAGCAC
>GZ300589.1 Sequence 17 from patent US 8173793
AGCAGTCGGTA
>GZ298239.1 Sequence 2 from patent US 8173394
ATTGGNCCACG
>GZ298221.1 Sequence 88 from patent US 8173393
GGTTCGANTCC
>GZ296439.1 Sequence 15 from patent US 8168854
AATGGTTACGA
>GZ275799.1 Sequence 2 from patent US 8168407
GGTTCGANTCC
>GZ275446.1 Sequence 2 from patent US 8168385
NNAGAAGCGGG
>GZ275392.1 Sequence 83 from patent US 8168381
TATCTACAGAG
>GZ275332.1 Sequence 22 from patent US 8168381
TCTCGAGCATG
>GZ253326.1 Sequence 53 from patent US 8163708
CGTTCGTTCTT
>GZ253317.1 Sequence 44 from patent US 8163708
TCTGATAAGCT
>GZ253308.1 Sequence 35 from patent US 8163708
GATTAGCATTA
>GZ253299.1 Sequence 26 from patent US 8163708
TGGATTTGCAC
>GZ253290.1 Sequence 17 from patent US 8163708
TGTCACACTCC
>GZ252925.1 Sequence 7 from patent US 8163528
ATGAGGTACCG
>GZ252477.1 Sequence 28 from patent US 8163493
ACGDAGNCNDG
>GZ252476.1 Sequence 27 from patent US 8163493
AGANGADTDNA
>GZ252475.1 Sequence 26 from patent US 8163493
ACANGADTDNA
>GZ252474.1 Sequence 25 from patent US 8163493
ACADGGNTNNA
>GZ252473.1 Sequence 24 from patent US 8163493
GCADGANTDNA
>GZ252226.1 Sequence 31 from patent US 8163482
CAGTCATCTCA
>GZ250864.1 Sequence 104 from patent US 8158768
TCGAACGTTCG
>GZ246778.1 Sequence 134 from patent US 8158355
AAAAAAAAAGC
>GZ246701.1 Sequence 57 from patent US 8158355
GCTCTTCNNNN
>GZ246696.1 Sequence 52 from patent US 8158355
CCTCNNNNNNN
>GZ246691.1 Sequence 47 from patent US 8158355
CCTTCNNNNNN
>GZ246684.1 Sequence 40 from patent US 8158355
CCCGCNNNNNN
>GZ246682.1 Sequence 38 from patent US 8158355
CGTCTCNNNNN
>GZ246679.1 Sequence 35 from patent US 8158355
GGTCTCNNNNN
>GZ246667.1 Sequence 23 from patent US 8158355
GCATCNNNNNN
>GZ246663.1 Sequence 19 from patent US 8158355
ACTGGGNNNNN
>GZ246158.1 Sequence 49 from patent US 8158123
GCATAAATAAT
>GZ246157.1 Sequence 48 from patent US 8158123
GCATNNNTAAT
>GZ244434.1 Sequence 192 from patent US 8153608
TCTGTNGTTCT
>GZ244433.1 Sequence 191 from patent US 8153608
TCTGANGTTCT
>GZ244427.1 Sequence 184 from patent US 8153608
TNNTNNTTCTG
>GZ244426.1 Sequence 183 from patent US 8153608
TNGTNGTTCTG
>GZ244425.1 Sequence 182 from patent US 8153608
TNGTNGTTCTG
>GZ244424.1 Sequence 181 from patent US 8153608
TNGTNGTTCTG
>GZ244423.1 Sequence 180 from patent US 8153608
TCNTCNTTCTG
>GZ244422.1 Sequence 179 from patent US 8153608
CTGTNGTTCTC
>GZ244421.1 Sequence 178 from patent US 8153608
CTGTNGTTCTC
>GZ244420.1 Sequence 177 from patent US 8153608
CTGTNGTTCTC
>GZ244419.1 Sequence 176 from patent US 8153608
CTGTCNTTCTC
>GZ244418.1 Sequence 175 from patent US 8153608
TCTGTNGTTCT
>GZ244417.1 Sequence 174 from patent US 8153608
TCTGTNGTTCT
>GZ244416.1 Sequence 173 from patent US 8153608
TCTGTCNTTCT
>GZ244415.1 Sequence 172 from patent US 8153608
TCNTCNTTCTG
>GZ244414.1 Sequence 171 from patent US 8153608
CTGTCNTTCTC
>GZ244413.1 Sequence 170 from patent US 8153608
TCTGTNGTTCT
>GZ244412.1 Sequence 159 from patent US 8153608
TCTGTCGTTCT
>GZ244411.1 Sequence 158 from patent US 8153608
TCTGACGTTCT
>GZ244406.1 Sequence 153 from patent US 8153608
CTATCTGACGT
>GZ244404.1 Sequence 151 from patent US 8153608
ACGTTCTCTGT
>GZ244400.1 Sequence 147 from patent US 8153608
CTATCTGACGT
>GZ244395.1 Sequence 142 from patent US 8153608
ACGTTCTCTGT
>GZ244361.1 Sequence 108 from patent US 8153608
CCTACTAGCGT
>GZ244357.1 Sequence 104 from patent US 8153608
GCGTTCTCATC
>GZ244326.1 Sequence 70 from patent US 8153608
TCTGACNTTCT
>GZ244325.1 Sequence 69 from patent US 8153608
TCTGANGTTCT
>GZ244320.1 Sequence 62 from patent US 8153608
TCTGTCNTTCT
>GZ244319.1 Sequence 61 from patent US 8153608
TCTGTNGTTCT
>GZ244318.1 Sequence 58 from patent US 8153608
TCTTTCNTTCT
>GZ244317.1 Sequence 57 from patent US 8153608
TCTTTNGTTCT
>GZ244312.1 Sequence 46 from patent US 8153608
TCTGTCGTTCT
>GZ244308.1 Sequence 41 from patent US 8153608
TCTGACGTTCT
>GZ244302.1 Sequence 35 from patent US 8153608
TCTGANNTTCT
>GZ244301.1 Sequence 34 from patent US 8153608
TCTGACNTTCT
>GZ244299.1 Sequence 32 from patent US 8153608
TCTGACNTTCT
>GZ244295.1 Sequence 28 from patent US 8153608
TCTGTNNTTCT
>GZ244294.1 Sequence 27 from patent US 8153608
TCTGTCNTTCT
>GZ244293.1 Sequence 26 from patent US 8153608
TCTGTCGTTCT
>GZ244288.1 Sequence 21 from patent US 8153608
TCTGACGTTCT
>GZ244204.1 Sequence 117 from patent US 8153606
GGATGAAGAAG
>GZ244126.1 Sequence 39 from patent US 8153606
CTTCTTCATCC
>GZ243920.1 Sequence 25 from patent US 8153604
GTTGAGTGTAG
>GZ243913.1 Sequence 16 from patent US 8153604
GTTAGGGTTAG
>GZ243912.1 Sequence 15 from patent US 8153604
TAGGGTTAGAC
>GZ243904.1 Sequence 7 from patent US 8153604
GTGGAAGGCGG
>GZ242573.1 Sequence 5 from patent US 8153388
GCTTTGATCTT
>HV570570.1 JP 2012500009-A/62: DEVICE FOR RAPID IDENTIFICATION OF NUCLEIC ACIDS FOR BINDING TO SPECIFIC CHEMICAL TARGETS
CAGGAGCACGG
>HV569762.1 WO 2012014988-A/15: Method of manufacturing an RNA-containing probe for detection of target base
CTACTGCCGTC
>HV569760.1 WO 2012014988-A/13: Method of manufacturing an RNA-containing probe for detection of target base
CCATCCACTTT
>HV569756.1 WO 2012014988-A/9: Method of manufacturing an RNA-containing probe for detection of target base
TCACAAACGAA
>HV569755.1 WO 2012014988-A/8: Method of manufacturing an RNA-containing probe for detection of target base
AAGGCCACAGA
>HV567678.1 JP 2012024090-A/111: QIAGEN GAITHERSBURG, INC
CCCCAAAACCG
>HV567639.1 JP 2012024090-A/72: QIAGEN GAITHERSBURG, INC
CCACGCGTCGG
>HV567632.1 JP 2012024090-A/65: QIAGEN GAITHERSBURG, INC
TGCTGGCGGCG
>HV567614.1 JP 2012024090-A/47: QIAGEN GAITHERSBURG, INC
TCCAGAACCAC
>HV567601.1 JP 2012024090-A/34: QIAGEN GAITHERSBURG, INC
CGCCCCATCTT
>HV566837.1 JP 2012032377-A/10: Filler for ion exchange liquid chromatography and method for detecting separation of target nucleic acid
NNNNNGAGACG
>HV565650.1 JP 2012023998-A/34: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
ATGTTTTAGAC
>HV565647.1 JP 2012023998-A/31: METHOD FOR REGULATING EXPRESSION OF OBJECTIVE GENE IN EUKARYOTIC CELL, RNA MOLECULE AND DNA MOLECULE
CTGGTATAGAC
>HV573677.1 JP 2012502074-A/98: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
CGGCCCGCGGC
>HV573676.1 JP 2012502074-A/97: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GCCGCGGGCCG
>HV573648.1 JP 2012502074-A/69: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGGTTTTTGGG
>HV573637.1 JP 2012502074-A/58: Composition comprising a complexed (m)RNA and a naked mRNA for providing or enhancing an immunostimulatory response in a mammal and uses thereof
GGTTTTTTTGG
>HV558748.1 WO 2012001820-A/14: PSA Binding Aptamer and Method for Diagnosis of Prostate Cancer
CGCCATCAAAG
>HV558747.1 WO 2012001820-A/13: PSA Binding Aptamer and Method for Diagnosis of Prostate Cancer
CGCCATCAGAT
>HV558746.1 WO 2012001820-A/12: PSA Binding Aptamer and Method for Diagnosis of Prostate Cancer
CGCCATCAAAT
>HV565511.1 JP 2011530309-A/7: POLYVALENT VACCINE
CCANNNNNTGG
>HV565507.1 JP 2011530309-A/3: POLYVALENT VACCINE
GCCNNNNNGGC
>HV565188.1 JP 2011530289-A/1151: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTACTTGCAGA
>HV565187.1 JP 2011530289-A/1150: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTACAAGATCC
>HV565185.1 JP 2011530289-A/1148: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GCAAGACAAGA
>HV565184.1 JP 2011530289-A/1147: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTCTGTACCTC
>HV565175.1 JP 2011530289-A/1138: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGAAATGATCC
>HV565157.1 JP 2011530289-A/1120: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTTGTAGTGTA
>HV565154.1 JP 2011530289-A/1117: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTGCATCGGGC
>HV565148.1 JP 2011530289-A/1111: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTGGTGCGAGG
>HV565146.1 JP 2011530289-A/1109: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGTTGTCGAC
>HV565141.1 JP 2011530289-A/1104: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGTTCACAGGG
>HV565124.1 JP 2011530289-A/1087: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATGAGGCCGGA
>HV565120.1 JP 2011530289-A/1083: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTCCCACTGTA
>HV565114.1 JP 2011530289-A/1077: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGAAACCTTCC
>HV565112.1 JP 2011530289-A/1075: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAGCCCATACA
>HV565110.1 JP 2011530289-A/1073: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTGTAGCACTC
>HV565101.1 JP 2011530289-A/1064: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCGGGACTCTC
>HV565098.1 JP 2011530289-A/1061: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTGAAAATCAA
>HV565093.1 JP 2011530289-A/1056: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTGCTCTTGGG
>HV565087.1 JP 2011530289-A/1050: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GACTGTGAGCT
>HV565084.1 JP 2011530289-A/1047: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTTAAATGGAA
>HV565082.1 JP 2011530289-A/1045: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAACTCAGCAG
>HV565081.1 JP 2011530289-A/1044: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGAGAGTGTAC
>HV565077.1 JP 2011530289-A/1040: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCTGTGACAAA
>HV565074.1 JP 2011530289-A/1037: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATTTAAATATG
>HV565070.1 JP 2011530289-A/1033: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGTAGTGAGGA
>HV565069.1 JP 2011530289-A/1032: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAGGAGACTTG
>HV565066.1 JP 2011530289-A/1029: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTATCTCGCCT
>HV565062.1 JP 2011530289-A/1025: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TGACATCATAT
>HV565057.1 JP 2011530289-A/1020: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGTTCTCTTCA
>HV565047.1 JP 2011530289-A/1010: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CACTATTATCA
>HV565045.1 JP 2011530289-A/1008: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATGTAGACTGC
>HV565044.1 JP 2011530289-A/1007: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAACATGATGG
>HV565042.1 JP 2011530289-A/1005: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CACATCATCAC
>HV565038.1 JP 2011530289-A/1001: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAATTGGTAGA
>HV565026.1 JP 2011530289-A/989: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AACGCAAGTTG
>HV565025.1 JP 2011530289-A/988: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCCTTTATCCT
>HV565023.1 JP 2011530289-A/986: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATCTTGCTGAG
>HV565018.1 JP 2011530289-A/981: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTGCTACCACT
>HV565014.1 JP 2011530289-A/977: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCCTTTTGCTT
>HV565013.1 JP 2011530289-A/976: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CACACACATAC
>HV565010.1 JP 2011530289-A/973: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGTTAGGAGCC
>HV565008.1 JP 2011530289-A/971: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTTGAGGCTCA
>HV565004.1 JP 2011530289-A/967: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACGCCAGTCAA
>HV565002.1 JP 2011530289-A/965: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAGCCCTTCAG
>HV565001.1 JP 2011530289-A/964: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAAGCCCTTCA
>HV565000.1 JP 2011530289-A/963: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CAAAAGCCCTT
>HV564999.1 JP 2011530289-A/962: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCAAAAGCCCT
>HV564994.1 JP 2011530289-A/957: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAAAAGCTCCG
>HV564993.1 JP 2011530289-A/956: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CAGCGGCCAGT
>HV564990.1 JP 2011530289-A/953: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAAGCCCTTCA
>HV564989.1 JP 2011530289-A/952: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAGAAGCCCTT
>HV564987.1 JP 2011530289-A/950: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCAGCATGGCC
>HV564965.1 JP 2011530289-A/928: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GCCTGAAACAC
>HV564961.1 JP 2011530289-A/924: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TGCCGTTCAGG
>HV564954.1 JP 2011530289-A/917: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAGACCACCAC
>HV564936.1 JP 2011530289-A/899: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGAAGAGAGG
>HV564935.1 JP 2011530289-A/898: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GCTGGAGTGGT
>HV564907.1 JP 2011530289-A/870: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACTGCATTTGT
>HV564904.1 JP 2011530289-A/867: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AACATGGGCTG
>HV564895.1 JP 2011530289-A/858: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGCCCATACAG
>HV564890.1 JP 2011530289-A/853: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGGAAGAGGAC
>HV564889.1 JP 2011530289-A/852: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGTGAGGTTA
>HV564851.1 JP 2011530289-A/814: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GATGTAGCCGC
>HV564844.1 JP 2011530289-A/807: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AATCCTCCTGA
>HV564841.1 JP 2011530289-A/804: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCAGCCTAGAG
>HV564839.1 JP 2011530289-A/802: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GCTGCTGAACC
>HV564837.1 JP 2011530289-A/800: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTCCTCAAGCA
>HV564836.1 JP 2011530289-A/799: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AATGGCCCTGA
>HV564831.1 JP 2011530289-A/794: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATCAGTTCTGC
>HV564815.1 JP 2011530289-A/778: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TGCTGACCTCA
>HV564805.1 JP 2011530289-A/768: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTTACCTGCGA
>HV564804.1 JP 2011530289-A/767: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GATGGGTTACC
>HV564792.1 JP 2011530289-A/755: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCTACAATTGG
>HV564778.1 JP 2011530289-A/741: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAAAGCTCCGG
>HV564775.1 JP 2011530289-A/738: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCTTCAGCGGC
>HV564774.1 JP 2011530289-A/737: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GCCCTTCAGCG
>HV564771.1 JP 2011530289-A/734: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTTCTCCCTGA
>HV564769.1 JP 2011530289-A/732: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGAAAGCCCT
>HV564762.1 JP 2011530289-A/725: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCTGCGGGTTT
>HV564760.1 JP 2011530289-A/723: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGTTCACGGCC
>HV564739.1 JP 2011530289-A/702: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTATTCAGTGG
>HV564738.1 JP 2011530289-A/701: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACTATTCAGTG
>HV564736.1 JP 2011530289-A/699: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACCCAAGCTTA
>HV564734.1 JP 2011530289-A/697: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGGTCGGAAC
>HV564724.1 JP 2011530289-A/687: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCTGTTTGTTC
>HV564709.1 JP 2011530289-A/672: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAGTGATATGG
>HV564704.1 JP 2011530289-A/667: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGAGGAAGAGG
>HV564699.1 JP 2011530289-A/662: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACAGCTACACC
>HV564695.1 JP 2011530289-A/658: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TGGTGATCTGG
>HV564694.1 JP 2011530289-A/657: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCAGAATTGCC
>HV564692.1 JP 2011530289-A/655: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TATCGGCATGC
>HV564683.1 JP 2011530289-A/646: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTGAGAAAGCT
>HV564675.1 JP 2011530289-A/638: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGAGAGAGAAA
>HV564668.1 JP 2011530289-A/631: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCTCTGAACAG
>HV564666.1 JP 2011530289-A/629: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGGAAAGTGAA
>HV564664.1 JP 2011530289-A/627: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TGAATTTCAGG
>HV564663.1 JP 2011530289-A/626: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTCTTTCTCTA
>HV564661.1 JP 2011530289-A/624: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ACTCCCAATAA
>HV564659.1 JP 2011530289-A/622: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CAACCACATGC
>HV564652.1 JP 2011530289-A/615: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CATAAGTTGTG
>HV564643.1 JP 2011530289-A/606: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAATGTGGGTA
>HV564640.1 JP 2011530289-A/603: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CATGCTGCTGG
>HV564635.1 JP 2011530289-A/598: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CCAGAGCTGTG
>HV564629.1 JP 2011530289-A/592: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GTGAAACCTCA
>HV564624.1 JP 2011530289-A/587: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCTGTGAAGTG
>HV564597.1 JP 2011530289-A/560: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TAGTAGGGAGG
>HV564593.1 JP 2011530289-A/556: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AAAGAACTACT
>HV564592.1 JP 2011530289-A/555: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GAGAAAGTTTG
>HV564570.1 JP 2011530289-A/533: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TTCCAGCCCAC
>HV564546.1 JP 2011530289-A/509: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
AGCAAGGTTTA
>HV565051.1 JP 2011530289-A/1014: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
ATGCTGTAGAC
>HV564093.1 JP 2011530289-A/56: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCTTCGGAGTT
>HV564086.1 JP 2011530289-A/49: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
TCTTCGGAGTT
>HV564080.1 JP 2011530289-A/43: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV564071.1 JP 2011530289-A/34: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CTACACAAATC
>HV564064.1 JP 2011530289-A/27: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CAGCGATTTTT
>HV564059.1 JP 2011530289-A/22: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV564056.1 JP 2011530289-A/19: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
CGGAGACAATG
>HV564046.1 JP 2011530289-A/9: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV564043.1 JP 2011530289-A/6: NUCLEIC ACID COMPOUNDS FOR INHIBITING PLK1 GENE EXPRESSION AND USES THEREOF
GATTTCCATGT
>HV563285.1 JP 2011530288-A/1151: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTACTTGCAGA
>HV563284.1 JP 2011530288-A/1150: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTACAAGATCC
>HV563282.1 JP 2011530288-A/1148: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GCAAGACAAGA
>HV563281.1 JP 2011530288-A/1147: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTCTGTACCTC
>HV563272.1 JP 2011530288-A/1138: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGAAATGATCC
>HV555583.1 JP 2012018592-A/2: A device for analyzing sequences, a method for analyzing sequences, and a computer program
AGCGTGATAGA
>HV555582.1 JP 2012018592-A/1: A device for analyzing sequences, a method for analyzing sequences, and a computer program
ATGCGTATAGT
>HV555558.1 JP 2012005458-A/32: METHOD FOR SELECTING AN APTAMER
GAATATCCTAC
>HV555557.1 JP 2012005458-A/31: METHOD FOR SELECTING AN APTAMER
ACACAGCCCGA
>HV555556.1 JP 2012005458-A/30: METHOD FOR SELECTING AN APTAMER
CAAATACTGTC
>HV555555.1 JP 2012005458-A/29: METHOD FOR SELECTING AN APTAMER
GTAAGACACCG
>HV555554.1 JP 2012005458-A/28: METHOD FOR SELECTING AN APTAMER
GAATATCCTAC
>HV555553.1 JP 2012005458-A/27: METHOD FOR SELECTING AN APTAMER
ACACAGCCCGA
>HV555552.1 JP 2012005458-A/26: METHOD FOR SELECTING AN APTAMER
CAAATACTGTC
>HV555551.1 JP 2012005458-A/25: METHOD FOR SELECTING AN APTAMER
GTAAGACACCG
>HV555550.1 JP 2012005458-A/24: METHOD FOR SELECTING AN APTAMER
AAAAATCCCAC
>HV555549.1 JP 2012005458-A/23: METHOD FOR SELECTING AN APTAMER
AAACAACCCGC
>HV555548.1 JP 2012005458-A/22: METHOD FOR SELECTING AN APTAMER
AAAAAACTCTC
>HV555547.1 JP 2012005458-A/21: METHOD FOR SELECTING AN APTAMER
GAAAGACCCCC
>HV555546.1 JP 2012005458-A/20: METHOD FOR SELECTING AN APTAMER
GAAAGACCCGC
>HV555545.1 JP 2012005458-A/19: METHOD FOR SELECTING AN APTAMER
AAAAATCCCCC
>HV555544.1 JP 2012005458-A/18: METHOD FOR SELECTING AN APTAMER
AAACAACTCTC
>HV555543.1 JP 2012005458-A/17: METHOD FOR SELECTING AN APTAMER
AAAAAACCCAC
>HV555542.1 JP 2012005458-A/16: METHOD FOR SELECTING AN APTAMER
CGGAGTTTGTT
>HV555541.1 JP 2012005458-A/15: METHOD FOR SELECTING AN APTAMER
TATTTGTGCGG
>HV555540.1 JP 2012005458-A/14: METHOD FOR SELECTING AN APTAMER
CCGCCATTAAA
>HV555539.1 JP 2012005458-A/13: METHOD FOR SELECTING AN APTAMER
ATAGACCCACC
>HV555538.1 JP 2012005458-A/12: METHOD FOR SELECTING AN APTAMER
CGGAGTTTGTT
>HV555537.1 JP 2012005458-A/11: METHOD FOR SELECTING AN APTAMER
TATTTGTGCGG
>HV555536.1 JP 2012005458-A/10: METHOD FOR SELECTING AN APTAMER
CCGCCATTAAA
>HV555535.1 JP 2012005458-A/9: METHOD FOR SELECTING AN APTAMER
ATAGACCCACC
>HV555534.1 JP 2012005458-A/8: METHOD FOR SELECTING AN APTAMER
GGGGGTTTTTT
>HV555533.1 JP 2012005458-A/7: METHOD FOR SELECTING AN APTAMER
TTTTTGGGGGG
>HV555532.1 JP 2012005458-A/6: METHOD FOR SELECTING AN APTAMER
CCCCCAAAAAA
>HV555531.1 JP 2012005458-A/5: METHOD FOR SELECTING AN APTAMER
AAAAACCCCCC
>HV555530.1 JP 2012005458-A/4: METHOD FOR SELECTING AN APTAMER
GGGGGGGGGGG
>HV555529.1 JP 2012005458-A/3: METHOD FOR SELECTING AN APTAMER
TTTTTTTTTTT
>HV555528.1 JP 2012005458-A/2: METHOD FOR SELECTING AN APTAMER
CCCCCCCCCCC
>HV555527.1 JP 2012005458-A/1: METHOD FOR SELECTING AN APTAMER
AAAAAAAAAAA
>HV563254.1 JP 2011530288-A/1120: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTTGTAGTGTA
>HV563251.1 JP 2011530288-A/1117: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTGCATCGGGC
>HV563245.1 JP 2011530288-A/1111: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTGGTGCGAGG
>HV563243.1 JP 2011530288-A/1109: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGTTGTCGAC
>HV563238.1 JP 2011530288-A/1104: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGTTCACAGGG
>HV563221.1 JP 2011530288-A/1087: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATGAGGCCGGA
>HV563217.1 JP 2011530288-A/1083: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTCCCACTGTA
>HV563211.1 JP 2011530288-A/1077: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGAAACCTTCC
>HV563209.1 JP 2011530288-A/1075: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAGCCCATACA
>HV563207.1 JP 2011530288-A/1073: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTGTAGCACTC
>HV563198.1 JP 2011530288-A/1064: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCGGGACTCTC
>HV563195.1 JP 2011530288-A/1061: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTGAAAATCAA
>HV563190.1 JP 2011530288-A/1056: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTGCTCTTGGG
>HV563184.1 JP 2011530288-A/1050: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GACTGTGAGCT
>HV563181.1 JP 2011530288-A/1047: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTTAAATGGAA
>HV563179.1 JP 2011530288-A/1045: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAACTCAGCAG
>HV563178.1 JP 2011530288-A/1044: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGAGAGTGTAC
>HV563174.1 JP 2011530288-A/1040: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCTGTGACAAA
>HV563171.1 JP 2011530288-A/1037: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATTTAAATATG
>HV563167.1 JP 2011530288-A/1033: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGTAGTGAGGA
>HV563166.1 JP 2011530288-A/1032: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAGGAGACTTG
>HV563163.1 JP 2011530288-A/1029: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTATCTCGCCT
>HV563159.1 JP 2011530288-A/1025: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TGACATCATAT
>HV563154.1 JP 2011530288-A/1020: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGTTCTCTTCA
>HV563148.1 JP 2011530288-A/1014: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATGCTGTAGAC
>HV563144.1 JP 2011530288-A/1010: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CACTATTATCA
>HV563142.1 JP 2011530288-A/1008: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATGTAGACTGC
>HV563141.1 JP 2011530288-A/1007: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAACATGATGG
>HV563139.1 JP 2011530288-A/1005: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CACATCATCAC
>HV563135.1 JP 2011530288-A/1001: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAATTGGTAGA
>HV563123.1 JP 2011530288-A/989: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AACGCAAGTTG
>HV563122.1 JP 2011530288-A/988: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCCTTTATCCT
>HV563120.1 JP 2011530288-A/986: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATCTTGCTGAG
>HV563115.1 JP 2011530288-A/981: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTGCTACCACT
>HV563111.1 JP 2011530288-A/977: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCCTTTTGCTT
>HV563110.1 JP 2011530288-A/976: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CACACACATAC
>HV563107.1 JP 2011530288-A/973: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGTTAGGAGCC
>HV563105.1 JP 2011530288-A/971: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTTGAGGCTCA
>HV563101.1 JP 2011530288-A/967: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACGCCAGTCAA
>HV563099.1 JP 2011530288-A/965: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAGCCCTTCAG
>HV563098.1 JP 2011530288-A/964: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAAGCCCTTCA
>HV563097.1 JP 2011530288-A/963: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CAAAAGCCCTT
>HV563096.1 JP 2011530288-A/962: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCAAAAGCCCT
>HV563091.1 JP 2011530288-A/957: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAAAAGCTCCG
>HV563090.1 JP 2011530288-A/956: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CAGCGGCCAGT
>HV563087.1 JP 2011530288-A/953: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAAGCCCTTCA
>HV563086.1 JP 2011530288-A/952: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAGAAGCCCTT
>HV563084.1 JP 2011530288-A/950: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCAGCATGGCC
>HV563062.1 JP 2011530288-A/928: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GCCTGAAACAC
>HV563058.1 JP 2011530288-A/924: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TGCCGTTCAGG
>HV563051.1 JP 2011530288-A/917: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAGACCACCAC
>HV563033.1 JP 2011530288-A/899: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGAAGAGAGG
>HV563032.1 JP 2011530288-A/898: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GCTGGAGTGGT
>HV563004.1 JP 2011530288-A/870: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACTGCATTTGT
>HV563001.1 JP 2011530288-A/867: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AACATGGGCTG
>HV562992.1 JP 2011530288-A/858: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGCCCATACAG
>HV562987.1 JP 2011530288-A/853: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGGAAGAGGAC
>HV562986.1 JP 2011530288-A/852: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGTGAGGTTA
>HV562948.1 JP 2011530288-A/814: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GATGTAGCCGC
>HV562941.1 JP 2011530288-A/807: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AATCCTCCTGA
>HV562938.1 JP 2011530288-A/804: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCAGCCTAGAG
>HV562936.1 JP 2011530288-A/802: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GCTGCTGAACC
>HV562934.1 JP 2011530288-A/800: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTCCTCAAGCA
>HV562933.1 JP 2011530288-A/799: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AATGGCCCTGA
>HV562928.1 JP 2011530288-A/794: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ATCAGTTCTGC
>HV562912.1 JP 2011530288-A/778: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TGCTGACCTCA
>HV562902.1 JP 2011530288-A/768: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTTACCTGCGA
>HV562901.1 JP 2011530288-A/767: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GATGGGTTACC
>HV562889.1 JP 2011530288-A/755: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCTACAATTGG
>HV562875.1 JP 2011530288-A/741: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAAAGCTCCGG
>HV562872.1 JP 2011530288-A/738: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCTTCAGCGGC
>HV562871.1 JP 2011530288-A/737: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GCCCTTCAGCG
>HV562868.1 JP 2011530288-A/734: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTTCTCCCTGA
>HV562866.1 JP 2011530288-A/732: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGAAAGCCCT
>HV562859.1 JP 2011530288-A/725: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCTGCGGGTTT
>HV562857.1 JP 2011530288-A/723: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGTTCACGGCC
>HV562836.1 JP 2011530288-A/702: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTATTCAGTGG
>HV562835.1 JP 2011530288-A/701: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACTATTCAGTG
>HV562833.1 JP 2011530288-A/699: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACCCAAGCTTA
>HV562831.1 JP 2011530288-A/697: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGGTCGGAAC
>HV562821.1 JP 2011530288-A/687: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCTGTTTGTTC
>HV562806.1 JP 2011530288-A/672: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAGTGATATGG
>HV562801.1 JP 2011530288-A/667: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGAGGAAGAGG
>HV562796.1 JP 2011530288-A/662: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACAGCTACACC
>HV562792.1 JP 2011530288-A/658: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TGGTGATCTGG
>HV562791.1 JP 2011530288-A/657: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCAGAATTGCC
>HV562789.1 JP 2011530288-A/655: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TATCGGCATGC
>HV562780.1 JP 2011530288-A/646: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTGAGAAAGCT
>HV562772.1 JP 2011530288-A/638: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGAGAGAGAAA
>HV562765.1 JP 2011530288-A/631: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCTCTGAACAG
>HV562763.1 JP 2011530288-A/629: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGGAAAGTGAA
>HV562761.1 JP 2011530288-A/627: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TGAATTTCAGG
>HV562760.1 JP 2011530288-A/626: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTCTTTCTCTA
>HV562758.1 JP 2011530288-A/624: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
ACTCCCAATAA
>HV562756.1 JP 2011530288-A/622: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CAACCACATGC
>HV562749.1 JP 2011530288-A/615: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CATAAGTTGTG
>HV562740.1 JP 2011530288-A/606: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAATGTGGGTA
>HV562737.1 JP 2011530288-A/603: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CATGCTGCTGG
>HV562732.1 JP 2011530288-A/598: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CCAGAGCTGTG
>HV562726.1 JP 2011530288-A/592: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GTGAAACCTCA
>HV562721.1 JP 2011530288-A/587: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCTGTGAAGTG
>HV562694.1 JP 2011530288-A/560: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TAGTAGGGAGG
>HV562690.1 JP 2011530288-A/556: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AAAGAACTACT
>HV562689.1 JP 2011530288-A/555: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GAGAAAGTTTG
>HV562667.1 JP 2011530288-A/533: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TTCCAGCCCAC
>HV562643.1 JP 2011530288-A/509: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
AGCAAGGTTTA
>HV562190.1 JP 2011530288-A/56: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCTTCGGAGTT
>HV562183.1 JP 2011530288-A/49: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
TCTTCGGAGTT
>HV562177.1 JP 2011530288-A/43: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV562168.1 JP 2011530288-A/34: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CTACACAAATC
>HV562161.1 JP 2011530288-A/27: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CAGCGATTTTT
>HV562156.1 JP 2011530288-A/22: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV562153.1 JP 2011530288-A/19: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
CGGAGACAATG
>HV562143.1 JP 2011530288-A/9: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GGATCTTATTT
>HV562140.1 JP 2011530288-A/6: NUCLEIC ACID COMPOUNDS FOR INHIBITING BIRC5 GENE EXPRESSION AND USES THEREOF
GATTTCCATGT
>GZ225640.1 Sequence 5 from patent US 8148511
TCCCGGCGGGA
>GZ224941.1 Sequence 15 from patent US 8148341
CAGTTCGTCCA
>GZ222553.1 Sequence 2 from patent US 8148068
NNAGAAGCGGG
>GZ216680.1 Sequence 1 from patent US 8143037
GARACTGRTTT
>GZ216375.1 Sequence 49 from patent US 8143026
CCGCCACCATG
>GZ211505.1 Sequence 40 from patent US 8143022
GGGACATGATC
>GZ211504.1 Sequence 39 from patent US 8143022
TATTACCTGCC
>GZ211239.1 Sequence 3 from patent US 8143006
ATCGAGCCCTG
>GZ210759.1 Sequence 37 from patent US 8143002
NNTTTATTTNN
>GZ208830.1 Sequence 13 from patent US 8137974
TTTCATCCCTA
>GZ208829.1 Sequence 12 from patent US 8137974
TTTCATCCCTG
>GZ208524.1 Sequence 129 from patent US 8137961
WATCAANNNNR
>GZ207373.1 Sequence 22 from patent US 8137906
ACTGGGNNNNN
>GZ207372.1 Sequence 21 from patent US 8137906
ACTGGGNNNNN
>GZ207366.1 Sequence 11 from patent US 8137906
CGTCTCNNNNN
>GZ207365.1 Sequence 10 from patent US 8137906
GGTCTCNNNNN
>GZ207364.1 Sequence 9 from patent US 8137906
GGTCTCNNNNN
>GZ207363.1 Sequence 8 from patent US 8137906
CGTCTCNNNNN
>HV553508.1 JP 2011527568-A/314: COMPLEMENT ANTAGONISTS AND USES THEREOF
CTGCCTTTAGA
>HV553507.1 JP 2011527568-A/313: COMPLEMENT ANTAGONISTS AND USES THEREOF
CTGCCTCTAGA
>HV550474.1 JP 2011246467-A/36: A NEW METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES
GCGGTTTGCGG
>HV550458.1 JP 2011246467-A/20: A NEW METHOD FOR THE DIAGNOSIS AND PROGNOSIS OF MALIGNANT DISEASES
GGTGGTGGTGG
>GZ200686.1 Sequence 6 from patent US 8135720
TGGCTGTACGT
>GZ200685.1 Sequence 5 from patent US 8135720
ATGGCTGTACG
>GZ200684.1 Sequence 4 from patent US 8135720
TATGGCTGTAC
>GZ200683.1 Sequence 3 from patent US 8135720
CTATGGCTGTA
>GZ200682.1 Sequence 2 from patent US 8135720
CCTATGGCTGT
>GZ197664.1 Sequence 16 from patent US 8133719
TGAGCGATTCG
>GZ197663.1 Sequence 15 from patent US 8133719
CATTAACGGAC
>GZ190708.1 Sequence 22 from patent US 8129119
TGGTTGGAACC
>GZ187052.1 Sequence 83 from patent US 8128938
TACAATAAACG
>GZ187051.1 Sequence 82 from patent US 8128938
TACTCTAGACG
>GZ183186.1 Sequence 12 from patent US 8124747
TATGCCCGGAG
>GZ182957.1 Sequence 23 from patent US 8124734
GTGGTGAAGAC
>GZ182453.1 Sequence 21 from patent US 8124590
TCGAGCGTTCT
>GZ181476.1 Sequence 29 from patent US 8124361
GGGGACTTTCC
>GZ181068.1 Sequence 6 from patent US 8124343
CTCCGCAGCAG
>GZ181067.1 Sequence 5 from patent US 8124343
CTCCCCAGCAG
>HV544503.1 JP 2011225554-A/2: method for preparing pentamethylenediamine and method for preparing polyamide resin
ACCAAGCTGAT
>JA775331.1 Sequence 46 from Patent WO2012021794
CCTTATATATC
>JA778897.1 Sequence 31 from Patent EP2419537
GGCAATGTGAT
>GZ164102.1 Sequence 4 from patent US 8114983
TGTCAACGTAA
>GZ164101.1 Sequence 3 from patent US 8114983
GCCACCCAGTA
>GZ164100.1 Sequence 2 from patent US 8114983
ACACACAAGCT
>GZ159936.1 Sequence 662 from patent US 8114974
GCCAGACCTAC
>GZ159923.1 Sequence 649 from patent US 8114974
CYNNGGSSANC
>GZ159920.1 Sequence 646 from patent US 8114974
ARRARAAAGGN
>GZ159896.1 Sequence 622 from patent US 8114974
CAATNTCTNCK
>GZ159885.1 Sequence 611 from patent US 8114974
TTTYCACATGC
>GZ159881.1 Sequence 607 from patent US 8114974
AAANGGNARAM
>GZ159880.1 Sequence 606 from patent US 8114974
CRSGCYWGKGC
>GZ159875.1 Sequence 601 from patent US 8114974
YKNTTTWYYTC
>GZ159870.1 Sequence 596 from patent US 8114974
GNCCSARTNGC
>GZ159865.1 Sequence 591 from patent US 8114974
GNGCCRSNNTM
>GZ159840.1 Sequence 566 from patent US 8114974
TTKTTTTYTTC
>GZ159833.1 Sequence 559 from patent US 8114974
CAYAMRTGYNC
>GZ158449.1 Sequence 10 from patent US 8114850
GGTGGTGGTGG
>GZ157703.1 Sequence 88 from patent US 8114628
GGTTCGANTCC
>GZ152379.1 Sequence 1 from patent US 8114596
GCCNNNNNGGC
>GZ152247.1 Sequence 4 from patent US 8114591
AAAGGGGCGTC
>GZ151945.1 Sequence 130 from patent US 8114418
TNGAANGTTCG
>GZ151944.1 Sequence 129 from patent US 8114418
TNGAANGTTCG
>GZ151942.1 Sequence 127 from patent US 8114418
TCGAANGTTCG
>GZ151934.1 Sequence 119 from patent US 8114418
TNGACCGTTCG
>GZ151933.1 Sequence 118 from patent US 8114418
TNGAACGTTCG
>GZ151927.1 Sequence 112 from patent US 8114418
TCGACCGTTCG
>GZ151918.1 Sequence 103 from patent US 8114418
TCGAACGTTCG
>GZ139633.1 Sequence 67 from patent US 8110653
GGTCTCNNNNN
>GZ139549.1 Sequence 70 from patent US 8110560
GTAAGTCTGCC
>GZ139547.1 Sequence 68 from patent US 8110560
ATACTTACCTG
>GZ126571.1 Sequence 5676 from patent US 8110198
GTGGTGAAGAC
>GZ107149.1 Sequence 112 from patent US 8119369
ACCTNGAGACC
>GZ107148.1 Sequence 111 from patent US 8119369
GGTCTCNAGGT
>GZ106979.1 Sequence 6 from patent US 8119347
GGGGTTTTGGG
>GZ106683.1 Sequence 91 from patent US 8119340
ATTACTACTAC
>GZ106664.1 Sequence 54 from patent US 8119340
ACTTTGACTAC
>GZ106654.1 Sequence 35 from patent US 8119340
TGTGCGAGAGA
>GZ106648.1 Sequence 23 from patent US 8119340
ATTACTACTAC
>GZ106646.1 Sequence 20 from patent US 8119340
TGTGCGAGAGG
>GZ106637.1 Sequence 2 from patent US 8119340
TGTGCGAGACA
>JA772988.1 Sequence 117 from Patent EP2352830
GGATGAAGAAG
>JA772910.1 Sequence 39 from Patent EP2352830
CTTCTTCATCC
>GZ037019.1 Sequence 1 from patent US 8088575
ACGTACGACGT
>JA762067.1 Sequence 3 from Patent WO2012013932
VTVTVTVGGGG
>FM197025.2 Triticum aestivum GSS, clone HC-15_E05_A_035.ab1, genomic survey sequence
GCGTGAAAAAA
>JA760667.1 Sequence 14 from Patent WO2012012716
GTGCCTGCTGT
>JA759290.1 Sequence 53 from Patent EP2411542
TTTTTTTTTTT
>JA758914.1 Sequence 143 from Patent EP2412830
GACTTGATACC
>HV538521.1 JP 2011211938-A/57: Plasmid vector
GGCCTCTCAGC
>HV538516.1 JP 2011211938-A/52: Plasmid vector
TGGTCGTGTTG
>HV538515.1 JP 2011211938-A/51: Plasmid vector
GCCGGGGTTGT
>HV538513.1 JP 2011211938-A/49: Plasmid vector
GCGGTGGTGTG
>HV538511.1 JP 2011211938-A/47: Plasmid vector
GCGCTGGGGTG
>HV538207.1 JP 2011193844-A/15: Method to identify the variety and strain of Lactococcus lactis subsp
CTGACAAGTCT
>HV541214.1 WO 2011125467-A/57: Plasmid vector
GGCCTCTCAGC
>HV541209.1 WO 2011125467-A/52: Plasmid vector
TGGTCGTGTTG
>HV541208.1 WO 2011125467-A/51: Plasmid vector
GCCGGGGTTGT
>HV541206.1 WO 2011125467-A/49: Plasmid vector
GCGGTGGTGTG
>HV541204.1 WO 2011125467-A/47: Plasmid vector
GCGCTGGGGTG
>JA734762.1 Sequence 16 from Patent EP2407558
GCGTACCTGAC
>JA734756.1 Sequence 10 from Patent EP2407558
GAGGGACGTGC
>JA734751.1 Sequence 5 from Patent EP2407558
CCAATGTCGCC
>JA725914.1 Sequence 8 from Patent EP2405272
GGGAAATTCCC
>JA730906.1 Sequence 4 from Patent WO2011161413
CGGGCTTCTCG
>JA730905.1 Sequence 3 from Patent WO2011161413
GCCCGAAGAGC
>JA730904.1 Sequence 2 from Patent WO2011161413
CGAGAAGCGGC
>JA730903.1 Sequence 1 from Patent WO2011161413
GCTCTTCGCCG
>JA695676.1 Sequence 1551 from Patent WO2011154542
GCACTTGTAGC
>JA718848.1 Sequence 143 from Patent EP2402465
GACTTGATACC
>GY807129.1 Sequence 89332 from patent US 8084598
AGGGTGCCTTA
>GY790716.1 Sequence 72919 from patent US 8084598
GCCATGATGCC
>GY716743.1 Sequence 15 from patent US 8086410
ACCGAGATCTT
>GY716742.1 Sequence 14 from patent US 8086410
ACCGGAGATCT
>GY716741.1 Sequence 13 from patent US 8086410
ACCGNNNNNNT
>GY716740.1 Sequence 12 from patent US 8086410
ACCGGAGATCT
>GY716738.1 Sequence 10 from patent US 8086410
ACCGAGATCTT
>GY716737.1 Sequence 9 from patent US 8086410
ACCGGAGATCT
>GY716369.1 Sequence 53 from patent US 8084596
GGCCACCATGC
>GY716339.1 Sequence 3 from patent US 8084596
TGACTCAGCGC
>GY716338.1 Sequence 2 from patent US 8084596
GTTAAGTTAAC
>GY711499.1 Sequence 46 from patent US 8080393
NNGAATGCNNN
>GY711473.1 Sequence 20 from patent US 8080393
NNGCTGAGGNN
>GY711472.1 Sequence 19 from patent US 8080393
NNCCTCAGCNN
>GY711471.1 Sequence 18 from patent US 8080393
NNCCTCAGCNN
>GY711470.1 Sequence 17 from patent US 8080393
NNGCTGAGGNN
>GY711410.1 Sequence 42 from patent US 8080387
ANGANGANATG
>HV535364.1 WO 2011118682-A/69: Aptamer against NGF and use thereof
CGAAAGAAACT
>HV535363.1 WO 2011118682-A/68: Aptamer against NGF and use thereof
CGAACAAAACT
>HV535362.1 WO 2011118682-A/67: Aptamer against NGF and use thereof
TGAAAGAAACC
>HV535361.1 WO 2011118682-A/66: Aptamer against NGF and use thereof
TGAAAAAAACC
>HV535360.1 WO 2011118682-A/65: Aptamer against NGF and use thereof
CGAAMRAAACT
>HV535359.1 WO 2011118682-A/64: Aptamer against NGF and use thereof
TGAAARAAACC
>HV515174.1 JP 2011167100-A/14: PQQGDH-binding aptamer
TGGAACCTACC
>HV532372.1 JP 2011182797-A/7: Recombinant influenza viruses for vaccines and gene therapy
TATTAGTAGAA
>HV532080.1 JP 2011182795-A/143: Compositions and methods for detection of hepatitis A virus nucleic acid
GACTTGATACC
>GY707517.1 Sequence 246 from patent US 8076068
CAAGTTTCGAG
>GY707037.1 Sequence 43 from patent US 8075903
AGAGCTCTCTC
>GY659426.1 Sequence 1107 from patent US 8071539
CCGCCACCATG
>GY657679.1 Sequence 20 from patent US 8071312
CCTNNNNNAGG
>GY652645.1 Sequence 306 from patent US 8071107
GCCACCATGGA
>JA681523.1 Sequence 2 from Patent WO2011147931
ACAGCCAGCCG
>JA677442.1 Sequence 179 from Patent EP2393028
GAAGGAGCTGA
>JA677432.1 Sequence 169 from Patent EP2393028
GCATTCCTCAC
>JA677431.1 Sequence 168 from Patent EP2393028
GCATTCCTCAG
>JA677417.1 Sequence 154 from Patent EP2393028
AAAGGGAGCCA
>JA677406.1 Sequence 143 from Patent EP2393028
ACGTCGGAGAT
>JA677392.1 Sequence 129 from Patent EP2393028
GCACAGAGCAT
>JA677391.1 Sequence 128 from Patent EP2393028
GCACAGAGCAC
>JA677352.1 Sequence 89 from Patent EP2393028
GGACGAGTAGC
>JA677351.1 Sequence 88 from Patent EP2393028
GGACGAGTAGA
>JA677346.1 Sequence 83 from Patent EP2393028
TTCAGGTGGCT
>JA677312.1 Sequence 49 from Patent EP2393028
GGTGTCGGAAA
>JA677311.1 Sequence 48 from Patent EP2393028
GGTGTCGGAAC
>JA677300.1 Sequence 37 from Patent EP2393028
GAGCTGGTGAA
>JA677299.1 Sequence 36 from Patent EP2393028
GAGCTGGTGAG
>GY533061.1 Sequence 8 from patent US 8068992
TATCATCTTTG
>GY531609.1 Sequence 96 from patent US 8067571
GCGTTCTTCCG
>GY531608.1 Sequence 95 from patent US 8067571
ATAGTGCTCAT
>GY531607.1 Sequence 94 from patent US 8067571
TGCTCATACTC
>GY531604.1 Sequence 75 from patent US 8067571
TCTCAGATGGT
>GY531599.1 Sequence 66 from patent US 8067571
CTTCGATAGTG
>GY530600.1 Sequence 81 from patent US 8067544
TTACTATGATA
>GY523071.1 Sequence 143 from patent US 8063197
GACTTGATACC
>GY522485.1 Sequence 4008 from patent US 8063184
TCCGCGCGTCC
>GY522091.1 Sequence 3614 from patent US 8063184
GCCTCCCTCCA
>GY522034.1 Sequence 3557 from patent US 8063184
GTGGCAGCCCG
>GY522004.1 Sequence 3527 from patent US 8063184
GCGCGCCCTCT
>GY521841.1 Sequence 3364 from patent US 8063184
GCACCCCGGGC
>GY521811.1 Sequence 3334 from patent US 8063184
GCCCCAGCAGG
>GY520379.1 Sequence 1794 from patent US 8063184
ATTCTCTCAGA
>GY519333.1 Sequence 748 from patent US 8063184
GGGCCAGAGGG
>GY519300.1 Sequence 715 from patent US 8063184
GGGCCAGAGGG
>GY518869.1 Sequence 196 from patent US 8063184
GGGCCAGAGGG
>GY515111.1 Sequence 51 from patent US 8058415
GTCTCCCGAGA
>GY512147.1 Sequence 6 from patent US 8058030
NNNNNNNNNNC
>GY511604.1 Sequence 210 from patent US 8057993
NNNNNNNNANC
>GY511582.1 Sequence 144 from patent US 8057993
NNGNANNAGNC
>GY511416.1 Sequence 15 from patent US 8057806
TATTAGTAGAA
>GY511249.1 Sequence 92 from patent US 8055451
CCATTGCTACC
>GY511248.1 Sequence 91 from patent US 8055451
CGTACACATGC
>GY510677.1 Sequence 27 from patent US 8053630
GTAATGATTRC
>GY510676.1 Sequence 25 from patent US 8053630
GTAATGATTRC
>HV511731.1 JP 2011520444-A/4: Method for efficient exon (44) skipping in Duchenne Muscular Dystrophy and associate means
CTGTTGAGAAA
>HV511475.1 JP 2011521624-A/322: RNAse H-Based Assays Utilizing Modified RNA Monomers
ACTGGACCTGA
>HV510053.1 JP 2011155986-A/6: Methods of Producing and Sequencing Modified Polynucleotides
NNNNNNNNNNC
>JA669856.1 Sequence 13 from Patent WO2011138671
GAATTCAGATC
>JA666466.1 Sequence 238 from Patent WO2011139710
CCTGCGGGTTT
>JA666464.1 Sequence 236 from Patent WO2011139710
AGTTCACGGCC
>JA659920.1 Sequence 11 from Patent WO2011133142
GGTGGTGGTGG
>GY506550.1 Sequence 306 from patent US 8048431
GCCACCATGGA
>GY506114.1 Sequence 16 from patent US 8044264
CCGTTAAATTT
>GY506113.1 Sequence 15 from patent US 8044264
GTACTAAAACC
>GY504483.1 Sequence 1346 from patent US 8043829
GCAGAGTCCAC
>GY504481.1 Sequence 1344 from patent US 8043829
GGGTCGAGACG
>GY504306.1 Sequence 689 from patent US 8043829
GCAGAGTCCAC
>GY504305.1 Sequence 688 from patent US 8043829
TTATTGTATAC
>GY504304.1 Sequence 687 from patent US 8043829
TATGCGAGACG
>GY504303.1 Sequence 686 from patent US 8043829
GCAGAGAATTC
>GY504300.1 Sequence 683 from patent US 8043829
TGGTTGAGACG
>HV505170.1 JP 2011518552-A/45: PROSTATE CANCER-SPECIFIC ALTERATIONS IN ERG GENE EXPRESSION AND DETECTION AND TREATMENT METHODS BASED ON THOSE ALTERATIONS
AAAAAAAAAAA
>HV505169.1 JP 2011518552-A/44: PROSTATE CANCER-SPECIFIC ALTERATIONS IN ERG GENE EXPRESSION AND DETECTION AND TREATMENT METHODS BASED ON THOSE ALTERATIONS
AAAAATAAACA
>HV456145.1 JP 2011136997-A/125: CONSENSUS/ANCESTRAL IMMUNOGENS
GCCACCATGGA
>GY487721.1 Sequence 69 from patent US 8039443
CCCAGGCTACG
>GY487720.1 Sequence 66 from patent US 8039443
CACAGGCTACG
>GY487717.1 Sequence 63 from patent US 8039443
CACAGGCTACG
>GY487711.1 Sequence 50 from patent US 8039443
CACAGGCTACG
>GY482873.1 Sequence 81 from patent US 8030453
GGGGACTTTCC
>GY482557.1 Sequence 140 from patent US 8030285
AGCGCTAGGGG
>GY482551.1 Sequence 134 from patent US 8030285
TGCGCAAGGGG
>GY482487.1 Sequence 70 from patent US 8030285
CGAGCGTTCTC
>GY480368.1 Sequence 148 from patent US 8030066
GGCCTAAAGGG
>GY480365.1 Sequence 145 from patent US 8030066
GTTCCGAAGGG
>GY480357.1 Sequence 137 from patent US 8030066
GGCCTAAAGGG
>GY480356.1 Sequence 136 from patent US 8030066
GTTCCGAAGGG
>GY480355.1 Sequence 135 from patent US 8030066
GGCCATAAGGG
>GY480288.1 Sequence 64 from patent US 8030066
TAGGCCAAGGG
>GY480287.1 Sequence 63 from patent US 8030066
CGGAACAAGGG
>GY480264.1 Sequence 40 from patent US 8030066
GAATAAGGGCG
>GY480259.1 Sequence 35 from patent US 8030066
AAGGGCGAGCT
>GY473312.1 Sequence 36 from patent US 8029802
GTAAATCCTGT
>GY473140.1 Sequence 36 from patent US 8029784
GCGGTTTGCGG
>GY473126.1 Sequence 20 from patent US 8029784
GGTGGTGGTGG
>GY472746.1 Sequence 60 from patent US 8029764
CTGTTGTATTG
>GY472738.1 Sequence 52 from patent US 8029764
CAATATTTTGT
>JA609499.1 Sequence 462 from Patent EP2374814
ATGGGGGGGAG
>HV446320.1 WO 1998013524-A/23: Probe and method for detecting polynucleotide
NCCATGATTAC
>HV446309.1 WO 1998013524-A/12: Probe and method for detecting polynucleotide
NCCATGATTAC
>HV450036.1 WO 1999060025-A/10: Gene recombination antibody
CTTGGTGGAGG
>HV453382.1 WO 2000061744-A/7: Fetal genes
ACCGCCCTCCG
>HV446088.1 WO 1998008869-A/7: Hematopoietic stem cell growth factor (SCGF)
CTTTAGAGCAC
>HV445954.1 WO 1998007866-A/24: Infectious laryngotracheobronchitis virus-origin antigen protein
GATCCAGCATG
>HV445940.1 WO 1998007866-A/10: Infectious laryngotracheobronchitis virus-origin antigen protein
GATCCAGCATG
>HV452950.1 WO 2000050608-A/13: Novel polypeptide
CTTTAGAGCAC
>HV448858.1 WO 1999027117-A/19: Cold-induction expression vector
CCGGGGATCCG
>HV447587.1 WO 1998049284-A/16: Method for detecting and isolating nuclear transport protein
CTGCATGCACC
>HV450674.1 WO 2000006708-A/4: Novel polypeptide
CTTTAGAGCAC
>GY472615.1 Sequence 160 from patent US 8034994
AACCAATCTCG
>JA536947.1 Sequence 306 from Patent EP2371387
GCCACCATGGA
>JA532849.1 Sequence 2 from Patent WO2011113889
AATTTTTGGAG
>JA532842.1 Sequence 15 from Patent EP2371970
AGGAGCGGGAG
>JA532841.1 Sequence 14 from Patent EP2371970
TCCTCTCCCTC
>JA530545.1 Sequence 9 from Patent EP2340315
ACTACRGTCAA
>JA530544.1 Sequence 8 from Patent EP2340315
CGTACKAAGAG
>JA515087.1 Sequence 59 from Patent WO2011107456
TGACAATCCCC
>JA515082.1 Sequence 54 from Patent WO2011107456
GAGATTCCCAT
>GY444769.1 Sequence 1358 from patent US 8013142
TATTCTTCGTT
>GY444768.1 Sequence 1357 from patent US 8013142
TACTCATGCCA
>GY443800.1 Sequence 389 from patent US 8013142
TCCACCCTCAA
>GY441082.1 Sequence 109 from patent US 8012714
CTAACTGGGGA
>GY440986.1 Sequence 13 from patent US 8012714
CTAACTGGGGA
>GY438752.1 Sequence 1107 from patent US 8012464
CCGCCACCATG
>GY365479.1 Sequence 44 from patent US 8026352
TCATCTCGCGA
>GY360332.1 Sequence 4 from patent US 8025880
CAGTCAAGCTT
>GY360167.1 Sequence 13 from patent US 8024129
CTTGACTGCGA
>GY360160.1 Sequence 5 from patent US 8024129
CTTGACTGCGA
>GY360013.1 Sequence 11 from patent US 8022271
GGTGTGGWWWG
>GY358733.1 Sequence 156 from patent US 8022045
GCAGACCCCGC
>GY358708.1 Sequence 125 from patent US 8022045
AGGCCCCTGAG
>GY358568.1 Sequence 25 from patent US 8021883
ATACTGAACCA
>GY357596.1 Sequence 11 from patent US 8021839
CTACGGGAGGC
>GY351854.1 Sequence 31 from patent US 8017744
TTTTTTTTCCT
>GY351579.1 Sequence 300 from patent US 8017559
AGCTTGAATTC
>GY350088.1 Sequence 6 from patent US 8017331
CTCCGCAGCAG
>GY350087.1 Sequence 5 from patent US 8017331
CTCCCCAGCAG
>GY350046.1 Sequence 2 from patent US 8017328
GGCACCATTCA
>GY345820.1 Sequence 12 from patent US 8008459
GCTCTTCNNNN
>GY345817.1 Sequence 9 from patent US 8008459
GCTCTTCNNNN
>GY344353.1 Sequence 3 from patent US 8008023
GGGGACTTTCC
>GY344253.1 Sequence 43 from patent US 8008016
AAGCTTGAGTC
>GY344252.1 Sequence 42 from patent US 8008016
GACAAGAGCTC
>GY344251.1 Sequence 41 from patent US 8008016
GTTGATGAGTC
>GY344250.1 Sequence 40 from patent US 8008016
GACAAATCAAC
>GY343910.1 Sequence 35 from patent US 8008006
CCANNNNNTGG
>GY343350.1 Sequence 14 from patent US 8007814
CCAGCTCTTCG
>GY343349.1 Sequence 13 from patent US 8007814
CCAGATCTTCG
>HV444740.1 JP 2011514163-A/79: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
TTTCAGATGGT
>HV444738.1 JP 2011514163-A/77: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
ATTTGACAAAC
>HV444734.1 JP 2011514163-A/73: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
CGGGACAAGTG
>HV444730.1 JP 2011514163-A/69: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
ATCAGTCTGAT
>HV444716.1 JP 2011514163-A/55: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
CACAACCTACT
>HV444714.1 JP 2011514163-A/53: Compositions and Methods for Analysis of Nucleic Acid Molecules During Amplification Reactions
TACAACCTACT
>HV444320.1 JP 2011516031-A/133: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTGTGTATCGT
>HV444319.1 JP 2011516031-A/132: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTGTCTAGACT
>HV444318.1 JP 2011516031-A/131: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTCTACTATCT
>HV444317.1 JP 2011516031-A/130: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTCGAGTGAGT
>HV444316.1 JP 2011516031-A/129: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTCGACACGCT
>HV444315.1 JP 2011516031-A/128: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTCATCGTCGT
>HV444314.1 JP 2011516031-A/127: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTATACATAGT
>HV444313.1 JP 2011516031-A/126: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTAGTGTCACT
>HV444312.1 JP 2011516031-A/125: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTAGTCACTGT
>HV444311.1 JP 2011516031-A/124: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTAGCTAGCGT
>HV444310.1 JP 2011516031-A/123: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTACTGAGTCT
>HV444309.1 JP 2011516031-A/122: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTACTATAGAT
>HV444308.1 JP 2011516031-A/121: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTACGCGACAT
>HV444307.1 JP 2011516031-A/120: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTACACTGTAT
>HV444306.1 JP 2011516031-A/119: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GCTCTCTACGT
>HV444305.1 JP 2011516031-A/118: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GCGTCGTGTCT
>HV444304.1 JP 2011516031-A/117: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GCGTAGACTAT
>HV444303.1 JP 2011516031-A/116: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GAGAGAGACGT
>HV444302.1 JP 2011516031-A/115: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GAGACGTCGCT
>HV444301.1 JP 2011516031-A/114: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GACTAGCTAGT
>HV444300.1 JP 2011516031-A/113: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GACGTATGACT
>HV444299.1 JP 2011516031-A/112: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GACGCTGTCGT
>HV444298.1 JP 2011516031-A/111: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTGTGACGTGT
>HV444297.1 JP 2011516031-A/110: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTGTCGTGCGT
>HV444296.1 JP 2011516031-A/109: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTCTACAGCGT
>HV444295.1 JP 2011516031-A/108: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTCGTCGAGAT
>HV444294.1 JP 2011516031-A/107: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTCGAGTCTCT
>HV444293.1 JP 2011516031-A/106: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTCACGTACAT
>HV444292.1 JP 2011516031-A/105: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTATGTAGAGT
>HV444291.1 JP 2011516031-A/104: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTATCGACACT
>HV444290.1 JP 2011516031-A/103: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTATATGTCGT
>HV444289.1 JP 2011516031-A/102: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTAGTACTCAT
>HV444288.1 JP 2011516031-A/101: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTAGACAGACT
>HV444287.1 JP 2011516031-A/100: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTACGATATGT
>HV444286.1 JP 2011516031-A/99: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTACACGCTCT
>HV444285.1 JP 2011516031-A/98: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTGACTCAGT
>HV444284.1 JP 2011516031-A/97: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTCTCACGAT
>HV444283.1 JP 2011516031-A/96: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTCGCAGTGT
>HV444282.1 JP 2011516031-A/95: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTCAGCGACT
>HV444281.1 JP 2011516031-A/94: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTATAGTGCT
>HV444280.1 JP 2011516031-A/93: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTAGCTCTCT
>HV444279.1 JP 2011516031-A/92: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTACAGATAT
>HV444278.1 JP 2011516031-A/91: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGCGCTATACT
>HV444277.1 JP 2011516031-A/90: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGCGATCGTAT
>HV444276.1 JP 2011516031-A/89: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGCAGTACGCT
>HV444275.1 JP 2011516031-A/88: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGATCGTATAT
>HV444274.1 JP 2011516031-A/87: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGAGTCATCGT
>HV444273.1 JP 2011516031-A/86: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGAGAGTGTGT
>HV444272.1 JP 2011516031-A/85: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGAGACACTAT
>HV444271.1 JP 2011516031-A/84: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CATAGTCGCGT
>HV444270.1 JP 2011516031-A/83: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CAGTCTCTAGT
>HV444269.1 JP 2011516031-A/82: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CAGCGTACTGT
>HV444268.1 JP 2011516031-A/81: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACTATACTCT
>HV444267.1 JP 2011516031-A/80: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACTACGATGT
>HV444266.1 JP 2011516031-A/79: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACGTGTATAT
>HV444265.1 JP 2011516031-A/78: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACGCTACGAT
>HV444264.1 JP 2011516031-A/77: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACGCGAGTCT
>HV444263.1 JP 2011516031-A/76: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CACGAGACAGT
>HV444262.1 JP 2011516031-A/75: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATGTGACTACT
>HV444261.1 JP 2011516031-A/74: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATGCTACGTCT
>HV444260.1 JP 2011516031-A/73: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATCTGAGACGT
>HV444259.1 JP 2011516031-A/72: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATCTCTCGTAT
>HV444258.1 JP 2011516031-A/71: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATCGTCAGTCT
>HV444257.1 JP 2011516031-A/70: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATCGCTCACGT
>HV444256.1 JP 2011516031-A/69: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATATAGAGTAT
>HV444255.1 JP 2011516031-A/68: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATAGAGCTAGT
>HV444254.1 JP 2011516031-A/67: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATACTAGCACT
>HV444253.1 JP 2011516031-A/66: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATACGCGTGCT
>HV444252.1 JP 2011516031-A/65: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATACACACGAT
>HV444251.1 JP 2011516031-A/64: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTCTGTCTGT
>HV444250.1 JP 2011516031-A/63: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTCGCGCTAT
>HV444249.1 JP 2011516031-A/62: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTATGCACGT
>HV444248.1 JP 2011516031-A/61: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGCTGTCGACT
>HV444247.1 JP 2011516031-A/60: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGCTAGATACT
>HV444246.1 JP 2011516031-A/59: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGCGTGTGCGT
>HV444245.1 JP 2011516031-A/58: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGCGCACGAGT
>HV444244.1 JP 2011516031-A/57: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGCAGCGTAGT
>HV444243.1 JP 2011516031-A/56: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGATCTAGTCT
>HV444242.1 JP 2011516031-A/55: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGATACGCTGT
>HV444241.1 JP 2011516031-A/54: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGAGTATCTCT
>HV444240.1 JP 2011516031-A/53: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGAGTACAGAT
>HV444239.1 JP 2011516031-A/52: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGACGTGATCT
>HV444238.1 JP 2011516031-A/51: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGACATATAGT
>HV444237.1 JP 2011516031-A/50: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGACACTCACT
>HV444236.1 JP 2011516031-A/49: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTGTAGCGCT
>HV444235.1 JP 2011516031-A/48: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTGCTGTACT
>HV444234.1 JP 2011516031-A/47: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTGATCTCGT
>HV444233.1 JP 2011516031-A/46: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTCTATATAT
>HV444232.1 JP 2011516031-A/45: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTCACTAGCT
>HV444231.1 JP 2011516031-A/44: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTCACACTGT
>HV444230.1 JP 2011516031-A/43: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTAGTGATAT
>HV444229.1 JP 2011516031-A/42: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGTCTAGCAT
>HV444228.1 JP 2011516031-A/41: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGTCGCTGAT
>HV444227.1 JP 2011516031-A/40: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGCTCTCTCT
>HV444226.1 JP 2011516031-A/39: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGCGAGAGAT
>HV444225.1 JP 2011516031-A/38: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGATGAGTGT
>HV444224.1 JP 2011516031-A/37: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGAGCGCGCT
>HV444223.1 JP 2011516031-A/36: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACAGTGTCGAT
>HV444222.1 JP 2011516031-A/35: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACAGCTCGTGT
>HV444221.1 JP 2011516031-A/34: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACAGAGACTCT
>HV444220.1 JP 2011516031-A/33: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACAGACTATAT
>HV444219.1 JP 2011516031-A/32: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACAGACAGCGT
>HV444218.1 JP 2011516031-A/31: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACACTCATACT
>HV444217.1 JP 2011516031-A/30: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACACAGTGAGT
>HV444216.1 JP 2011516031-A/29: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTGTACGACGT
>HV444215.1 JP 2011516031-A/28: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTCGTACGTAT
>HV444214.1 JP 2011516031-A/27: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
GTACAGTACGT
>HV444213.1 JP 2011516031-A/26: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CTACTCGTAGT
>HV444212.1 JP 2011516031-A/25: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGTACGTCGAT
>HV444211.1 JP 2011516031-A/24: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGATACTACGT
>HV444210.1 JP 2011516031-A/23: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGACGAGTACT
>HV444209.1 JP 2011516031-A/22: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CGACGACGCGT
>HV444208.1 JP 2011516031-A/21: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
CAGTACGTACT
>HV444207.1 JP 2011516031-A/20: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ATAGTATACGT
>HV444206.1 JP 2011516031-A/19: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTGTAGTAGT
>HV444205.1 JP 2011516031-A/18: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTCGTACACT
>HV444204.1 JP 2011516031-A/17: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTAGACGTCT
>HV444203.1 JP 2011516031-A/16: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTACTACTAT
>HV444202.1 JP 2011516031-A/15: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGTACGAGAGT
>HV444201.1 JP 2011516031-A/14: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
AGACTCGACGT
>HV444200.1 JP 2011516031-A/13: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTCGCGTCGT
>HV444199.1 JP 2011516031-A/12: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTATACGAGT
>HV444198.1 JP 2011516031-A/11: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACTACGTCTCT
>HV444197.1 JP 2011516031-A/10: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGTAGATCGT
>HV444196.1 JP 2011516031-A/9: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGTACTGTGT
>HV444195.1 JP 2011516031-A/8: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGTACACACT
>HV444194.1 JP 2011516031-A/7: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGCGTCTAGT
>HV444193.1 JP 2011516031-A/6: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGAGTAGACT
>HV444192.1 JP 2011516031-A/5: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGACACGTAT
>HV444191.1 JP 2011516031-A/4: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACACTACTCGT
>HV444190.1 JP 2011516031-A/3: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACACGTAGTAT
>HV444189.1 JP 2011516031-A/2: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACACGACGACT
>HV444188.1 JP 2011516031-A/1: SYSTEM AND METHOD FOR IMPROVED PROCESSING OF NUCLEIC ACIDS FOR PRODUCTION OF SEQUENCABLE LIBRARIES
ACGACGTACGT
>HV445230.1 JP 2011516065-A/4: COMPOSITIONS AND USE OF EPAS1 INHIBITORS
TGTCAACGTAA
>HV445229.1 JP 2011516065-A/3: COMPOSITIONS AND USE OF EPAS1 INHIBITORS
GCCACCCAGTA
>HV445228.1 JP 2011516065-A/2: COMPOSITIONS AND USE OF EPAS1 INHIBITORS
ACACACAAGCT
>HV351613.1 JP 2011103889-A/4: MODULATION OF TELOMERE-INITIATED CELL SIGNALING
GATCGATCGAT
>HV351612.1 JP 2011103889-A/3: MODULATION OF TELOMERE-INITIATED CELL SIGNALING
CTAACCCTAAC
>HV351611.1 JP 2011103889-A/2: MODULATION OF TELOMERE-INITIATED CELL SIGNALING
GTTAGGGTTAG
>JA476358.1 Sequence 62 from Patent EP2329045
CAGGAGCACGG
>JA492379.1 Sequence 1 from Patent WO2011087707
TCCGTATGGTG
>JA505009.1 Sequence 17 from Patent WO2011098775
TTTGCAGGGCC
>JA488446.1 Sequence 39 from Patent EP2351766
GATCTATCTGC
>JA468949.1 Sequence 191 from Patent EP2357231
TCAGTCGCAGT
>JA468948.1 Sequence 190 from Patent EP2357231
TTGACTGTTGA
>JA468947.1 Sequence 189 from Patent EP2357231
TGCTGCTTGTG
>JA468946.1 Sequence 188 from Patent EP2357231
TGCTGCTTGTG
>JA468945.1 Sequence 187 from Patent EP2357231
TGCTGCTTGTG
>JA468944.1 Sequence 186 from Patent EP2357231
TGCTGCTGCTG
>JA468943.1 Sequence 185 from Patent EP2357231
TGCTGCCTTTG
>JA468942.1 Sequence 184 from Patent EP2357231
TGTTGTGTGAC
>JA468941.1 Sequence 183 from Patent EP2357231
TTGAACGACTT
>JA468940.1 Sequence 182 from Patent EP2357231
TGTTGTGTGAC
>JA468939.1 Sequence 181 from Patent EP2357231
TGCTGCTGCTG
>JA468938.1 Sequence 180 from Patent EP2357231
TGCTGCCTTTG
>JA468937.1 Sequence 179 from Patent EP2357231
TGTTGTGTGAC
>JA468936.1 Sequence 178 from Patent EP2357231
TGCTGCCTTTG
>JA468935.1 Sequence 177 from Patent EP2357231
TTGCTGAACGC
>JA468934.1 Sequence 176 from Patent EP2357231
TGCTTGAACGC
>JA468933.1 Sequence 175 from Patent EP2357231
TGCTGACGACT
>JA468932.1 Sequence 174 from Patent EP2357231
TGCGCTGAACT
>JA468931.1 Sequence 173 from Patent EP2357231
TGCGACTGACT
>JA468930.1 Sequence 172 from Patent EP2357231
TGCGAACGCTT
>JA468929.1 Sequence 171 from Patent EP2357231
TGACTGCGACT
>JA468928.1 Sequence 170 from Patent EP2357231
TGACGCTGACT
>JA468927.1 Sequence 169 from Patent EP2357231
TGGCTTGACGC
>JA468926.1 Sequence 168 from Patent EP2357231
AACTGTTGACC
>JA468925.1 Sequence 167 from Patent EP2357231
CTGAAGCTTGT
>JA468924.1 Sequence 166 from Patent EP2357231
CTGAAGCTTGT
>JA468923.1 Sequence 165 from Patent EP2357231
TGCTGCTTCTG
>JA468922.1 Sequence 164 from Patent EP2357231
TGCTGCTTCTG
>JA468921.1 Sequence 163 from Patent EP2357231
TGCCTTTGCTG
>JA468920.1 Sequence 162 from Patent EP2357231
TTCTGCTTCTG
>JA468919.1 Sequence 161 from Patent EP2357231
TGCTGCTTCTG
>JA468918.1 Sequence 160 from Patent EP2357231
TGCCTTTGCTG
>JA468917.1 Sequence 159 from Patent EP2357231
TTCTGCTTCTG
>JA468916.1 Sequence 158 from Patent EP2357231
GTCCTTGCTTG
>JA468915.1 Sequence 157 from Patent EP2357231
TGACGATGAGT
>JA468914.1 Sequence 156 from Patent EP2357231
TGCTGCTTCTG
>JA468913.1 Sequence 155 from Patent EP2357231
TGCTGCTTGTG
>JA468912.1 Sequence 154 from Patent EP2357231
TGAACGTGAAC
>JA468911.1 Sequence 153 from Patent EP2357231
TGAAGCTTGAA
>JA468910.1 Sequence 152 from Patent EP2357231
TGCTGCTGCTG
>JA468909.1 Sequence 151 from Patent EP2357231
CAACGAACCCT
>JA468908.1 Sequence 150 from Patent EP2357231
TGCTGCTTGTG
>JA468907.1 Sequence 149 from Patent EP2357231
TGCTGCTTGTG
>JA468906.1 Sequence 148 from Patent EP2357231
TGCTGCTTGTG
>JA468905.1 Sequence 147 from Patent EP2357231
TGCTGCCTTTG
>JA468904.1 Sequence 146 from Patent EP2357231
TGCTGCCTTTG
>JA468903.1 Sequence 145 from Patent EP2357231
TGCTGCCTTTG
>JA468902.1 Sequence 144 from Patent EP2357231
TGCTGCCTTTG
>JA468901.1 Sequence 143 from Patent EP2357231
TGCTGCCTTTG
>JA468900.1 Sequence 142 from Patent EP2357231
TGATGGAACGA
>JA468899.1 Sequence 141 from Patent EP2357231
TTGAACGACTT
>JA468898.1 Sequence 140 from Patent EP2357231
TTGTTGAACGA
>JA468897.1 Sequence 139 from Patent EP2357231
TTGACGATGAG
>JA468896.1 Sequence 138 from Patent EP2357231
TGATGAAGCTT
>JA468895.1 Sequence 137 from Patent EP2357231
GTTGAGGAACT
>JA468894.1 Sequence 136 from Patent EP2357231
TTGAGCTGGAC
>JA468893.1 Sequence 135 from Patent EP2357231
TGAGCGTGAAC
>JA468892.1 Sequence 134 from Patent EP2357231
TGCGAGACTGC
>JA468891.1 Sequence 133 from Patent EP2357231
TGTTGAACGAC
>JA468890.1 Sequence 132 from Patent EP2357231
TGTTGAGGAAC
>JA468889.1 Sequence 131 from Patent EP2357231
TGACGATGAGT
>JA468888.1 Sequence 130 from Patent EP2357231
TGGCTTGACGC
>JA468887.1 Sequence 129 from Patent EP2357231
TGAGCGTGAAC
>JA468886.1 Sequence 128 from Patent EP2357231
TGTTGAACGAC
>JA468885.1 Sequence 127 from Patent EP2357231
TGACTGATGAC
>JA468884.1 Sequence 126 from Patent EP2357231
GTTGAACGACT
>JA468883.1 Sequence 125 from Patent EP2357231
TGCGAGACTGC
>JA468882.1 Sequence 124 from Patent EP2357231
TGTTGAGGAAC
>JA468881.1 Sequence 123 from Patent EP2357231
TGATGAGGACT
>JA468880.1 Sequence 122 from Patent EP2357231
TGACGATGAGT
>JA468879.1 Sequence 121 from Patent EP2357231
TGCTGCTTGAA
>JA468878.1 Sequence 120 from Patent EP2357231
TGGCTTGACGC
>JA468877.1 Sequence 119 from Patent EP2357231
TGCTGCTTCTG
>JA468876.1 Sequence 118 from Patent EP2357231
TGCTGCTTCTG
>JA468875.1 Sequence 117 from Patent EP2357231
TGCTGCCTTTG
>JA468874.1 Sequence 116 from Patent EP2357231
TGCTGCTTCTG
>JA468873.1 Sequence 115 from Patent EP2357231
TGCCTTTGCTG
>JA468872.1 Sequence 114 from Patent EP2357231
TGCTGCCTTTG
>JA468871.1 Sequence 113 from Patent EP2357231
TTCTGCTTCTG
>JA468870.1 Sequence 112 from Patent EP2357231
GTCCTTGCTTG
>JA468869.1 Sequence 111 from Patent EP2357231
TGCTGCCTTTG
>JA468868.1 Sequence 110 from Patent EP2357231
TGCTGCCTTTG
>JA468867.1 Sequence 109 from Patent EP2357231
TGCTGCCTTTG
>JA468866.1 Sequence 108 from Patent EP2357231
TGCTGCCTTTG
>JA468865.1 Sequence 107 from Patent EP2357231
TGCTGCCTTTG
>JA468864.1 Sequence 106 from Patent EP2357231
TGCTGCCTTTG
>JA468863.1 Sequence 105 from Patent EP2357231
TGCTGCCTTTG
>JA468862.1 Sequence 104 from Patent EP2357231
TGCTGCCTTTG
>JA468861.1 Sequence 103 from Patent EP2357231
TGCTGCCTTTG
>JA468860.1 Sequence 102 from Patent EP2357231
AAGACTGAACT
>JA468859.1 Sequence 101 from Patent EP2357231
CCGACTTGGAC
>JA468858.1 Sequence 100 from Patent EP2357231
TCGACTTCCAG
>JA468857.1 Sequence 99 from Patent EP2357231
TTGGACTCCAG
>JA468856.1 Sequence 98 from Patent EP2357231
AACTGCTGGAT
>JA468855.1 Sequence 97 from Patent EP2357231
ACGTCTGACGA
>JA468854.1 Sequence 96 from Patent EP2357231
CGATGCGATGA
>JA468853.1 Sequence 95 from Patent EP2357231
ACTTTGACGAT
>JA468852.1 Sequence 94 from Patent EP2357231
ACGATTGTGAC
>JA468851.1 Sequence 93 from Patent EP2357231
CGTTGTGATGA
>JA468850.1 Sequence 92 from Patent EP2357231
CAACGACCTGT
>JA468849.1 Sequence 91 from Patent EP2357231
CAACGACCTGT
>JA468848.1 Sequence 90 from Patent EP2357231
AACGAACCGAC
>JA468847.1 Sequence 89 from Patent EP2357231
CCGATGCATCG
>JA468846.1 Sequence 88 from Patent EP2357231
TGTTGTGTGAC
>JA468845.1 Sequence 87 from Patent EP2357231
GCACACTTGTT
>JA468844.1 Sequence 86 from Patent EP2357231
CACTGTTGAGA
>JA468843.1 Sequence 85 from Patent EP2357231
AACTGTTGACC
>JA468842.1 Sequence 84 from Patent EP2357231
ATGCTGCGCTG
>JA468841.1 Sequence 83 from Patent EP2357231
ATGCTGCGCTG
>JA468840.1 Sequence 82 from Patent EP2357231
ATGCTGCGCTG
>JA468839.1 Sequence 81 from Patent EP2357231
CAACGACCTGT
>JA468838.1 Sequence 80 from Patent EP2357231
AACTGTTGACC
>JA468837.1 Sequence 79 from Patent EP2357231
CACTGTTGAGA
>JA468836.1 Sequence 78 from Patent EP2357231
CAACGACCTGT
>JA468835.1 Sequence 77 from Patent EP2357231
AACTGTTGACC
>JA468834.1 Sequence 76 from Patent EP2357231
CACTGTTGAGA
>JA468833.1 Sequence 75 from Patent EP2357231
AAAAAAAAAAA
>JA468832.1 Sequence 74 from Patent EP2357231
AGCACAACTGT
>JA468831.1 Sequence 73 from Patent EP2357231
CCGATGCATCG
>JA468830.1 Sequence 72 from Patent EP2357231
CCGATGCATCG
>JA468829.1 Sequence 71 from Patent EP2357231
CCGATGCATCG
>JA468828.1 Sequence 70 from Patent EP2357231
CCGATGCCGAC
>JA468827.1 Sequence 69 from Patent EP2357231
CCGATGCCGAC
>JA468826.1 Sequence 68 from Patent EP2357231
CCGATGCCGAC
>JA468825.1 Sequence 67 from Patent EP2357231
GTGCCTGATGA
>JA468824.1 Sequence 66 from Patent EP2357231
GTGCCTGATGA
>JA468823.1 Sequence 65 from Patent EP2357231
GTGCCTGATGA
>JA468822.1 Sequence 64 from Patent EP2357231
CCGATGCATCG
>JA468821.1 Sequence 63 from Patent EP2357231
CCGATGCCGAC
>JA468820.1 Sequence 62 from Patent EP2357231
GTGCCTGATGA
>JA468819.1 Sequence 61 from Patent EP2357231
TTGACGTTGAC
>JA468818.1 Sequence 60 from Patent EP2357231
TTGACGTTGAC
>JA468817.1 Sequence 59 from Patent EP2357231
TTGACGTTGAC
>JA468816.1 Sequence 58 from Patent EP2357231
TTGACGTTGAC
>JA468815.1 Sequence 57 from Patent EP2357231
TGTTCGAACAC
>JA468814.1 Sequence 56 from Patent EP2357231
TGTTGTTTGTG
>JA468813.1 Sequence 55 from Patent EP2357231
TGCTGCTTTTG
>JA468812.1 Sequence 54 from Patent EP2357231
TTGACTGATGA
>JA468811.1 Sequence 53 from Patent EP2357231
TGCTGCTTGAA
>JA468810.1 Sequence 52 from Patent EP2357231
TGATGAAGCTT
>JA468809.1 Sequence 51 from Patent EP2357231
TGTTGTTTGTG
>JA468808.1 Sequence 50 from Patent EP2357231
TGCTGCTTTTG
>JA468807.1 Sequence 49 from Patent EP2357231
AGTGTTTTCTG
>JA468806.1 Sequence 48 from Patent EP2357231
TGCGCGAACTT
>JA468805.1 Sequence 47 from Patent EP2357231
TGACGACTTGC
>JA468804.1 Sequence 46 from Patent EP2357231
TGACGACTGCT
>JA468803.1 Sequence 45 from Patent EP2357231
TGACGACGCTT
>JA468802.1 Sequence 44 from Patent EP2357231
TGCTGCTTCTG
>JA468801.1 Sequence 43 from Patent EP2357231
TGCTGCCTTTG
>JA468800.1 Sequence 42 from Patent EP2357231
TGCTGCTTCTG
>JA468799.1 Sequence 41 from Patent EP2357231
TGACGATGAGT
>JA468798.1 Sequence 40 from Patent EP2357231
TGCTGCCTTTG
>JA468797.1 Sequence 39 from Patent EP2357231
TGCTGCTTCTG
>JA468796.1 Sequence 38 from Patent EP2357231
TGCTGCTTCTG
>JA468795.1 Sequence 37 from Patent EP2357231
TGCTGCTTGTG
>JA468794.1 Sequence 36 from Patent EP2357231
TGCTGCTTGTG
>JA468793.1 Sequence 35 from Patent EP2357231
CTGAAGCTTGT
>JA468792.1 Sequence 34 from Patent EP2357231
GATTGTGACGT
>JA468791.1 Sequence 33 from Patent EP2357231
TGCTGCCTTTG
>JA468790.1 Sequence 32 from Patent EP2357231
TGCTGCTTGTG
>JA468789.1 Sequence 31 from Patent EP2357231
TGCTGCTTGTG
>JA468788.1 Sequence 30 from Patent EP2357231
TGTTGTGTGAC
>JA468787.1 Sequence 29 from Patent EP2357231
TGCTGCTTCTG
>JA468786.1 Sequence 28 from Patent EP2357231
TGCTGCTTCTG
>JA468785.1 Sequence 27 from Patent EP2357231
TGCTGCCTTTG
>JA468784.1 Sequence 26 from Patent EP2357231
TGCTGCCTTTG
>JA468783.1 Sequence 25 from Patent EP2357231
TGCTGCCTTTG
>JA468782.1 Sequence 24 from Patent EP2357231
TGCTGCTTCTG
>JA468781.1 Sequence 23 from Patent EP2357231
TGCTGCTTGTG
>JA468780.1 Sequence 22 from Patent EP2357231
TGCTGCTTGTG
>JA468779.1 Sequence 21 from Patent EP2357231
TGCTGCTTGTG
>JA468778.1 Sequence 20 from Patent EP2357231
TGCTGCCTTTG
>JA468777.1 Sequence 19 from Patent EP2357231
TGCTGCCTTTG
>JA468776.1 Sequence 18 from Patent EP2357231
TGCTGCCTTTG
>JA468775.1 Sequence 17 from Patent EP2357231
TGCTGCTTGTG
>JA468774.1 Sequence 16 from Patent EP2357231
TGCTGCTTGTG
>JA468773.1 Sequence 15 from Patent EP2357231
TGCTGCTTGTG
>JA468772.1 Sequence 14 from Patent EP2357231
TGCTGCTTGTG
>JA468771.1 Sequence 13 from Patent EP2357231
TGCTGCTTGTG
>JA468770.1 Sequence 12 from Patent EP2357231
ATGCTGCGCTG
>JA468769.1 Sequence 11 from Patent EP2357231
GTGCCTGATGA
>JA468768.1 Sequence 10 from Patent EP2357231
TTGACGTTGAC
>JA468767.1 Sequence 9 from Patent EP2357231
GTCCTTTGCTG
>JA468766.1 Sequence 8 from Patent EP2357231
TTCTGCTTCTG
>JA468765.1 Sequence 7 from Patent EP2357231
GTCCTTGCTTG
>JA468764.1 Sequence 6 from Patent EP2357231
TGCTGCCTTTG
>JA468763.1 Sequence 5 from Patent EP2357231
TGCTGCTTGTG
>JA468762.1 Sequence 4 from Patent EP2357231
GTCCTTTGCTG
>JA468761.1 Sequence 3 from Patent EP2357231
TGCTGCCTTTG
>JA468760.1 Sequence 2 from Patent EP2357231
TGCTGCCTTTG
>JA468759.1 Sequence 1 from Patent EP2357231
TTCTGCTTCTG
>JA467267.1 Sequence 5 from Patent EP2279411
CAGGGGCGGCT
>JA508528.1 Sequence 1 from Patent EP2342360
CTAACCCTAAC
>JA465201.1 Sequence 170 from Patent EP2338897
TTACTTAGTTA
>JA465200.1 Sequence 169 from Patent EP2338897
ACCACCTCCGG
>JA459884.1 Sequence 7 from Patent EP2345716
TATTAGTAGAA
>JA457091.1 Sequence 48 from Patent WO2011103274
GGTCAGGAGTT
>JA453531.1 Sequence 10 from Patent WO2011057119
GCCAATCCTAC
>JA412159.1 Sequence 8 from Patent WO2011067711
GTAAGAAATGA
>JA425407.1 Sequence 191 from Patent EP2348112
TCAGTCGCAGT
>JA425406.1 Sequence 190 from Patent EP2348112
TTGACTGTTGA
>JA425405.1 Sequence 189 from Patent EP2348112
TGCTGCTTGTG
>JA425404.1 Sequence 188 from Patent EP2348112
TGCTGCTTGTG
>JA425403.1 Sequence 187 from Patent EP2348112
TGCTGCTTGTG
>JA425402.1 Sequence 186 from Patent EP2348112
TGCTGCTGCTG
>JA425401.1 Sequence 185 from Patent EP2348112
TGCTGCCTTTG
>JA425400.1 Sequence 184 from Patent EP2348112
TGTTGTGTGAC
>JA425399.1 Sequence 183 from Patent EP2348112
TTGAACGACTT
>JA425398.1 Sequence 182 from Patent EP2348112
TGTTGTGTGAC
>JA425397.1 Sequence 181 from Patent EP2348112
TGCTGCTGCTG
>JA425396.1 Sequence 180 from Patent EP2348112
TGCTGCCTTTG
>JA425395.1 Sequence 179 from Patent EP2348112
TGTTGTGTGAC
>JA425394.1 Sequence 178 from Patent EP2348112
TGCTGCCTTTG
>JA425393.1 Sequence 177 from Patent EP2348112
TTGCTGAACGC
>JA425392.1 Sequence 176 from Patent EP2348112
TGCTTGAACGC
>JA425391.1 Sequence 175 from Patent EP2348112
TGCTGACGACT
>JA425390.1 Sequence 174 from Patent EP2348112
TGCGCTGAACT
>JA425389.1 Sequence 173 from Patent EP2348112
TGCGACTGACT
>JA425388.1 Sequence 172 from Patent EP2348112
TGCGAACGCTT
>JA425387.1 Sequence 171 from Patent EP2348112
TGACTGCGACT
>JA425386.1 Sequence 170 from Patent EP2348112
TGACGCTGACT
>JA425385.1 Sequence 169 from Patent EP2348112
TGGCTTGACGC
>JA425384.1 Sequence 168 from Patent EP2348112
AACTGTTGACC
>JA425383.1 Sequence 167 from Patent EP2348112
CTGAAGCTTGT
>JA425382.1 Sequence 166 from Patent EP2348112
CTGAAGCTTGT
>JA425381.1 Sequence 165 from Patent EP2348112
TGCTGCTTCTG
>JA425380.1 Sequence 164 from Patent EP2348112
TGCTGCTTCTG
>JA425379.1 Sequence 163 from Patent EP2348112
TGCCTTTGCTG
>JA425378.1 Sequence 162 from Patent EP2348112
TTCTGCTTCTG
>JA425377.1 Sequence 161 from Patent EP2348112
TGCTGCTTCTG
>JA425376.1 Sequence 160 from Patent EP2348112
TGCCTTTGCTG
>JA425375.1 Sequence 159 from Patent EP2348112
TTCTGCTTCTG
>JA425374.1 Sequence 158 from Patent EP2348112
GTCCTTGCTTG
>JA425373.1 Sequence 157 from Patent EP2348112
TGACGATGAGT
>JA425372.1 Sequence 156 from Patent EP2348112
TGCTGCTTCTG
>JA425371.1 Sequence 155 from Patent EP2348112
TGCTGCTTGTG
>JA425370.1 Sequence 154 from Patent EP2348112
TGAACGTGAAC
>JA425369.1 Sequence 153 from Patent EP2348112
TGAAGCTTGAA
>JA425368.1 Sequence 152 from Patent EP2348112
TGCTGCTGCTG
>JA425367.1 Sequence 151 from Patent EP2348112
CAACGAACCCT
>JA425366.1 Sequence 150 from Patent EP2348112
TGCTGCTTGTG
>JA425365.1 Sequence 149 from Patent EP2348112
TGCTGCTTGTG
>JA425364.1 Sequence 148 from Patent EP2348112
TGCTGCTTGTG
>JA425363.1 Sequence 147 from Patent EP2348112
TGCTGCCTTTG
>JA425362.1 Sequence 146 from Patent EP2348112
TGCTGCCTTTG
>JA425361.1 Sequence 145 from Patent EP2348112
TGCTGCCTTTG
>JA425360.1 Sequence 144 from Patent EP2348112
TGCTGCCTTTG
>JA425359.1 Sequence 143 from Patent EP2348112
TGCTGCCTTTG
>JA425358.1 Sequence 142 from Patent EP2348112
TGATGGAACGA
>JA425357.1 Sequence 141 from Patent EP2348112
TTGAACGACTT
>JA425356.1 Sequence 140 from Patent EP2348112
TTGTTGAACGA
>JA425355.1 Sequence 139 from Patent EP2348112
TTGACGATGAG
>JA425354.1 Sequence 138 from Patent EP2348112
TGATGAAGCTT
>JA425353.1 Sequence 137 from Patent EP2348112
GTTGAGGAACT
>JA425352.1 Sequence 136 from Patent EP2348112
TTGAGCTGGAC
>JA425351.1 Sequence 135 from Patent EP2348112
TGAGCGTGAAC
>JA425350.1 Sequence 134 from Patent EP2348112
TGCGAGACTGC
>JA425349.1 Sequence 133 from Patent EP2348112
TGTTGAACGAC
>JA425348.1 Sequence 132 from Patent EP2348112
TGTTGAGGAAC
>JA425347.1 Sequence 131 from Patent EP2348112
TGACGATGAGT
>JA425346.1 Sequence 130 from Patent EP2348112
TGGCTTGACGC
>JA425345.1 Sequence 129 from Patent EP2348112
TGAGCGTGAAC
>JA425344.1 Sequence 128 from Patent EP2348112
TGTTGAACGAC
>JA425343.1 Sequence 127 from Patent EP2348112
TGACTGATGAC
>JA425342.1 Sequence 126 from Patent EP2348112
GTTGAACGACT
>JA425341.1 Sequence 125 from Patent EP2348112
TGCGAGACTGC
>JA425340.1 Sequence 124 from Patent EP2348112
TGTTGAGGAAC
>JA425339.1 Sequence 123 from Patent EP2348112
TGATGAGGACT
>JA425338.1 Sequence 122 from Patent EP2348112
TGACGATGAGT
>JA425337.1 Sequence 121 from Patent EP2348112
TGCTGCTTGAA
>JA425336.1 Sequence 120 from Patent EP2348112
TGGCTTGACGC
>JA425335.1 Sequence 119 from Patent EP2348112
TGCTGCTTCTG
>JA425334.1 Sequence 118 from Patent EP2348112
TGCTGCTTCTG
>JA425333.1 Sequence 117 from Patent EP2348112
TGCTGCCTTTG
>JA425332.1 Sequence 116 from Patent EP2348112
TGCTGCTTCTG
>JA425331.1 Sequence 115 from Patent EP2348112
TGCCTTTGCTG
>JA425330.1 Sequence 114 from Patent EP2348112
TGCTGCCTTTG
>JA425329.1 Sequence 113 from Patent EP2348112
TTCTGCTTCTG
>JA425328.1 Sequence 112 from Patent EP2348112
GTCCTTGCTTG
>JA425327.1 Sequence 111 from Patent EP2348112
TGCTGCCTTTG
>JA425326.1 Sequence 110 from Patent EP2348112
TGCTGCCTTTG
>JA425325.1 Sequence 109 from Patent EP2348112
TGCTGCCTTTG
>JA425324.1 Sequence 108 from Patent EP2348112
TGCTGCCTTTG
>JA425323.1 Sequence 107 from Patent EP2348112
TGCTGCCTTTG
>JA425322.1 Sequence 106 from Patent EP2348112
TGCTGCCTTTG
>JA425321.1 Sequence 105 from Patent EP2348112
TGCTGCCTTTG
>JA425320.1 Sequence 104 from Patent EP2348112
TGCTGCCTTTG
>JA425319.1 Sequence 103 from Patent EP2348112
TGCTGCCTTTG
>JA425318.1 Sequence 102 from Patent EP2348112
AAGACTGAACT
>JA425317.1 Sequence 101 from Patent EP2348112
CCGACTTGGAC
>JA425316.1 Sequence 100 from Patent EP2348112
TCGACTTCCAG
>JA425315.1 Sequence 99 from Patent EP2348112
TTGGACTCCAG
>JA425314.1 Sequence 98 from Patent EP2348112
AACTGCTGGAT
>JA425313.1 Sequence 97 from Patent EP2348112
ACGTCTGACGA
>JA425312.1 Sequence 96 from Patent EP2348112
CGATGCGATGA
>JA425311.1 Sequence 95 from Patent EP2348112
ACTTTGACGAT
>JA425310.1 Sequence 94 from Patent EP2348112
ACGATTGTGAC
>JA425309.1 Sequence 93 from Patent EP2348112
CGTTGTGATGA
>JA425308.1 Sequence 92 from Patent EP2348112
CAACGACCTGT
>JA425307.1 Sequence 91 from Patent EP2348112
CAACGACCTGT
>JA425306.1 Sequence 90 from Patent EP2348112
AACGAACCGAC
>JA425305.1 Sequence 89 from Patent EP2348112
CCGATGCATCG
>JA425304.1 Sequence 88 from Patent EP2348112
TGTTGTGTGAC
>JA425303.1 Sequence 87 from Patent EP2348112
GCACACTTGTT
>JA425302.1 Sequence 86 from Patent EP2348112
CACTGTTGAGA
>JA425301.1 Sequence 85 from Patent EP2348112
AACTGTTGACC
>JA425300.1 Sequence 84 from Patent EP2348112
ATGCTGCGCTG
>JA425299.1 Sequence 83 from Patent EP2348112
ATGCTGCGCTG
>JA425298.1 Sequence 82 from Patent EP2348112
ATGCTGCGCTG
>JA425297.1 Sequence 81 from Patent EP2348112
CAACGACCTGT
>JA425296.1 Sequence 80 from Patent EP2348112
AACTGTTGACC
>JA425295.1 Sequence 79 from Patent EP2348112
CACTGTTGAGA
>JA425294.1 Sequence 78 from Patent EP2348112
CAACGACCTGT
>JA425293.1 Sequence 77 from Patent EP2348112
AACTGTTGACC
>JA425292.1 Sequence 76 from Patent EP2348112
CACTGTTGAGA
>JA425291.1 Sequence 75 from Patent EP2348112
AAAAAAAAAAA
>JA425290.1 Sequence 74 from Patent EP2348112
AGCACAACTGT
>JA425289.1 Sequence 73 from Patent EP2348112
CCGATGCATCG
>JA425288.1 Sequence 72 from Patent EP2348112
CCGATGCATCG
>JA425287.1 Sequence 71 from Patent EP2348112
CCGATGCATCG
>JA425286.1 Sequence 70 from Patent EP2348112
CCGATGCCGAC
>JA425285.1 Sequence 69 from Patent EP2348112
CCGATGCCGAC
>JA425284.1 Sequence 68 from Patent EP2348112
CCGATGCCGAC
>JA425283.1 Sequence 67 from Patent EP2348112
GTGCCTGATGA
>JA425282.1 Sequence 66 from Patent EP2348112
GTGCCTGATGA
>JA425281.1 Sequence 65 from Patent EP2348112
GTGCCTGATGA
>JA425280.1 Sequence 64 from Patent EP2348112
CCGATGCATCG
>JA425279.1 Sequence 63 from Patent EP2348112
CCGATGCCGAC
>JA425278.1 Sequence 62 from Patent EP2348112
GTGCCTGATGA
>JA425277.1 Sequence 61 from Patent EP2348112
TTGACGTTGAC
>JA425276.1 Sequence 60 from Patent EP2348112
TTGACGTTGAC
>JA425275.1 Sequence 59 from Patent EP2348112
TTGACGTTGAC
>JA425274.1 Sequence 58 from Patent EP2348112
TTGACGTTGAC
>JA425273.1 Sequence 57 from Patent EP2348112
TGTTCGAACAC
>JA425272.1 Sequence 56 from Patent EP2348112
TGTTGTTTGTG
>JA425271.1 Sequence 55 from Patent EP2348112
TGCTGCTTTTG
>JA425270.1 Sequence 54 from Patent EP2348112
TTGACTGATGA
>JA425269.1 Sequence 53 from Patent EP2348112
TGCTGCTTGAA
>JA425268.1 Sequence 52 from Patent EP2348112
TGATGAAGCTT
>JA425267.1 Sequence 51 from Patent EP2348112
TGTTGTTTGTG
>JA425266.1 Sequence 50 from Patent EP2348112
TGCTGCTTTTG
>JA425265.1 Sequence 49 from Patent EP2348112
AGTGTTTTCTG
>JA425264.1 Sequence 48 from Patent EP2348112
TGCGCGAACTT
>JA425263.1 Sequence 47 from Patent EP2348112
TGACGACTTGC
>JA425262.1 Sequence 46 from Patent EP2348112
TGACGACTGCT
>JA425261.1 Sequence 45 from Patent EP2348112
TGACGACGCTT
>JA425260.1 Sequence 44 from Patent EP2348112
TGCTGCTTCTG
>JA425259.1 Sequence 43 from Patent EP2348112
TGCTGCCTTTG
>JA425258.1 Sequence 42 from Patent EP2348112
TGCTGCTTCTG
>JA425257.1 Sequence 41 from Patent EP2348112
TGACGATGAGT
>JA425256.1 Sequence 40 from Patent EP2348112
TGCTGCCTTTG
>JA425255.1 Sequence 39 from Patent EP2348112
TGCTGCTTCTG
>JA425254.1 Sequence 38 from Patent EP2348112
TGCTGCTTCTG
>JA425253.1 Sequence 37 from Patent EP2348112
TGCTGCTTGTG
>JA425252.1 Sequence 36 from Patent EP2348112
TGCTGCTTGTG
>JA425251.1 Sequence 35 from Patent EP2348112
CTGAAGCTTGT
>JA425250.1 Sequence 34 from Patent EP2348112
GATTGTGACGT
>JA425249.1 Sequence 33 from Patent EP2348112
TGCTGCCTTTG
>JA425248.1 Sequence 32 from Patent EP2348112
TGCTGCTTGTG
>JA425247.1 Sequence 31 from Patent EP2348112
TGCTGCTTGTG
>JA425246.1 Sequence 30 from Patent EP2348112
TGTTGTGTGAC
>JA425245.1 Sequence 29 from Patent EP2348112
TGCTGCTTCTG
>JA425244.1 Sequence 28 from Patent EP2348112
TGCTGCTTCTG
>JA425243.1 Sequence 27 from Patent EP2348112
TGCTGCCTTTG
>JA425242.1 Sequence 26 from Patent EP2348112
TGCTGCCTTTG
>JA425241.1 Sequence 25 from Patent EP2348112
TGCTGCCTTTG
>JA425240.1 Sequence 24 from Patent EP2348112
TGCTGCTTCTG
>JA425239.1 Sequence 23 from Patent EP2348112
TGCTGCTTGTG
>JA425238.1 Sequence 22 from Patent EP2348112
TGCTGCTTGTG
>JA425237.1 Sequence 21 from Patent EP2348112
TGCTGCTTGTG
>JA425236.1 Sequence 20 from Patent EP2348112
TGCTGCCTTTG
>JA425235.1 Sequence 19 from Patent EP2348112
TGCTGCCTTTG
>JA425234.1 Sequence 18 from Patent EP2348112
TGCTGCCTTTG
>JA425233.1 Sequence 17 from Patent EP2348112
TGCTGCTTGTG
>JA425232.1 Sequence 16 from Patent EP2348112
TGCTGCTTGTG
>JA425231.1 Sequence 15 from Patent EP2348112
TGCTGCTTGTG
>JA425230.1 Sequence 14 from Patent EP2348112
TGCTGCTTGTG
>JA425229.1 Sequence 13 from Patent EP2348112
TGCTGCTTGTG
>JA425228.1 Sequence 12 from Patent EP2348112
ATGCTGCGCTG
>JA425227.1 Sequence 11 from Patent EP2348112
GTGCCTGATGA
>JA425226.1 Sequence 10 from Patent EP2348112
TTGACGTTGAC
>JA425225.1 Sequence 9 from Patent EP2348112
GTCCTTTGCTG
>JA425224.1 Sequence 8 from Patent EP2348112
TTCTGCTTCTG
>JA425223.1 Sequence 7 from Patent EP2348112
GTCCTTGCTTG
>JA425222.1 Sequence 6 from Patent EP2348112
TGCTGCCTTTG
>JA425221.1 Sequence 5 from Patent EP2348112
TGCTGCTTGTG
>JA425220.1 Sequence 4 from Patent EP2348112
GTCCTTTGCTG
>JA425219.1 Sequence 3 from Patent EP2348112
TGCTGCCTTTG
>JA425218.1 Sequence 2 from Patent EP2348112
TGCTGCCTTTG
>JA425217.1 Sequence 1 from Patent EP2348112
TTCTGCTTCTG
>JA431232.1 Sequence 42 from Patent WO2011097388
ATGCATGCATG
>JA442411.1 Sequence 27 from Patent WO2011097663
GGGGGCTGCCT
>JA416317.1 Sequence 27 from Patent EP2357253
GGGGGCTGCCT
>JA446325.1 Sequence 10 from Patent EP2363133
GATCGATCGAT
>JA446324.1 Sequence 9 from Patent EP2363133
CTAACCCTAAC
>JA446320.1 Sequence 5 from Patent EP2363133
GTTAGGGTTAG
>JA443891.1 Sequence 23 from Patent EP2361978
GAGAAGCCGAA
>JA443887.1 Sequence 19 from Patent EP2361978
AAGAGGGTGGC
>JA393381.1 Sequence 25 from Patent WO2011062777
GCGCCGGTCTG
>JA393380.1 Sequence 24 from Patent WO2011062777
GCGCCGGCTCA
>JA393379.1 Sequence 23 from Patent WO2011062777
ACGCCGGCTCG
>JA393378.1 Sequence 22 from Patent WO2011062777
GCACCAGTCTG
>JA393377.1 Sequence 21 from Patent WO2011062777
GCGTCGGCTCG
>JA393376.1 Sequence 20 from Patent WO2011062777
GCACCGGTCTG
>JA393375.1 Sequence 19 from Patent WO2011062777
ATGCCGGCTCA
>JA393374.1 Sequence 18 from Patent WO2011062777
ACGCAAACTCA
>JA393373.1 Sequence 17 from Patent WO2011062777
ACGCCGGCTCA
>JA393372.1 Sequence 16 from Patent WO2011062777
ACGCAAGCTCA
>GY342367.1 Sequence 5324 from patent US 8003775
GTGGTGAAGAC
>GY338653.1 Sequence 81 from patent US 8003347
GGGGACTTTCC
>GY337265.1 Sequence 130 from patent US 8003115
TNGAANGTTCG
>GY337264.1 Sequence 129 from patent US 8003115
TNGAANGTTCG
>GY337262.1 Sequence 127 from patent US 8003115
TCGAANGTTCG
>GY337254.1 Sequence 119 from patent US 8003115
TNGACCGTTCG
>GY337253.1 Sequence 118 from patent US 8003115
TNGAACGTTCG
>GY337247.1 Sequence 112 from patent US 8003115
TCGACCGTTCG
>GY337238.1 Sequence 103 from patent US 8003115
TCGAACGTTCG
>GY335838.1 Sequence 8 from patent US 7999149
CCATAAACCCC
>GY334842.1 Sequence 7 from patent US 7999091
CTCGTCGGATC
>GY334841.1 Sequence 6 from patent US 7999091
GATCCGACGAC
>GY334838.1 Sequence 3 from patent US 7999091
GTCGTCGGATC
>GY334837.1 Sequence 2 from patent US 7999091
GATCCGACGAC
>GY333520.1 Sequence 25 from patent US 7998938
GTTGAGTGTAG
>GY333513.1 Sequence 16 from patent US 7998938
GTTAGGGTTAG
>GY333512.1 Sequence 15 from patent US 7998938
TAGGGTTAGAC
>GY333504.1 Sequence 7 from patent US 7998938
GTGGAAGGCGG
>GY333080.1 Sequence 29 from patent US 7998904
TGGTACGAATT
>GY333020.1 Sequence 1 from patent US 7998734
AGATCTCCACC
>GY328202.1 Sequence 71 from patent US 7996157
ATACGCTGNCN
>GY328201.1 Sequence 70 from patent US 7996157
ATNCGCTGTCC
>GY328200.1 Sequence 69 from patent US 7996157
ATACNCTGNCC
>GY328199.1 Sequence 68 from patent US 7996157
NTACGCTGTCC
>GY328198.1 Sequence 67 from patent US 7996157
ATANGCTGTCC
>GY328197.1 Sequence 66 from patent US 7996157
ATACGNTCTCN
>GY328196.1 Sequence 65 from patent US 7996157
ANACGCTCTNC
>GY328195.1 Sequence 64 from patent US 7996157
NTACGCTNTCC
>GY328194.1 Sequence 63 from patent US 7996157
ATACGCTGTCC
>GY328193.1 Sequence 62 from patent US 7996157
ATACGCTGTCN
>GY328192.1 Sequence 61 from patent US 7996157
GNNAANCCATA
>GY328191.1 Sequence 60 from patent US 7996157
GGTAATCCTTA
>GY328190.1 Sequence 59 from patent US 7996157
GGTAATCCATA
>GY326510.1 Sequence 17 from patent US 7994301
AGCAGTCGGTA
>GY326509.1 Sequence 16 from patent US 7994301
AGCAGTCGGTA
>GY324947.1 Sequence 88 from patent US 7993872
GGTTCGANTCC
>HV345211.1 JP 2011510640-A/98: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
CGGCCCGCGGC
>HV345210.1 JP 2011510640-A/97: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
GCCGCGGGCCG
>HV345182.1 JP 2011510640-A/69: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
GGGTTTTTGGG
>HV345171.1 JP 2011510640-A/58: Nucleic acids of formula (I) (NuGlXmGnNv)a and derivatives thereof as an immune-stimulating agent/adjuvant
GGTTTTTTTGG
>HV340587.1 JP 2011101647-A/191: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV340586.1 JP 2011101647-A/190: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>HV340579.1 JP 2011101647-A/183: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNNTNNTTCTG
>HV340578.1 JP 2011101647-A/182: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>HV340577.1 JP 2011101647-A/181: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>HV340576.1 JP 2011101647-A/180: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TNGTNGTTCTG
>HV340575.1 JP 2011101647-A/179: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>HV340574.1 JP 2011101647-A/178: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV340573.1 JP 2011101647-A/177: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV340572.1 JP 2011101647-A/176: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTNGTTCTC
>HV340571.1 JP 2011101647-A/175: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>HV340570.1 JP 2011101647-A/174: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV340569.1 JP 2011101647-A/173: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV340568.1 JP 2011101647-A/172: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>HV340567.1 JP 2011101647-A/171: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCNTCNTTCTG
>HV340566.1 JP 2011101647-A/170: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTGTCNTTCTC
>HV340565.1 JP 2011101647-A/169: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV340554.1 JP 2011101647-A/158: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>HV340553.1 JP 2011101647-A/157: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>HV340548.1 JP 2011101647-A/152: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>HV340546.1 JP 2011101647-A/150: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>HV340542.1 JP 2011101647-A/146: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CTATCTGACGT
>HV340537.1 JP 2011101647-A/141: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
ACGTTCTCTGT
>HV340503.1 JP 2011101647-A/107: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
CCTACTAGCGT
>HV340499.1 JP 2011101647-A/103: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
GCGTTCTCATC
>HV340466.1 JP 2011101647-A/70: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>HV340465.1 JP 2011101647-A/69: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANGTTCT
>HV340458.1 JP 2011101647-A/62: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>HV340457.1 JP 2011101647-A/61: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNGTTCT
>HV340454.1 JP 2011101647-A/58: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTCNTTCT
>HV340453.1 JP 2011101647-A/57: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTTTNGTTCT
>HV340442.1 JP 2011101647-A/46: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>HV340437.1 JP 2011101647-A/41: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>HV340431.1 JP 2011101647-A/35: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGANNTTCT
>HV340430.1 JP 2011101647-A/34: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>HV340428.1 JP 2011101647-A/32: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACNTTCT
>HV340424.1 JP 2011101647-A/28: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTNNTTCT
>HV340423.1 JP 2011101647-A/27: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCNTTCT
>HV340422.1 JP 2011101647-A/26: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGTCGTTCT
>HV340417.1 JP 2011101647-A/21: MODULATION OF IMMUNOSTIMULATORY PROPERTIES OF OLIGONUCLEOTIDE-BASED COMPOUNDS BY UTILIZING MODIFIED IMMUNOSTIMULATORY DINUCLEOTIDES
TCTGACGTTCT
>HV347128.1 JP 2011511051-A/11: BIOLOGICAL MATERIALS AND USES THEREOF
GGTGGTGGTGG
>HV335456.1 JP 2011087567-A/3: Method for analyzing function of DNA in tissue constituting vascular bundle of plant
CTATAAATATC
>HV348156.1 JP 2011512821-A/87: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
ATCTTCCTCGC
>HV348155.1 JP 2011512821-A/86: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
AGCTTCCTGTA
>HV348154.1 JP 2011512821-A/85: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
TTCTTCCTATG
>HV348153.1 JP 2011512821-A/84: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
CCATTCCTAGG
>HV348152.1 JP 2011512821-A/83: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
AACTTCCTGTC
>HV348151.1 JP 2011512821-A/82: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
GCTCTCCTCGG
>HV348150.1 JP 2011512821-A/81: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
GCTCTCCTCCC
>HV348149.1 JP 2011512821-A/80: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
AACCTCCTCTC
>HV348148.1 JP 2011512821-A/79: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
GGTCTCCTAAA
>HV348147.1 JP 2011512821-A/78: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
AGTCTCCTTTC
>HV348146.1 JP 2011512821-A/77: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
ATGCTCCTACA
>HV348145.1 JP 2011512821-A/76: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
TGGCTCCTACC
>HV348144.1 JP 2011512821-A/75: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
ACGCTCCTGCT
>HV348121.1 JP 2011512821-A/52: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
CCTCGAGCGAC
>HV348120.1 JP 2011512821-A/51: Cold Shock Protein Compositions and Methods and Kits for the Use Thereof
AATCGAGCTGT
>GY319998.1 Sequence 25 from patent US 7985551
GCGCCGGTCTG
>GY319997.1 Sequence 24 from patent US 7985551
GCGCCGGCTCA
>GY319996.1 Sequence 23 from patent US 7985551
ACGCCGGCTCG
>GY319995.1 Sequence 22 from patent US 7985551
GCACCAGTCTG
>GY319994.1 Sequence 21 from patent US 7985551
GCGTCGGCTCG
>GY319993.1 Sequence 20 from patent US 7985551
GCACCGGTCTG
>GY319992.1 Sequence 19 from patent US 7985551
ATGCCGGCTCA
>GY319991.1 Sequence 18 from patent US 7985551
ACGCAAACTCA
>GY319990.1 Sequence 17 from patent US 7985551
ACGCCGGCTCA
>GY319989.1 Sequence 16 from patent US 7985551
ACGCAAGCTCA
>GY319870.1 Sequence 3 from patent US 7985547
NNNNNGAAGAG
>GY319869.1 Sequence 2 from patent US 7985547
CTCTTCNNNNN
>GY314974.1 Sequence 10 from patent US 7981604
AAAAAAAAAAA
>GY312279.1 Sequence 4 from patent US 7989613
GGGTCTGGCCC
>GY311455.1 Sequence 21 from patent US 7989603
GTTGAGTGTAG
>GY311454.1 Sequence 20 from patent US 7989603
GTTAGGGTTAG
>GY311451.1 Sequence 17 from patent US 7989603
GTTGAGTGTAG
>GY311450.1 Sequence 16 from patent US 7989603
GTTAGGGTTAG
>GY311279.1 Sequence 25 from patent US 7989428
GTTGAGTGTAG
>GY311272.1 Sequence 16 from patent US 7989428
GTTAGGGTTAG
>GY311271.1 Sequence 15 from patent US 7989428
TAGGGTTAGAC
>GY311263.1 Sequence 7 from patent US 7989428
GTGGAAGGCGG
>GY310723.1 Sequence 71 from patent US 7989185
GTAGGAAGGTG
>GY310714.1 Sequence 61 from patent US 7989185
GAAACCCATGG
>GY310709.1 Sequence 56 from patent US 7989185
AGACCTTGGTT
>GY310708.1 Sequence 51 from patent US 7989185
TCCAGAAATAG
>GY310667.1 Sequence 9 from patent US 7989185
ACCAAGAATAG
>GY310664.1 Sequence 5 from patent US 7989185
GTGGAAGGATG
>HV322525.1 WO 2011048852-A/4: pectin lyase, enzymatic preparation, method for converting plant into single-celled form
TCCGGCTCTGC
>HV332159.1 JP 2011505824-A/21: Improved chimeric Meganuclease Enzymes and uses thereof
AAGTTCCGGCG
>HV332158.1 JP 2011505824-A/20: Improved chimeric Meganuclease Enzymes and uses thereof
ANNNTCCNNNG
>HV332010.1 JP 2011505798-A/57: RNA ANTAGONIST COMPOUNDS FOR THE MODULATION OF MCL-1
TAGCACCATGG
>HV323391.1 WO 2011046214-A/3: Methylated DNA binding peptide
GGGGCGGGGCC
>HV323390.1 WO 2011046214-A/2: Methylated DNA binding peptide
GGCCCCGCCCC
>HV323389.1 WO 2011046214-A/1: Methylated DNA binding peptide
GGGGCGGGGCC
>HV043090.1 JP 2009132737-A/42: NUCLEIC ACID COMPOSITIONS FOR STIMULATING IMMUNE RESPONSES
TCGGTCGTTTT
>HV041853.1 JP 2009114198-A/44: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ACACAGAAGGG
>HV041851.1 JP 2009114198-A/42: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CTCCAGTCCAG
>HV041850.1 JP 2009114198-A/41: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCTAGCTCCA
>HV041849.1 JP 2009114198-A/40: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TCACAGGCTCA
>HV041848.1 JP 2009114198-A/39: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCCAGGAGGG
>HV041847.1 JP 2009114198-A/38: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TTTCAGATCCA
>HV041846.1 JP 2009114198-A/37: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ACGCAGTGCAA
>HV041845.1 JP 2009114198-A/36: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCCCAGGCGAC
>HV041844.1 JP 2009114198-A/35: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
ATACAGGGGAT
>HV041843.1 JP 2009114198-A/34: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CACAGGTATTA
>HV041842.1 JP 2009114198-A/33: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGCTGGTGAGT
>HV041841.1 JP 2009114198-A/32: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
GCCAGGTACAG
>HV041840.1 JP 2009114198-A/31: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
AGCAGGTGGGC
>HV041839.1 JP 2009114198-A/30: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
GGAAGGTCAGT
>HV041838.1 JP 2009114198-A/29: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGGAGGTACCA
>HV041837.1 JP 2009114198-A/28: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CCGAGGTGAGC
>HV041836.1 JP 2009114198-A/27: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
CAGTCGTGAGG
>HV041835.1 JP 2009114198-A/26: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
TGGAGGTGAGA
>HV041834.1 JP 2009114198-A/25: MN/CA IX-SPECIFIC MONOCLONAL ANTIBODIES GENERATED FROM MN/CA IX-DEFICIENT MICE AND METHODS OF USE
AGAAGGTAAGT
>HV187299.1 JP 2005528713-A/37: METHOD FOR SOLVING FREQUENCY, FREQUENCY DISTRIBUTION AND SEQUENCE-MATCHING PROBLEMS
TATAACGTATT
>HV187290.1 JP 2005528713-A/28: METHOD FOR SOLVING FREQUENCY, FREQUENCY DISTRIBUTION AND SEQUENCE-MATCHING PROBLEMS
ATTAGACACGG
>HV187281.1 JP 2005528713-A/19: METHOD FOR SOLVING FREQUENCY, FREQUENCY DISTRIBUTION AND SEQUENCE-MATCHING PROBLEMS
GGATACGTCGT
>HV187272.1 JP 2005528713-A/10: METHOD FOR SOLVING FREQUENCY, FREQUENCY DISTRIBUTION AND SEQUENCE-MATCHING PROBLEMS
CGTATAACGTA
>HV199375.1 JP 2001510985-A/10: Human telomerase catalytic subunit
RGGGRMTYYCC
>HV199374.1 JP 2001510985-A/9: Human telomerase catalytic subunit
TGGGCTTCCCC
>HV199257.1 JP 2001505412-A/21: Encapsulation of polypeptides within the starch matrix
AGATAATGCAG
>HV201913.1 JP 2000037146-A/7: Plant having modified androecium cell
ATGCATCTAAT
>HV195560.1 JP 2000515006-A/3: Sequencing by linking code adapter
NRRGATCYNNN
>HV195268.1 JP 1999225761-A/17: Oligonucleotide probe and method for determing the presence of prokaryote using the same
CCGTAAACGAT
>HV195264.1 JP 1999225761-A/13: Oligonucleotide probe and method for determing the presence of prokaryote using the same
TAATACCGCAT
>HV192732.1 JP 2000511414-A/8: Recombinant neospora antigens and their uses
AAGTCAACGCG
>HV192731.1 JP 2000511414-A/7: Recombinant neospora antigens and their uses
AGTCAAACGCG
>HV201374.1 JP 1999332565-A/3: Plant ubiquitin promoter system
GGTGTGGTTTG
>HV201373.1 JP 1999332565-A/2: Plant ubiquitin promoter system
GGTGTGGAAAG
>HV208593.1 JP 2002503671-A/1: Oligodeoxyribonucleotides comprising O6-benzylguanine and their use
TGTGAGCTGTG
>HV234063.1 JP 2009504192-A/153: HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
GATCGATCTGG
>HV234062.1 JP 2009504192-A/152: HUMAN RIBOSOMAL DNA (rDNA) AND RIBOSOMAL RNA (rRNA) NUCLEIC ACIDS AND USES THEREOF
GATCGATGTGG
>HV208472.1 JP 2002500040-A/2: Extension of cellular lifespan, methods and reagents
TTAGGSCCTAA
>HV227533.1 JP 2003125789-A/18: Recombinant Bone Morphogenetic Protein
TCGACTGGTTT
>HV221636.1 JP 2003509064-A/165: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
TGTCATCCAAG
>HV221635.1 JP 2003509064-A/164: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
CTTGGATGACA
>HV221634.1 JP 2003509064-A/163: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
TGTCACCCAAG
>HV221633.1 JP 2003509064-A/162: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
CTTGGGTGACA
>HV221632.1 JP 2003509064-A/161: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GCAGCTGCTCA
>HV221631.1 JP 2003509064-A/160: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
TGAGCAGCTGC
>HV221630.1 JP 2003509064-A/159: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GCAGCCGCTCA
>HV221629.1 JP 2003509064-A/158: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
TGAGCGGCTGC
>HV221628.1 JP 2003509064-A/157: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GGCTCTCTCAC
>HV221627.1 JP 2003509064-A/156: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GTGAGAGAGCC
>HV221626.1 JP 2003509064-A/155: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GGCTCCCTCAC
>HV221625.1 JP 2003509064-A/154: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
GTGAGGGAGCC
>HV221624.1 JP 2003509064-A/153: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
AATGGTGAATT
>HV221623.1 JP 2003509064-A/152: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
AATTCACCATT
>HV221622.1 JP 2003509064-A/151: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
AATGGCGAATT
>HV221621.1 JP 2003509064-A/150: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
AATTCGCCATT
>HV221620.1 JP 2003509064-A/149: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
AGGCTAGGGGG
>HV221619.1 JP 2003509064-A/148: Polymorphisms in the human hPXR gene and their use in diagnostic and therapeutic applications
CCCCCTAGCCT
